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 i 
Abstract 
 
Whey protein fractionation is an important industrial process that requires effective 
large-scale processes. Although packed bed chromatography has been used 
extensively, it suffers from low processing rates due to high back-pressures 
generated at high flow rates. Batch chromatography has been applied but generally 
has a low efficiency. More recently, adsorptive membranes have shown great 
promise for large-scale protein purification, particularly from large-volume dilute 
feedstocks. A new method for producing versatile adsorptive membranes by 
combining membrane and chromatographic resin matrices has been developed but 
not previously applied to whey protein fractionation. In this work, a series of mixed 
matrix membranes (MMMs) were developed for membrane chromatography using 
ethylene vinyl alcohol (EVAL) based membranes and various types of adsorbent 
resin. The feasibility of MMM was tested in bovine whey protein fractionation 
processes. 
 
Flat sheet anion exchange MMMs were cast using EVAL and crushed Lewatit® 
MP500 (Lanxess, Leverkusen, Germany) anion resin, expected to bind the acidic 
whey proteins β-lactoglobulin (β-Lac), α-lactalbumin (α-Lac) and bovine serum 
albumin (BSA). The MMM showed a static binding capacity of 120 mg β-Lac g-1 
membrane (36 mg β-Lac mL-1 membrane)  and 90 mg α-Lac g-1 membrane (27 mg α-
Lac mL-1 membrane). It had a selective binding towards β-Lac in whey with a 
binding preference order of β-Lac > BSA > α-Lac. In batch whey fractionation, 
average binding capacities of 75.6 mg β-Lac g-1 membrane, 3.5 mg α-Lac g-1 
membrane and 0.5 mg BSA g-1 membrane were achieved with a β-Lac elution 
recovery of around 80%.  
 
Crushed SP Sepharose™ Fast Flow (GE Healthcare Technologies, Uppsala, Sweden) 
resin was used as an adsorbent particle in preparing cation exchange MMMs for 
lactoferrin (LF) recovery from whey. The static binding capacity of the cationic 
MMM was 384 mg LF g-1membrane or 155 mg LF mL-1 membrane, exceeding the 
capacity of several commercial adsorptive membranes. Adsorption of lysozyme onto 
the embedded ion exchange resin was visualized by confocal laser scanning 
 ii 
microscopy. In LF isolation from whey, cross-flow operation was used to minimize 
membrane fouling and to enhance the protein binding capacity. LF recovery as high 
as of 91% with a high purity (as judged by the presence of a single band in gel 
electrophoresis) was achieved from 150 mL feed whey.  
 
The MMM preparation concept was extended, for the first time, to produce a 
hydrophobic interaction membrane using crushed Phenyl Sepharose™ (GE 
Healthcare Technologies, Uppsala, Sweden) resin and tested for the feasibility in 
whey protein fractionation. Phenyl Sepharose MMM showed binding capacities of 
20.54 mg mL-1 of β-Lac, 45.58 mg mL-1 of α-Lac, 38.65 mg mL-1 of BSA and 42.05 
mg mL-1 of LF for a pure protein solution (binding capacity values given on a 
membrane volume basis). In flow through whey fractionation, the adsorption 
performance of the Phenyl Sepharose MMM was similar to the HiTrap™ Phenyl 
hydrophobic interaction chromatography column. However, in terms of processing 
speed and low pressure drop across the column, the benefits of using MMM over a 
packed bed column were clear. 
 
A novel mixed mode interaction membrane was synthesized in a single membrane by 
incorporating a certain ratio of SP Sepharose cation resin and Lewatit MP500 anion 
resin into an EVAL base polymer solution. The mixed mode cation and anion 
membrane chromatography developed was able to bind basic and acidic proteins 
simultaneously from a solution. Furthermore, the ratio of the different types of 
adsorptive resin incorporated into the membrane matrix could be customised for 
protein recovery from a specific feedstream. The customized mixed mode MMM 
consisting of 42.5 wt% of MP500 anionic resin and 7.5 wt% SP Sepharose cationic 
resin showed a binding capacity of 7.16 mg α-Lac g-1 membrane, 11.40 mg LF g-1 
membrane, 59.21 mg β-Lac g-1 membrane and 6.79 mg IgG g-1 membrane from 
batch fractionation of 1 mL LF-spiked whey. A tangential flow process using this 
membrane was predicted to be able to produce 125 g total whey protein per L 
membrane per h. 
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length of the block is about 220 mm with 45 mm equal width and 
height. Each edge of the block was milled to have different recess 
thicknesses of 200, 300, 400 and 500 µm. 
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Figure 3-3: Chromatogram for whey assayed using Resource RPC 1 mL 
reverse phase chromatography. Abbreviation: α-Lac- α- lactalbumin, 
LF- lactoferrin, BSA - bovine serum albumin, β-Lac - β-
lactoglobulin, IgG - immunoglobulin. 
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Figure 3-4: Typical SDS-PAGE for whey protein run under (a) non-
reducing and (b) reducing condition. 
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Figure 3-5: AKTAcrossflow™ tangential flow filtration system. 
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which give an effective membrane area of 50 cm2. 
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Figure 4-1: Structure of EVAL and mixed matrix membranes. (a) EVAL 
membrane cross section; (b) EVAL membrane top surface; (c) 
EVAL membrane bottom surface; (d) MMM cross section; (e) 
MMM top surface; (f) MMM bottom surface. 
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Figure 4-2: Binding capacity of intact MP500 Lewatit anion exchange 
resin for β-Lac at various pH values. Error bars are ± one standard 
deviation (n=3). 
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Figure 4-3: Static binding capacity of intact and ground MP500 resin for 
a range of β-Lac and α-Lac solution concentrations at pH 6 and room 
temperature (20°C). Error bars are ± one standard deviation (n=3). 
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Figure 4-4: Static binding capacity of an EVAL membrane and a MMM 
for β-Lac and α-Lac. For β-Lac (salt) and α-Lac (salt) data, the 
conductivity of the binding buffer was the same as that of a typical 
whey solution (6.14 mS cm-1). All measurements were at pH 6 and 
room temperature (20°C). Error bars are ± one standard deviation 
(n=3). 
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Figure 4-5: Individual protein bound onto anion exchange MMM using a 
1 mL of whey solution with different initial concentration. Whey 
was diluted with the binding buffer in a serial dilution. Error bars are 
± one standard deviation (n=3). 
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Figure 4-6: Individual protein bound onto anion exchange MMM using a 
1 mL of simulated whey solution with different initial of β-Lac 
concentration. The concentration of α-Lac and BSA was kept 
constant at 1.2 mg mL-1 and 0.15 mg mL-1 respectively. Error bars 
are ± one standard deviation (n=3). 
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Figure 4-7: Effect of flow rate on the β-Lac dynamic binding capacity of 
MMM chromatography for pure (salt-free) protein solution of 3 mg 
mL-1 and 4 mg mL-1, whey and a pure protein solution 3 mg mL-1 
having the same conductivity as whey (6.14 mS cm-1). All 
measurements were at pH 6 and room temperature (20°C). Error bars 
are ± one standard deviation (n=3). 
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Figure 5-1: Adsorption and desorption of lysozyme on Amberlite and 
Lewatit cation exchange resins. The binding buffer was 20 mM 
sodium phosphate, pH 6.0 (no salt) and the elution buffer was 1 M 
NaCl in binding buffer. A triplicate sample was used for each resin. 
Error bars are ± one standard deviation (n = 3). 
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Figure 5-2: CLSM images of a cation exchange MMM at increasing 
depths through the membrane. LZY was labeled with FITC dye, 
showing binding to the SP Sepharose resin particles within the 
membrane matrix. 
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Figure 5-3: Static (equilibrium) binding capacities of intact and ground 
SP Sepharose resin and a cation exchange MMM for LZY and LF. 
The adsorption data was fitted using the Langmuir isotherm using 
triplicate adsorbents samples. Error bars are ± one standard deviation 
(n = 3). 
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Figure 5-4: Adsorption and desorption of LF at various salt 
concentrations and LZY at 1 M NaCl for a cation exchange MMM. 1 
mg of protein (1 mL of 1 mg mL-1 protein solution in 20 mM sodium 
phosphate pH, 6.0 (no salt)) was adsorbed to the membrane and 
recovered using different salt concentrations during elution. A 
triplicate sample was used for each salt concentration. Error bars are 
± one standard deviation (n = 3). 
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Figure 5-5: Chromatogram of a typical cross flow experiment (three 
pieces membrane) recorded by the AKTAcrossflow™ system. The 
solid line represents the absorbance value and the dotted line 
represents the conductivity in the permeate. 
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Figure 5-6: Typical TMP profiles during whey loading for differing 
numbers of cation exchange MMM in the module. 150 mL of whey 
was passed through the membrane, with both permeate and retentate 
recycled to the feed solution. 
 
 
5-15 
 xiii 
 
Figure 5-7: SDS-PAGE gel of selected fractions from a cross-flow 
experiment. Lane 1 - marker; Lane 2 – feed whey. Experiment using 
one piece of membrane: Lane 3 –whey (retentate) after loading; 
Lane 4 – permeate from washing step; Lane 5 –permeate from 
elution step. Experiment using two pieces of membrane: Lane 6 –
retentate whey; Lane 7 – permeate washing; Lane 8 – permeate 
elution. Experiment using three pieces of membrane: Lane 9 – 
retentate whey; Lane 10 – permeate washing; Lane 11 – permeate 
elution; Lane 12 – feed whey. 
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Figure 5-8: Chromatograms for RPC of various solutions in a cross-flow 
experiment using two pieces of cation exchange MMM for LF 
recovery from whey. (a) whey –14X dilution with RPC running 
buffer (b) retentate whey – 6X dilution with RPC running buffer (c) 
permeate washing – 2X dilution with RPC running buffer (d) 
permeate elution – 2X dilution with RPC running buffer. Retention 
volumes for α-Lac, LF, BSA and β-Lac were approximately 11, 14, 
16 and 19 mL, respectively. 
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Figure 6-1: Phenyl Sepharose binding capacity at various ammonium 
sulphate salt concentrations. 1 mg mL-1 of single protein solution 
was incubated with the resin for 12 h at room temperature, 22°C. 
Error bars are ± one standard deviation (n=3). 
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Figure 6-2: Precipitation of 1 mg mL-1 of single protein solution at 22°C 
under gentle mixing by inversion for 12 h in 20 mM sodium 
phosphate buffer pH 6 at various ammonium sulphate 
concentrations. Error bars are ± one standard deviation (n=3). 
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Figure 6-3: Static (equilibrium) binding capacity of intact and ground 
Phenyl Sepharose resin for single whey protein component in 2 M 
ammonium sulphate in 20 mM sodium phosphate buffer pH 6. Error 
bars are ± one standard deviation (n=3). 
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Figure 6-4: Static (equilibrium) binding capacity of Phenyl Sepharose 
MMM for single whey protein component in 2 M ammonium 
sulphate in 20 mM sodium phosphate buffer pH 6. Error bars are ± 
one standard deviation (n=3). 
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Figure 6-5: Single protein binding of Phenyl Sepharose MMM and 
EVAL base membrane at different ammonium salt concentration in 
20 mM sodium phosphate buffer. 2 mg mL-1 of feed protein was 
prepared in different salt concentration binding buffer and elution 
was done using salt free buffer. (a) MMM at 0 M salt; (b) MMM at 
1.0 M salt; (c) MMM at 1.5 M salt; (d) MMM at 2.0 M salt; (e) 
MMM at 2.5 M salt and (f) EVAL at 2.0 M salt. Error bars are ± one 
standard deviation (n=3). 
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Figure 6-6: Typical chromatogram for whey fractionation in flow 
through mode using the AKTAexplorer 100 liquid chromatography 
system for (a) a Phenyl Sepharose MMM and (b) a HiTrap Phenyl 
column. 
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Figure 6-7: SDS-PAGE of whey protein fractions using hydrophobic 
interaction MMM chromatography: Lane 1 – protein marker, lane 2 
– feed whey, lane 3 – unbound fraction, lane 4 – elution fraction, and 
using Phenyl Sepharose column: lane 6 – feed whey, lane 7 – 
unbound fraction, lane 8 – elution fraction. 
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Figure 6-8: Linear gradient elution from a hydrophobic interaction 
column for whey protein fractionation. 2 mL of whey was loaded 
onto (a) a 0.304 mL Phenyl Sepharose mixed matrix membrane 
chromatography column and (b) a 1 mL HiTrap Phenyl Sepharose 
column. 
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Figure 6-9: Fractions from gradient elution of whey protein using a 
hydrophobic interaction column. The lane number corresponds to the 
fractions in figure 6-8. Lanes 1 and 2 represent protein markers and 
feed whey, respectively. 
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Figure 7-1: Chromatogram for quaternary protein mixture and its 
respective individual proteins assayed by 1 mL Resource RPC 
column. 
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Figure 7-2: Static binding capacity of SP Sepharose based adsorbent for 
pure LZY in ground resin, a cation exchange membrane (CEX 
MMM) and mixed mode interaction membrane (MMM 1). Error 
bars are ± one standard deviation (n=3). 
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Figure 7-3: Static binding capacity of MP500 based adsorbent for pure 
β-Lac in ground resin, a pure anion exchanger membrane (AEX 
MMM) and a mixed mode interaction membrane (MMM 1). 
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Figure 7-4: Protein binding capacity of mixed mode MMM 1 for 
quaternary protein mixtures at different initial acidic and basic 
protein concentrations. The initial concentrations of BSA and β-Lac 
were fixed at 0.5 mg mL-1 (a), (b), 2.0 mg mL-1 (c), (d) and 4.0 mg 
mL-1 (e), (f). The binding capacity for acidic proteins (BSA and β- 
Lac) are represented in (a), (c) and (e) and for basic proteins 
(cytochrome C and lysozyme) in (b), (d) and (f). The x-axis 
represents the initial basic protein concentration. Error bars are ± one 
standard deviation (n=3). 
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Figure 7-5: Protein binding capacity of mixed mode MMM 1 for 
quaternary protein mixtures at different initial acidic and basic 
protein concentrations. The initial concentration for cytochrome C 
and lysozyme were fixed at 0.5 mg mL-1 (a), (b), 2.0 mg mL-1 (c), (d) 
and 4.0 mg mL-1 (e), (f). The binding capacity for acidic proteins 
(BSA and β-Lac) are represented in (a), (c) and (e) and for the basic 
proteins (cytochrome C and lysozyme) in (b), (d) and (f). The x-axis 
represents the initial acidic protein concentration. Error bars are ± 
one standard deviation (n=3). 
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Figure 7-6: Protein binding capacity of mixed mode MMM 1 to ternary 
protein system of BSA, β-Lac and LZY. Error bars are ± one 
standard deviation (n=3). 
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Figure 7-7: Protein binding capacity of mixed mode MMM 1 to a binary 
protein system of BSA and β-Lac. Error bars are ± one standard 
deviation (n=3). 
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Figure 7-8: Protein binding capacity of mixed mode MMM 1 for the 
binary protein system of β-Lac and LF at various initial 
concentrations. One set of experiment was conducted with a constant 
initial lactoferrin concentration at (a) 0.5 mg mL-1, (b) 2.0 mg mL-1 
and (c) 4.0 mg mL-1, while the concentration of β-lactoglobulin was 
varied from 0.5 to 4.0 mg mL-1. Another set of experiments was 
conducted with a constant initial β-lactoglobulin concentration at (a) 
0.5 mg mL-1, (b) 2.0 mg mL-1 and (c) 4.0 mg mL-1, while the 
concentration of lactoferrin was varied from 0.5 to 4.0 mg mL-1. 
Error bars are ± one standard deviation (n=3). 
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Figure 7-9: Typical chromatogram for elution of binary LZY and β-Lac 
using pH elution followed by 1 M NaCl elution. 
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Figure 7-10: SDS-PAGE gel for batch whey fractionation by mixed 
mode MMM 2. Lane 1 – marker, normal whey fractionation: lane 2 
– whey (4X dilution), lane 3 – unbound fraction (4X dilution), lane 4 
– washing fraction, lane 5 – elution fraction, LF-spiked whey: lane 6 
– LF-spiked whey (4X dilution), lane 7 – unbound fraction (4X 
dilution), lane 8 – washing fraction, lane 9 – elution fraction. 
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Figure 7-11: Typical chromatogram for cross-flow whey fractionation 
experiments in the AKTAcrossflow system. 
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Figure 7-12: SDS-PAGE of several fractions from cross-flow 
fractionation of whey. Lane 1 – marker, lane 2 – LF-spiked whey 
(4X dilution), lane 3- unbound whey in retentate side (4X dilution), 
lane 4 – washing fraction in permeate side, lane 5 – elution fraction 
in elution side, lane 6 – marker. 
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Figure 7-13: Unbound and elution fraction of whey proteins loaded at 
different injection volumes of whey into 3 layers of mixed mode 
MMM (mass 303.56 mg , diameter 44 mm, thickness 600 µm). 
Bound protein was eluted isocratically with 1 M NaCl in 20 mM 
sodium phosphate buffer pH 6. SDS-PAGE was run under 
nonreducing conditions. Lane 1 – marker, lane 2 – whey (4X 
dilution), lane 3 – unbound fraction ( 5 mL whey), lane 4 – elution 
fraction ( 5 mL whey), lane 5 – unbound fraction ( 3 mL whey), lane 
6 – elution fraction ( 3 mL whey), lane 7 – unbound fraction ( 1.5 
mL whey), lane 8 – elution fraction ( 1.5 mL whey), lane 9 – 
unbound fraction ( 1 mL whey), lane 10 – elution fraction ( 1 mL 
whey), lane 11 – unbound fraction ( 0.75 mL whey), lane 12 – 
elution fraction ( 0.75 mL whey), lane 13 – unbound fraction ( 0.5 
mL whey), lane 14 – elution fraction ( 0.5 mL whey), lane 15 – 
unbound fraction ( 0.3 mL whey), lane 16 – elution fraction ( 0.3 mL 
whey). 
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Figure 7-14: Linear elution gradient to 100 % buffer B. Lane 1 and lane 
2 in the SDS-PAGE gel represent a marker and feed whey 
respectively. 
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Figure 7-15: Linear elution gradient to 50% buffer B, followed by step 
elution at 100% buffer B. Lane 1 and lane 2 in the SDS-PAGE gel 
represent a marker and feed whey respectively. 
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Figure 7-16: pH elution at pH 4 followed by step elution at 100% buffer 
B. Lane 1 and lane 2 in the SDS-PAGE gel represent a marker and 
feed whey respectively. 
 
 
7-30 
 
 
 xviii 
List of Tables 
          Page 
Table 2-1: Mixed matrix membrane chromatography prepared using 
different materials with various formats. 
2-8 
 
Table 2-2: Whey protein composition (Andersson and Mattiasson 2006). 
 
2-11 
 
Table 2-3: Immunoglobulin (Ig) concentrations in bovine and human 
serum and mammary secretions (Hurley 2003). 
 
2-17 
 
Table 2-4: Comparison between different types of column 
chromatographic mode (Chaga 2001; Suen et al. 2003). 
 
2-19 
 
Table 2-5: Advantages and disadvantages of several types of stationary 
matrix in chromatography process (Ghosh 2003). 
 
2-20 
 
Table 2-6: Selected chromatography technique for whey protein 
fractionation in the past 10 years. 
 
2-21 
 
Table 2-7: Protein separation using high performance tangential flow 
filtration (adapted from Zydney 1998). 
 
2-29 
 
Table 2-8: Whey protein fractionation using membrane chromatography. 
 
2-33 
 
Table 4-1: Composition of β-lactoglobulin, α-lactalbumin and bovine 
serum albumin in whey prepared in this study. Data shown is based 
on average values ± one standard deviation (n=3). 
 
4-2 
 
Table 4.2: Freundlich isotherm constants (Equation 3.3) for different 
types of adsorbents in static binding experiments. 
 
4-8 
 
Table 4-3: Whey protein fractionation using MMM chromatography in 
batch adsorption at room temperature overnight. 
 
4-12 
 
Table 5-1: Average water flux, LF binding capacity and recovery for 
cation exchange mixed matrix membranes using differing numbers 
of membranes in a plate-and-frame module. The total amount of LF 
in 150 mL of whey feed was 17.63 mg. 
 
5-13 
 
Table 6-1: Langmuir isotherm constant for different proteins by Phenyl 
Sepharose mixed matrix membrane chromatography. 
 
6-8 
 
Table 6-2: Whey protein concentration before and after addition of 
ammonium sulphate salt at pH 6. After salt addition whey was 
centrifuged at 17, 902 g at 4 °C for 20 min. Data shown is based on 
average values ± one standard deviation (n=3). 
 
6-10 
 
 
 
 
 
 
 xix 
Table 6-3: Flow through fractionation of whey by (a) Phenyl Sepharose 
mixed matrix membrane chromatography and (b) HiTrap Phenyl 1 
mL column at 2 M ammonium sulphate concentration pH 6. Bound 
protein was eluted in step elution with salt free buffer. Data shown is 
based on average values ± one standard deviation (n=3). 
6-12 
 
Table 7-1: Batch binding and elution for pure β-Lac, pure LZY and a 
binary β-Lac and LZY mixture by in mixed mode MMM 1. Data 
shown is based on the average values ± one standard deviation 
(n=3). 
 
7-16 
 
Table 7-2: Flow through binding and elution for β-Lac in different feed 
solutions and different membrane types. The total β-Lac loaded onto 
the column was 2 mg and bound protein was eluted isocratically 
using 1 M NaCl salt. Data shown is based on the averages values ± 
one standard deviation (n=3). 
 
7-17 
 
Table 7-3: Flow through binding and elution for LZY in different feed 
solutions and membrane types. Total LZY loaded onto the column 
was 2 mg and bound protein was eluted isocratically using 1 M 
NaCl. Data shown is based on the averages values ± one standard 
deviation (n=3). 
 
7-19 
 
Table 7-4: Elution recovery of LZY and β-Lac at different pH of elution 
in flow through experiment for mixed mode MMM 1. Data shown is 
based on the averages values ± one standard deviation (n=3). 
 
7-20 
 
Table 7-5: Batch binding of mixed mode MMM 2 for (a) whey and (b) 
LF-spiked whey. 1 mL of whey was incubated with 2.64 cm2 of 
membrane at pH 6 and elute with 1 M NaCl in 20 mM sodium 
phosphate pH 6. Mass of membrane used was 18.53 ± 0.64 mg. Data 
shown is based on the averages values ± one standard deviation 
(n=3). 
 
7-22 
 
Table 7-6: Binding properties of mixed mode MMM 2 for 30 mL of 
whey (LF spiked) in a cross flow system. Data shown is based on the 
averages values ± one standard deviation (n=3). 
 
7-23 
 
 xx 
Symbols and Abbreviations 
 
Symbols 
c equilibrium protein concentration, mg mL-1 
cF feed protein concentration, mg mL-1 
K, n Freundlich constants 
Kd Langmuir dissociation constant, mg mL-1 
m dry mass of the MMM 
q equilibrium protein binding capacities, mg protein bound g-1 adsorbent  
qDBC dynamic binding capacity  
qm maximum protein binding capacities, mg protein bound g-1 adsorbent 
VBT permeate volume at 10% breakthrough 
Vdry volume of the dry membrane 
Vwet volume of the swollen membrane 
ε porosity 
 
Abbreviations 
AEX anion exchanger membrane 
ATPS aqueous two phase systems 
ATRP atom transfer radical polymerization 
BIB 2-bromoisobutyryl bromide 
BOD biological oxygen demand 
BP benzophenone 
BSA bovine serum albumin 
CEW chicken egg white 
CEX cation exchanger membrane 
CLSM confocal laser scanning microscopy 
COD chemical oxygen demand 
CV column volume 
DEAE diethylaminoethyl 
DF diafiltration 
DI deionized 
DMSO dimethysulfoxide 
 xxi 
EDTA ethylenediaminetetraacetic acid 
EVAL ethylene vinyl alcohol 
FITC fluorescein isothiocynate 
GMP glycomacropeptide 
Hb hemoglobulin 
HCl hydrochloric acid 
HEMA 2-hydroxyethelmethacrylate 
HIC hydrophobic interaction chromatography 
HIgG human immunoglobulin 
HPTFF high performance tangential flow filtration 
IgG immunoglobulin G 
Igs immunoglobulins 
LF lactoferrin 
LMH L m-2 h-1 
LP lactoperoxidase 
LZY lysozyme 
MAET-MAC 2-(methacryloyloxy)ethyl-trimethylammonium chloride 
MAPA methacrylamidophenyalanine 
MF microfiltration 
MMM mixed matrix membrane 
MPh monophenyl trimethoxysilane 
MW molecular weight 
NaCl sodium chloride 
NaOH sodium hydoxide 
Na2SO4 sodium sulphate 
NF  nanofiltration 
(NH4)2SO4 ammonium sulphate 
PES polyethersulfone 
poly(DMAEMA) poly(2-dimethyl aminoethyl methacrylate) 
PP polypropylene 
PSF polysulfone 
PVDF polyvinylidene fluoride 
Q quaternary ammonium 
 xxii 
RO reverse osmosis 
RPC reverse phase chromatography 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEM scanning electron microscope 
SP sulfopropyl 
TFA trifluoroacetic acid 
TMP transmembrane pressure 
UF ultrafiltration,  
WPC whey protein concentrate 
WPI whey protein isolate 
α-Lac α-lactalbumin 
β-Lac β-lactoglobulin 
 
 
  1-1 
1 Introduction 
1.1 Background 
The interest of industry in producing new products or/and improving current 
products processing using biotechnology has raised new challenges for the separation 
engineer. Most products produced from a bioreactor contain many impurities that 
need to be separated. Sequential techniques and cost effective separations are 
required to reduce the overall cost because most of the bioproduction cost depends 
heavily on the purification process. The requirements for separation processes are 
more demanding if food or pharmaceutical products are involved, because they need 
much higher purity and have more stringent safety regulations than other industrial 
products.  
 
Conventional techniques for bioproduct separation (bioseparation) involve several 
steps such as impurities removal, product isolation, product purification and 
polishing. Chromatography is a well-known unit operation that is involved in 
virtually all of the bioseparation steps mentioned above. In chromatography, the type 
of matrix and the principle of interaction between the matrix and the protein are 
important factors that must always be considered. This subject is important for 
chromatographic research internationally as efforts are made to produce efficient 
chromatographic systems for protein separation. 
 
Currently, most chromatography systems use packed bed columns to contain the 
stationary phase or matrix. However several limitations have been identified within 
this system. Their weaknesses, such as high pressure drop, long processing times due 
to slow intraparticle diffusion and complicated scale up procedures (Ghosh 2002; 
Kawai et al. 2003; Klein 2000; Van Reis and Zydney 2001; Zou et al. 2001), have 
encouraged the search for new kinds of column material and configuration.  
 
Membrane chromatography, which uses adsorptive membranes, is one of the 
alternatives to packed bed chromatography. Adsorptive membranes which have a 
specific functionality or ligand will bind to the target protein with different 
adsorption mechanisms depending on the type of ligand. Membrane chromatography 
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systems have shown distinct advantages such as (Ghosh 2002; Kawai et al. 2003; 
Wickramasinghe et al. 2006; Zou et al. 2001): 
 
a) Low pressure drop across the column 
b) Convective mass transfer properties of solutes to the binding sites 
c) High flow rate operation with maintain performance 
d) Easy column packing with low column clogging tendency 
e) Uncomplicated scale up procedures 
f) Low cost and the ability to be used as a single disposable device, 
especially for pharmaceutical or food applications which require very 
stringent cleaning protocols 
 
Various types of membrane chromatography, which cover a wide range of 
applications have been reviewed by several authors (Charcosset 1998; Ghosh 2002; 
Kawai et al. 2003; Klein 2000; Saito et al. 1999). Both ion exchange and affinity 
interaction membrane chromatography processes have been widely reported and 
several ion exchange membranes are now commercially available from a variety of 
manufacturers, such as Sartorius, Vivascience, Millipore and Pall (Ghosh 2002). 
Most membranes chromatography are in flat sheet or radial flow configurations but 
lab-scale hollow fiber membranes have been developed by several authors for both 
cation (Camperi et al. 1999; Shinano et al. 1993; Tsuneda et al. 1994) and anion 
(Kubota et al. 1997) exchange. 
 
Research efforts continue in the search for lower cost, easily prepared adsorptive 
membranes with high binding capacities. Three steps are usually involved in the 
preparation of adsorptive membranes: (1) preparation of the base membrane, (2) 
chemical activation of the base membrane and (3) coupling of ligands to the 
activated membrane (Zeng and Ruckenstein 1999). The latter two steps may require 
harsh chemical and physical conditions that can cause undesirable and irreversible 
changes in the membrane structure. The concept of mixed matrix membrane (MMM) 
chromatography, developed by Wessling’s group (Avramescu et al. 2003), is an 
alternative that provides a simple method for the preparation of adsorptive 
membranes, yet, results in a high quality membrane chromatography performance.  
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MMMs are prepared by incorporating an ion exchange resin (or any adsorptive resin) 
into a membrane polymer solution prior to membrane casting. The chemical 
modifications necessary for incorporating adsorptive ligands are thus decoupled from 
the membrane preparation step. The availability of various low cost resins suitable 
for protein adsorption can make this technique cost effective. 
 
Protein fractionation from milk or whey has become increasingly important during 
the past two decades as the dairy industry globally has moved from being solely 
based on commodity food production to earning a significant income from specialty 
proteins (Fee and Chand 2005; Fee and Chand 2006; Goodall et al. 2008). In view of 
the large volumes of whey that are produced every day in a milk processing plant, a 
high throughput chromatographic system such as membrane chromatography has 
significant potential for improving process efficiency (Splitt et al. 1996). Milk and 
whey protein separation using conventional packed bed chromatography is well 
known in the dairy industry; however membrane adsorber use began to expand in the 
industry only a few years ago. MMM chromatography has not previously been 
applied to whey protein fractionation. Most of the MMM prepared have been mainly 
applied to model protein mixtures and not many real feed streams have been tested. 
Therefore, the potential use of MMM for whey protein fractionation is the principal 
subject of this research, for which a range of MMM chromatography processes will 
be developed. 
 
1.2 Objectives 
The main objective of this research was to produce and characterise the performance 
of a range of membranes for MMM chromatography for potential use in whey 
protein fractionation. Different types of adsorptive MMM chromatography were 
developed with specific objectives as below: 
 
1) Anion exchange MMM chromatography was developed by incorporating a 
Lewatit® MP500 (Lanxess, Leverkusen, Germany) anion exchanger resin into 
an ethylene vinyl alcohol (EVAL) base membrane. The anionic MMM was 
expected to bind acidic whey proteins such as β-lactoglobulin (β-Lac), α-
lactalbumin (α-Lac) and bovine serum albumin (BSA). 
  1-4 
 
2) A cation exchange MMM was developed using a SP Sepharose™ (GE 
Healthcare Technologies, Uppsala, Sweden) resin to recover lactoferrin (LF) 
from whey. The performance of the membrane was evaluated and the 
feasibility of using cross-flow filtration in the separation process was studied. 
In addition, the protein binding to the cation resin in the membrane matrix 
was visualized using a confocal laser scanning microscopy (CLSM) 
technique.  
 
3) The concept of mixed matrix membrane chromatography was extended to the 
development of hydrophobic interaction MMM chromatography. Phenyl 
Sepharose™ (GE Healthcare Technologies) resin was selected as the 
adsorbent particle in the membrane matrix and was tested for whey protein 
fractionation. This is first time the concept of MMM chromatography was 
used to prepare a hydrophobic membrane chromatography material rather 
than ion exchange type membrane. 
 
4) Mixed mode interaction membrane chromatography in a single membrane 
material was fabricated using the concept of MMM preparation. Before this, 
the mixed mode interaction in membrane was normally achieved by 
alternating different layers of membranes having different functionalities 
(anion and cation) in one module. The novel mixed mode interaction MMM 
chromatography was evaluated for separation of a model protein mixture as 
well as whey solution. 
 
1.3 Thesis organization 
Following the introduction in Chapter 1, relevant background for the current research 
is presented in Chapter 2. Thus, Chapter 2 reviews the properties and interest in 
whey protein fractionation. Several separation technologies conducted in past studies 
are summarized, emphasizing column based chromatography, conventional 
membrane filtration and membrane chromatography. In Chapter 3, the general 
experimental methodology is described. The results for each part of the major 
experimental work is then given in a specific chapter according to the type of MMM 
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developed. Chapter 4 describes the development of anion exchanger MMM from 
Lewatit MP500 for fractionation of acidic proteins from whey. The static and 
dynamic binding capacity of the membrane are measured and tested for whey 
fractionation in batch operation. Chapter 5 shows how a cation exchange MMM is 
fabricated using SP Sepharose resin. This cationic MMM was used for LF recovery 
in a cross-flow operation with different numbers of MMM layers inserted in a plate-
and-frame membrane module to increase LF adsorption. Hydrophobic interaction 
MMM was developed using Phenyl Sepharose resin and this is described in Chapter 
6. The possibility of using hydrophobic membranes in whey protein fractionation is 
also evaluated in Chapter 6. In Chapter 7, the development of mixed mode 
interaction MMM chromatography was studied. By combining anion and cation 
resins in a membrane matrix in different proportions, the mixed mode membrane was 
tested for different protein separations. Conclusions and recommendations for future 
work are presented in Chapter 8. 
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2 Literature review 
2.1 Introduction 
In this chapter two main topics will be reviewed. The first part relates to the 
background of membrane chromatography and the methods used for preparing 
adsorptive membranes. In the second part, the properties and applications of whey 
protein are described, followed by different processes for whey protein fractionation.  
 
2.2 Membrane chromatography 
Protein separation by packed bed column chromatography is very common in 
downstream processing. However, several limitations of packed bed column 
chromatography have been indentified such as a high pressure drop, relatively slow 
intra-bead mass transport, difficulty in column packing and complicated scale up 
procedure (Ghosh 2002; Kawai et al. 2003; Klein 2000; Van Reis and Zydney 2001; 
Zou et al. 2001). These limitations have led to the development of membrane 
chromatography technology.  
 
Membrane chromatography, also known as membrane adsorption, uses an adsorptive 
membrane which carries specific functionality similar to a chromatography resin. 
This combines the principles of chromatography and membrane filtration in a single 
separation device. Normally, the pore size of the membrane chromatography material 
is in the range of microfiltration (MF) membranes. Besides having the advantages of 
membrane filtration in general, membrane chromatography may be preferred over 
column chromatography in terms of low pressure drop, high flow rate operation 
while maintaining adsorption capacity, convective mass transfer properties, low 
clogging tendency and easy column packing and scale up (Ghosh 2002; Kawai et al. 
2003; Klein 2000; Van Reis and Zydney 2001; Zeng and Ruckenstein 1999; Zou et 
al. 2001).  
 
However, the binding capacity of membrane chromatography for smaller proteins is 
sometimes lower than conventional gel-type chromatography media (Ghosh 2002; 
Wickramasinghe et al. 2006). One way to improve this capacity is by making a three-
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dimensional hydrogel on the internal membrane surface, in the submicron range, 
where ligands are immobilized (Gebauer et al. 1997; Ventura et al. 2008). Large pore 
size distribution of membrane chromatography also influences the membrane 
capacity. The presence of pores that are too large could result in radial concentration 
gradients within the pores which in turn could lead to early breakthrough. This may 
result in the dynamic capacity being less than the static capacity (Wickramasinghe et 
al. 2006). Another potential limitation of membrane chromatography is non-uniform 
flow distribution across the membrane, due to the large diameter-to-length ratio of 
the modules (Charcosset 2006). However, with a proper design of flow distributors, 
this problem should be minimal (Ghosh and Wong 2006).  
 
Similar to conventional chromatography media, different types of interaction are also 
possible for membrane chromatography, such as anion exchange, cation exchange, 
hydrophobic interaction and affinity interaction. In preparing MMM chromatography 
in the current study, ion exchange and hydrophobic interaction were exploited. 
Therefore, in the following section, various reaction schemes used to prepare 
different types of ion exchange and hydrophobic interaction membrane 
chromatography materials are reviewed. This is followed by a review of the literature 
related to the preparation and applications of MMM chromatography.  
  
2.3 Preparation of ion exchange membranes 
In order to produce high capacity ion exchange membranes, various preparation 
routes have been proposed. However, some of them are complicate and difficult to 
implement at large production scale. In the following paragraphs, a few recent 
examples for making anion and cation exchanger membranes will be described.  
 
Surface-initiated atom transfer radical polymerization (ATRP) has been used to 
prepare anion exchange membranes from commercial MF base membrane. A two-
step modification process was involved in preparing a weak anion exchange 
membrane from a regenerated cellulose membrane by Bhut et al. (2008). In the first 
step, initiator molecules, 2-bromoisobutyryl bromide (BIB) were anchored to the 
membrane pore surfaces. ATRP was used in the second step to grow poly(2-dimethyl 
aminoethyl methacrylate) (poly(DMAEMA)) chains on the initiator sites. The mass 
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of the poly(DMAEMA) grafted on the membrane surface was controlled by varying 
the polymerization time from 3 h to 12 h. For a membrane produced with a 12 h 
polymerization time, the maximum binding capacity for BSA was 66.3 mg mL-1, 
which is about three times higher than commercial Sartobind® D membrane 
(Sartorius, Gottingen, Germany). In a later publication (Bhut and Husson 2009), the 
BIB initiator grafting density was increased by increasing the concentration of BIB 
in solution during the membrane initiator-functionalization reaction. The dynamic 
binding capacity of this membrane was measured between 80-90 mg BSA mL-1 for 
linear flow velocities in the range of 53-530 cm h-1 (Bhut and Husson 2009). 
 
He and Ulbricht (2008) used a photo-grafting technique to prepare anion exchange 
membrane from a hydrophilized polypropylene (PP) MF membrane. The architecture 
of the grafted layer and grafting density could be controlled by using two different 
preparation routes, synergist immobilization or adsorption. In the adsorption method, 
hydrophilized PP membrane was soaked in benzophenone (BP) solution in the first 
step. Then, the pre-coated membrane was immersed in monomer solution of 2-
(methacryloyloxy)ethyl-trimethylammonium chloride (MAET-MAC) saturated with 
BP, followed by15 min UV irradiation at a UV intensity around 6.5 mW cm-2. For 
the synergist immobilization method, partial aminolysis of the thin hydrophilic 
polyacrylate layer was carried out as a pre-treatment in the initial step. The 
membrane was then immersed in a MAET-MAC monomer solution and subjected to 
UV irradiation treatment. To obtain a cross-linked grafted layer, a certain amount of 
cross-linker, N,N’-methylene-bis-acrylamide can be added in monomer solution in 
the synergist immobilization method. Based on the high grafting efficiency and 
better controllability, the synergist immobilization method was preferred for 
preparation of a well-defined membrane adsorber with a three-dimensional grafted 
layer (He and Ulbricht 2008). 
 
Zhang et al. (2008) used electrospun cellulose acetate nanofibers that randomly 
overlaid into felts as a base membrane for making anion exchanger membrane. The 
diameters of the nanofibers were in the range from ten nanometers to microns and 
the pore sizes within the nanofiber felts were in the range from submicrons to 
microns. The cellulose acetate nanofiber felts were then converted into regenerated 
cellulose nanofiber felts by hydrolysis/deacetylation in a sodium hydroxide (NaOH) 
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aqueous solution. Subsequently, the regenerated cellulose nanofibers were treated 
with an aqueous solution containing 2-(diethylamino) ethyl chloride hydrochloride in 
an alkali condition at 90°C to introduce a diethylaminoethyl (DEAE) ligand onto the 
membrane. The adsorptive membrane felt showed a maximum binding capacity of 
40 mg BSA g-1 membrane, which was higher than a commercial DEAE membrane 
adsorber which had a capacity of 33.5 mg BSA g-1 membrane. 
 
Chiu et al. (2007) prepared a cation exchange membrane based on glass membranes 
for isolating lysozyme (LZY) from hen egg albumin. The glass membrane was first 
treated with piranha solution (70% H2SO4: 30% H2O2 (v/v)) at 95°C for 1 h to 
increase the density of silanol groups. The pre-treated membrane was then coated 
with a solution of monophenyl trimethoxysilane (MPh) in dimethylformamide and 
hydrochloric acid (HCl). Finally, the MPh-coated membrane was incubated in 
chlorosulfonic acid for 48 h to introduce sulfonic ligand on the membrane. For LZY 
isolation from egg albumin, the purification factor obtained by this cationic glass 
membrane was in the range 28.0-31.6 with the LZY recovery of 72.6-81.1% and 
purity of 78.9%.  
 
Camperi et al. (1999) prepared a cation hollow fiber membrane by using an epoxy 
activated polysulfone based membrane. The hollow fiber membrane was incubated in 
a mixture of sodium sulfite/isopropyl alcohol/water (10 wt %/15 wt %/75 wt %) at 
37 °C for 1-10 h. The remaining epoxy groups were then hydrolyzed into diol groups 
by treatment with 0.5 M sulfuric acid at 80 °C for 2 h. The cationic hollow fiber 
membrane showed a maximum binding capacity of 84 ± 9 mg LZY mL-1 and a 
dynamic binding capacity of 67% of the maximum capacity value.  
 
A different approach was used by Fang et al. (2004) to prepare their cation exchange 
membrane. They modified polysulfone (PSF) powder to produce sulfonated PSF 
rather than modifying a prepared membrane. The sulfonation reaction was optimized 
in terms of reaction temperature and time. They also investigated the effects of 
membrane preparation conditions such as type of coagulation bath, relative humidity, 
exposure duration of gel-casted membrane and the ratio of additives to solvent in the 
polymer casting solution. The sulfonated cation exchange membrane showed a 
saturation capacity of 140 µg LZY cm-2 or 15.6 mg LZY mL-1 for experiments with 
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pure LZY at pH 7.4. For the isolation of LZY from hen egg white, a purification 
factor of 20.7 and a LZY recovery of 51.1% were obtained using one piece of the 
membrane under operation in dead-end filtration mode at 10 mL min-1 in a plate-and-
frame module. 
 
2.4 Preparation of hydrophobic interaction membranes  
Based on the literature to date, the main separation chemistry utilized in membrane 
chromatography is ion exchange, followed by affinity interactions (Ghosh 2002). 
There are relatively few reports on hydrophobic interaction-based membrane 
chromatographic separations. Alkyl (e.g., butyl and octyl) and aryl (e.g., phenyl) 
groups are representative ligands for hydrophobic interaction chromatography (HIC). 
The number of hydrophobic amino acid side chains on the protein surface (such as 
valine, tryptophan, phenylalanine, leucine), and the ligand-polymer structure, the 
surface ligand density, the type and concentration of salt, pH of the medium and 
temperature influence the hydrophobic interaction separation of proteins. By 
manipulating separation process parameters, it is possible to enhance the 
hydrophobic interaction between the protein and hydrophobic ligand to affect the 
separation of protein molecules (Roper and Lightfoot 1995). In addition, HIC is an 
ideal “next step” after protein precipitation with ammonium sulphate ((NH4)2SO4) or 
elution in high salt concentration during ion exchange chromatography. 
 
Kubota’s group, (Kubota et al. 1995; Kubota et al. 1996; Kubota et al. 1997a; Kubota 
et al. 1997b) is among the first groups involved in preparing hydrophobic interaction 
membrane chromatography. A series of polyethylene based hollow fiber HIC 
membrane was prepared by them. The polyethylene base membrane was modified 
with radiation-induced graft polymerization with glycidyl methacrylate monomer 
and attached with different types of hydrophobic ligand. HIC membranes were 
prepared at different ligand density and reaction conditions. Phenyl (Kubota et al. 
1995; Kubota et al. 1997b) and butyl amine (Kubota et al. 1997a) membranes were 
prepared and tested with a single bovine serum albumin (BSA) protein. A binding 
capacity as high as 30 mg BSA g-1 membrane (Kubota et al. 1997a) was achieved, 
with repeated cycles of adsorption and elution being possible when 1 M NaOH 
regeneration was included between each cycle (Kubota et al. 1997b). 
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Arica et al. (2001) prepared HIC membranes with phenylalanine as a hydrophobic 
ligand. Two main reactions were involved. In the first reaction, phenylalanine was 
reacted with 2-methacrylochloride to produce a co-monomer of 
methacrylamidophenyalanine (MAPA). Then, a co-monomer of MAPA was reacted 
with 2-hydroxyethelmethacrylate (HEMA) monomer by UV-initiated 
photopolymerization at different HEMA/MAPA ratios to produce a flat sheet HIC 
membrane. The HIC membrane was tested for γ-globulins adsorption and showed a 
maximum adsorption capacity of 2.37 mg γ-globulins g-1 dry membrane. 
 
Suen’s group prepared an inorganic HIC membrane based on an alumina membrane 
(Chang and Suen 2006), modified with C8 and C18, and a glass fiber membrane 
(Chen et al. 2007), modified with a few types of short-chain organosilicon 
derivatives. Alumina HIC membrane however, had a low protein elution recovery 
using a salt-free elution buffer as normally applied to recover the bound protein from 
HIC. In order to recover the bound LZY and conalbumin from the alumina HIC 
membrane, 70% acetonitrile and 70% isoproponal were necessary, respectively, 
which are uncommon elution buffers for hydrophobic interaction chromatography 
because of their denaturing effects on the eluted proteins. Normally such buffers 
would only be used in reverse-phase chromatography, indicating that the membranes 
prepared were more hydrophobic than is normally consistent with HIC. 
 
Commercial polyvinylidene fluoride (PVDF) MF membranes may also possibly 
perform in HIC in the presence of a high concentration (NH4)2SO4 buffer, as 
demonstrated by Ghosh’s group (Ghosh 2001; Ghosh 2005). A PDVF MF membrane 
was able to bind monoclonal antibody at 2 M (NH4)2SO4 concentration (Ghosh 2001) 
and human immunoglobulin (HIgG) at 1.5 M (NH4)2SO4 concentration (Ghosh 
2005). More recently, it was found that this PVDF based HIC membrane could also 
be used to separate monoclonal antibody aggregates (i.e. monomer, dimmer, trimer 
etc.) very efficiently compared with size exclusion chromatography (Wang and 
Ghosh 2008; Wang et al. 2006). Based on the fact that the hydrophobicity of 
monoclonal antibodies increases with the degree of aggregation, a linear salt gradient 
elution in HIC membrane is able to discriminate different types of monoclonal 
antibody aggregates. Sartorius has expanded its membrane adsorber product range 
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recently by introducing a new Sartobind Phenyl membrane (Fraud et al. 2008) as a 
hydrophobic interaction membrane. 
 
2.5 Mixed matrix membrane chromatography 
It is believed that excessive or harsh chemical modification, as normally practiced in 
transforming a ready made membrane to membrane chromatography as described 
above, may unintentionally and irreversibly damage the membrane structure. The 
concept of a mixed matrix membrane preparation method was introduced by 
Wessling’s group (Avramescu et al. 2003b; Avramescu et al. 2003c) in order to 
overcome the complicated routes for preparing membrane chromatography materials. 
MMMs are prepared by incorporating any adsorptive resin into a membrane polymer 
solution prior to membrane casting. The (chemical) incorporation of adsorptive 
ligands are thus decoupled from the membrane preparation step. This preparation 
concept provides a simple procedure and produces a competitive membrane 
chromatography performance.  Different types of adsorptive resin may be used to 
produce various types of MMM to suit specific applications. Table 2-1 lists MMM 
prepared in the previous literature, with some selected images of MMMs shown in 
figure 2-1.  
 
In the early development of MMM chromatography, Avramescu et al. (2003c) 
demonstrated that this preparation concept is flexible and offers the possibility to 
easily adjust the geometry, the adsorption capacity as well as the functionality of the 
membranes. They prepared various geometries of mixed matrix materials from an 
EVAL polymer and a Lewatit CNP80WS cation resin in the form of flat sheet, solid 
fiber and hollow fiber membranes. In static adsorption experiments, a protein 
capacity of 135 mg BSA g-1 membrane or 45 mg BSA mL-1 membrane was achieved. 
In a later publication, different types of resin were incorporated into the EVAL base 
membrane to prepare cation exchange MMMs by incorporating Lewatit SP112 resin 
and anion exchange MMMs by incorporating Lewatit MP500  resin (Avramescu et 
al. 2003b). They investigated the performance of these MMMs for separation of two 
similarly sized proteins, BSA and bovine hemoglobulin (Hb). By using a proper 
selection of the system pH, either anionic or cationic MMMs were able to separate 
the mixture of BSA and Hb effectively.  
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Table 2-1: Mixed matrix membrane chromatography prepared using different materials with various formats. 
Authors Membrane matrix Adsorbent resin Adsorbent loading, % Configuration 
Avramescu et al. 2008 Polyethersulfone  Lewatit CNP80WS - cation resin 50 Hollow fiber 
Saiful et al. 2006 Ethylene vinyl alcohol  Lewatit CNP80WS - cation resin 65 Flat sheet 
Zhang et al. 2006 Polyethersulfone Lewatit CNP80WS - cation resin 
Lewatit SP112WS - cation resin 
10-85 
50 
Solid fiber 
Kiyono et al. 2004 Polysulfone Amberlite IR120 - cation resin 20-50 Hollow fiber 
Avramescu et al. 2004  Ethylene vinyl alcohol Lewatit SP112WS - cation resin 65 Flat sheet 
Avramescu et al. 2003a Ethylene vinyl alcohol Lewatit SP112WS - cation resin 
Lewatit K2629- cation resin 
65 Flat sheet 
Avramescu et al. 2003b Ethylene vinyl alcohol Lewatit SP112WS - cation resin 
Lewatit MP500 - anion resin 
65 Flat sheet and solid fiber 
Avramescu et al. 2003c Ethylene vinyl alcohol Lewatit CNP80WS - cation resin 25-75 Flat sheet 
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  (a)     (b) 
 
  (c)     (d) 
Figure 2-1: Mixed matrix membrane chromatography in different geometries (a) flat 
membrane, (b) flat membrane, higher magnification, (c) full fiber, and (d) hollow 
fiber (adapted from Avramescu et al. 2009). 
 
PSF and polyethersulfone (PES) have also been used as the base polymer in MMM 
preparation. Kiyono et al. (2004) prepared a hollow fiber MMM from a combination 
of a PSF base membrane and Amberlite® IR120 cation resin as the adsorbent particle 
in the matrix. This hollow fiber membrane was tested for diffusion dialysis using 
NaOH, NaCl and sodium sulphate (Na2SO4) solutions. More recently, Avramescu et 
al. (2008) incorporated Lewatit CNP80WS into a PES based membrane matrix to 
prepare a cationic hollow fiber MMM. This hollow fiber MMM showed a static 
binding capacity of 210 mg LZY g-1 membrane or 60 mg LZY mL-1 membrane from 
a pure protein solution and was used to recover LZY from chicken egg white (CEW). 
The LZY concentration increased from about 3% in the feed solution to around 83% 
in the desorption buffer after a single adsorption-desorption cycle for LZY isolation 
from CEW. This gives a purification factor of about 27. 
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Most of the MMM prepared have been mainly applied to a model protein mixture. 
There are still lack of applications on MMM’s for real feed streams and in particular 
no examples of whey protein fractionation has been conducted in the past. In whey 
protein fractionation, low-cost and effective membranes are required for isolation of 
food-grade proteins (which have a much lower value than many of the 
pharmaceutical-grade) which normally purified by expensive column 
chromatography. Also, hydrophobic interaction and mixed mode adsorption 
(particularly customized for a specific feed composition, such as whey) have not 
been demonstrated with MMM’s. Therefore there are lot of opportunities exist in 
whey protein fractionation using MMM.  
 
2.6 Whey protein  
Whey is the liquid byproduct of casein precipitation of milk in the cheese or casein 
manufacturing industries and of milk concentration prior to milk powder production. 
Depending on the quality of the milk, 10 kg of milk will produce only 1-2 kg of 
cheese, while the rest of it will emerge as liquid whey (Bhattacharjee et al. 2006). 
Enormous quantities of whey are produced annually worldwide. The world 
production of cheese whey per year is estimated at 130 million tons, accounting for 
around 780,000 tons of protein (Monteiro et al. 2008). Figure 2-2 shows the main 
components of bovine milk, where whey protein only represents about 20% of the 
total protein in milk. The detailed composition and properties of individual whey 
proteins are given in table 2-2. 
 
The disposal of whey, having a biological oxygen demand (BOD) value of about 35-
60 g L−1 and a chemical oxygen demand (COD) value of 80-100 g L−1 as sewage, 
causes severe environmental pollution problems (Bhattacharjee et al. 2006). 
Government and other regulatory authorities in most countries have restricted or 
banned the disposal of untreated whey (Smithers 2008). This legislative restriction 
on whey disposal encouraged a deeper exploration of whey protein-based 
ingredients. 
 
 
 2-11 
 
 
Figure 2-2: Main components of bovine milk and composition of bovine protein 
(Splitt et al. 1996). 
 
 
Table 2-2: Whey protein composition (Andersson and Mattiasson 2006). 
Protein Concentration 
(mg mL-1) 
Molecular weight 
(kDa) 
Isoelectric point 
β-Lactoglobulin 2-4 18 5.2 
α-Lactalbumin 1.2-1.5 14 4.5-4.8 
Immunoglobulins  0.6-0.9 150-1000 5.5-8.3 
Bovine serum albumin 0.3-0.6 69 4.7-4.9 
Lactoferrin 0.02-0.2 78-92 8-9.5 
Lactoperoxidase 0.02-0.05 78-89 9.5 
 
 
For bulk use, whey protein can be converted into whey protein concentrate (WPC) 
(35-80% protein) or whey protein isolate (WPI) (80-95% protein) (Brans et al. 2004). 
WPC is a mixture of all whey proteins obtained by membrane concentration of whey, 
retaining significant amounts of the minerals, lipids, and lactose from whey. WPI is a 
higher quality and higher value mixture of the whey proteins, manufactured using 
either membrane filtration or ion-exchange adsorption (Turhan and Etzel 2004). WPI 
is normally included in sports formulas, infant formulas or medical formulas, mainly 
Bovine Milk 
Water  
(90%) 
Proteins  
(2-6%) 
Fat  
(2-7%) 
Carbohydrates  
(3.5-5.5%) 
Minerals  
(0.7%) 
Caseins  
(80%) 
β-Lactoglobulin 
(10.2%) 
α-Lactalbumin 
(5%) 
Albumin (BSA) 
(1.3%) 
Immunoglobulins 
(2.5%) 
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due to its high protein content. It also can used as a source of pure proteins or can be 
hydrolysed to obtain valuable peptides (Lucena et al. 2007). 
 
In the past two decades, the dairy industry globally has moved from being based 
solely on commodity food production to earning a significant income from individual 
proteins from whey (Fee and Chand 2006; Horton 1995; Huffman and Harper 1999). 
With advances in science and technology, the added value of whey has increased 
dramatically over the past 50 years, as depicted in figure 2-3 (adapted from Smithers 
2008).  Whey components, particularly proteins and peptides, will increasingly be 
preferred as ingredients for functional foods and nutraceuticals and as active 
medicinal agents (Smithers 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2-3: Schematic representation of the relative increase in value of whey 
protein/peptide products with increasing underpinning scientific knowledge of whey 
solids and advances in technology and marketplace sophistication over the past 
approximately 50 years (adapted from Smithers 2008). 
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However, the unique nutritional, therapeutic and functional characteristics of the 
individual whey proteins are largely unrealized due to interactions between 
components and degradation during processing. Thus, there is a challenge in whey 
protein fractionation to produce individual whey proteins with well characterized 
functional and biological properties by a process which will not denature but retain 
its nutritional and other properties (Bhattacharjee et al. 2006). In the following 
section, the properties and applications of the main whey protein components are 
described. (Note: unless otherwise stated, the information below relates to bovine 
milk and whey – the protein content in the milk and whey of other species, notably 
humans, differs significantly). 
 
2.7 Whey protein components 
2.7.1 β-Lactoglobulin – properties and applications 
β-Lac is the major protein in bovine whey, although, importantly, it is virtually 
absent from human milk and whey. It represents approximately 58% of whey protein 
or 10% of total milk protein (Lozano et al. 2008). The concentration of β-Lac in 
whey is in the range of 2-4 mg mL-1 (Andersson and Mattiasson 2006). The primary 
structure of β-Lac consists of 162 amino acids with a molecular weight (MW) of 
approximately 18.4 kDa. Six genetic variants of bovine β-Lac are known so far, with 
the most common being the A and B variants. β-Lac A and B variants differ only at 
two positions of amino acid residue, 64 and 118, which are Asp and Val for β-Lac A 
and Gly and Ala for β-Lac B (Elofsson et al. 1997). Because β-Lac A has one more 
negative charge in terms of the amino acid compositions, it has slightly lower pI 
value (pI 5.1) than β-Lac B (pI 5.2) although the MW are essentially the same 
(Yamamoto and Ishihara 1999). 
 
The secondary structure of β-Lac comprises nine strands of β structure, a short α 
helix segment and three helicoidal turns. Its quaternary structure depends on the 
medium pH: it occurs mainly as a stable dimer, with a MW of 36.7 kDa, at pH values 
between 5.2 and 7; as an octamer, with a MW of 140 kDa, at pH values between 3.5 
and 5.2; and as a monomer, with two-cysteine residues per monomer, at pH 3.0 and 
above 8.0 (de Wit 1989). 
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β-Lac is a good source of essential amino acids and has a potential use in power 
drinks due to its good solubility (Horton 1995). Good gelling formation and better 
foam stabilizer compared to other whey proteins would make β-Lac suitable for 
confection production (Cowan and Ritchie 2007; Zydney 1998). Some of the 
biological functions of β-Lac that were identified by previous publications was 
summarized by Madureira et al. (2007). β-Lac plays a role in regulation of mammary 
gland phosphorus metabolism, transporter for vitamin D, cholesterol and retinol, 
transfer of passive immunity to the newborn and enhancement of pregrastic esterase 
activity (Madureira et al. 2007).   
 
The β-Lac content of bovine milk is much higher than in human milk (El-Agamy 
2007; Fox and McSweeney 1998) and this has been identified as a potential source of 
allergic reactions to infant formulae seen in some children (El-Agamy 2007; Monaci 
et al. 2006; Suutari et al. 2006). Therefore, the removal of β-Lac from whey would 
broaden the applications of whey products derivatives in the food industry (Casal et 
al. 2006). β-Lac free whey would also serve as the primary protein constituent of 
hypoallergenic infant formulas with protein compositions that are more similar to 
that of human milk (Casal et al. 2006). 
 
2.7.2 α-Lactalbumin – properties and applications 
α-Lac is the second largest protein component  in bovine milk, comprising 
approximately 3.4% of total milk protein or 20% of the whey protein. The 
concentration of α-Lac in whey protein is in the range of 1.2-1.5 mg mL-1 
(Andersson and Mattiasson 2006). On the other hand, α-Lac is the predominant whey 
protein in human milk with a concentration of  2.44 ± 0.64 mg mL-1 (after 30 days of 
lactation), as determined by Jackson et al. (2004).  
 
α-Lac is a strong Ca2+ binding protein with four disulphide bonds consisting of 123 
amino acids in a single peptide chain. Its MW is about 14.2 kDa with a pI of 4.2. At 
the amino acid level, the homology between human and bovine α-Lac can be 
described as having 76% fully conserved residues (93 out of 123 amino acids) 
(Chatterton et al. 2006).  
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α-Lac is the preferred protein source for infant formulas due to its high tryptophan 
content, high digestibility, and lower potential for causing allergies, when compared 
to β-Lac (Gurgel et al. 2000; Zydney 1998). Besides that, owing to its high content in 
tryptophan it is applicable as a nutraceutical and due to its high cytotoxicity it 
possesses therapeutic uses (Konrad and Kleinschmidt 2008). α-Lac also has strong 
affinity for glycosylated receptors on the surface of oocytes and spermatozoids and 
may thus have potential as a contraceptive agent (Zydney 1998). Its biological 
functions reported  were included as a cancer preventer, lactose synthesis and 
treatment of chronic stress-induced disease (Madureira et al. 2007). 
 
2.7.3 Bovine serum albumin – properties and applications 
BSA exists in whey at concentration between 0.3-0.6 mg mL-1 (Andersson and 
Mattiasson 2006). The MW of BSA is about 69 kDa and it has a pI of around 4.7-4.9 
(Andersson and Mattiasson 2006). It consists of 582 amino acid residues with 17 
intramolecular disulfide bonds and a single free thiol (Burr 2001).  
 
Some biological functions of BSA are fatty acid binding, anti mutagenic function and 
cancer prevention (Madureira et al. 2007).  BSA also has a good gelling properties 
(Matsudomi et al. 1991) and it is also widely used in food and therapeutic 
applications  (Zydney 1998). 
 
2.7.4 Lactoferrin – properties and applications 
LF is glycoprotein and a member of a transferrin family, which is capable in binding 
and transferring iron (Adlerova et al. 2008; Levay and Viljoen 1995). The 
concentration of LF in bovine milk and whey is relatively low and varies throughout 
the milking season, generally falling within the range 20-400 mg L-1 (Palmano and 
Elgar 2002). On the other hand, the concentration of LF in human milk is around 
1000-3000 mg L-1 (Wakabayashi et al. 2006). 
 
LF comprised of a single polypeptide chain containing 703 amino acids folded into 
two globular lobes, each with one iron binding sites. There are three forms of LF 
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according to its iron saturation: apolactoferrin (iron free), monoferric form (one 
ferric ion), and hololactoferrin (binds two Fe3+ ions) (Adlerova et al. 2008; Levay 
and Viljoen 1995). Besides iron, LF is capable of binding a large amount of other 
compounds and substances such as lipopolysacharides, heparin, glycosaminoglycans, 
DNA, or other metal ions like Al3+, Ga3+, Mn3+, Co3+, Cu2+, Zn2+ etc. However, its 
affinity for these other ions is much lower (Adlerova et al. 2008). 
 
LF has diverse bioactivity, including broad spectrum antimicrobial activity, 
promotion of iron transfer and absorption, cancer prevention, cell proliferation and 
differentiation, antiviral, antibacterial and antiparasitic activity (Adlerova et al. 2008; 
Horton 1995; Lu et al. 2007; Tomita et al. 2009; Wakabayashi et al. 2006). It was 
proved by many scientific findings that oral administration of LF exerts beneficial 
effects on the health of humans and animal, including anti-infective, anticancer and 
anti-inflammatory effects (Wakabayashi et al. 2006; Yamauchi et al. 2006). LF also 
has been commercially used as a natural bioactive ingredient in supplement foods 
(e.g. infant formulae and dietary supplement tablets), skin care and oral health care 
products (Wakabayashi et al. 2006). More recently, the discovery of LF, an 
antimicrobial peptide produced from pepsin digestion of lactoferrin, which showed a 
similar function as LF, attracted more interest in the exploration of LF application 
(Tomita et al. 2009). 
 
2.7.5 Immunoglobulins – properties and applications 
Immunoglobulins (Igs) are very complex proteins which consist of two long (heavy) 
and two shorter (light) polypeptide chains linked by disulphides bond. There are five 
classes of Ig: IgA, IgG, IgD, IgE and IgM. Only IgG, IgA and IgM present in milk. 
IgG can be further divided into a subclasses of IgG1 and IgG2. The principal Ig in 
bovine milk is IgG1, while in human milk it is IgA (Fox and McSweeney 1998). 
Table 2-3 shows the concentration of Ig found in bovine and human serum and 
mammary secretions. Detailed structures of different Ig classes can be found in the 
literature (El-Loly 2007; Fox and McSweeney 1998). 
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Table 2-3: Immunoglobulin concentrations in bovine and human serum and 
mammary secretions (Hurley 2003). 
 Concentration, mg mL-1 
Species Immunoglobulin 
 Blood serum Colostrum Milk 
Bovine Total IgG  25.0 32-212 0.72 
 IgG1  14.0 20-200 0.60 
 IgG2  11.0 12.0 0.12 
 IgA  0.4 3.5 0.13 
 IgM  3.1 8.7 0.04 
      
Human Total IgG  12.1 0.4 0.04 
 IgA  2.5 17.4 1.00 
 IgM  0.9 1.6 0.10 
 
 
In addition to antigen binding, all Igs exhibit one or more effectors functions, which 
are capable of preventing the adhesion of microbes to surfaces, inhibiting bacterial 
metabolism by blocking enzymes, agglutinating bacteria and neutralizing toxins and 
viruses (El-Loly 2007). Addition of bovine Igs in infant formulae and other foods 
may help to reduce viral and microbial infections and may provide consumers with 
improved immune activity (Gapper et al. 2007). In fact, the specific concentration of 
Ig can be raised in colostrum or milk by immunizing cows with its pathogen or 
antigen. This technique was used to produce hyperimmune colostral or milk 
products. A few commercial hyperimmune milk products are already on market and 
more applications can be expected in the coming years (Mehra et al. 2006).  
 
2.7.6 Lactoperoxidase – properties and applications 
Lactoperoxidase (LP) is among the most abundant enzymes found in milk protein. 
The concentration of LP in bovine milk is about 30 mg L-1 constituting about 1% of 
the whey proteins, while in human milk it is only 5% of that in bovine milk (Shakeel 
ur et al. 2002). LP has a MW of 78-89 kDa (Andersson and Mattiasson 2006) with 
612 amino acid residues (Seifu et al. 2005) and pI value around 9.6 (Andersson and 
Mattiasson 2006). The levels of iron and carbohydrate in LP are 0.068-0.079% and 
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9.9-10.2%, respectively (Shakeel ur et al. 2002). The secondary structure of LP 
consists of 65% β-structure, 23% α-helix and 12% uncoordinated structures (Shakeel 
ur et al. 2002). 
 
LP catalyzes the oxidation of thiocynate by hydrogen peroxide and generates 
intermediate products with antibacterial properties which kill or inhibit the growth of 
wide range of bacteria, viruses, fungi, molds and protozoa (Korhonen 2009; Seifu et 
al. 2005; Shakeel ur et al. 2002). LP has also been used to preserve raw milk quality 
during transportation from the farmer to the dairy plant in the area where is not 
possible to used mechanical refrigeration (Seifu et al. 2005). In the following section, 
several major techniques for whey protein fractionation will summarized and 
highlighted. 
 
2.8 Column based chromatography for whey protein 
fractionation 
Chromatography is a very well known unit operation in downstream processing of 
protein mixture. In chromatographic techniques, the principle separation occurs due 
to the different migration of the component of interest between the stationary phase 
(i.e. matrix phase) and continuous phase (i.e. solvent) in the system. Chromatography 
media (i.e. stationary phase) is normally packed into a column from several 
centimeters to several meters diameter, depending on the process scale. Various 
types of chromatography mode or interaction are available, such as size exclusion, 
ion exchange, hydrophobic interaction and reverse phase chromatography. They 
differ in terms of the separation mechanism and selection of stationary and 
continuous phase. Table 2-4 gives a brief performance comparison between several 
types of chromatographic interaction that are normally used in column 
chromatography (Chaga 2001; Suen et al. 2003). The advantages and disadvantages 
between different formats of stationary phase in chromatographic system are given in 
table 2-5 (Ghosh 2003).  
 
Previous studies on whey fractionation using column chromatography are 
summarized in table 2-6. Most of them appeared in the literature for the past 10
 2
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Table 2-4: Comparison between different types of column chromatographic mode (Chaga 2001; Suen et al. 2003). 
Affinity 
Property 
Group-specific Bio-specific 
Ion exchange HIC/RPC1 
Adsorption capacity  
 
Medium-high Low High Medium-high 
Selectivity Medium-high 
 
High Low-medium Low-medium 
Recovery High Medium High Medium 
 
Loading condition 
 
Mild Mild Mild Sometimes harsh 
 
Elution condition 
 
Mild Harsh Mild Mild 
 
Regeneration Complete Sometimes incomplete 
 
Complete Incomplete 
Cost Low High Low Low 
1
 HIC- hydrophobic interaction chromatography, RPC- reversed-phase chromatography 
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Table 2-5: Advantages and disadvantages of several types of stationary matrix in 
chromatography process (Ghosh 2003). 
Processes Advantages Disadvantages 
Packed bed 
 
Establish process 
High resolution 
High binding capacity 
Suitable for gradient 
chromatography 
 
Slow process 
Low reproducibility (with soft 
gels) 
Susceptible to column blinding 
Variability of column packing 
Monolith 
 
Fast 
High reproducibility 
Suitable for gradient 
chromatography 
Predominance of convective 
transport 
Low pressure drop 
 
Expensive 
 
Membrane 
 
Fast 
High reproducibility 
Predominance of convective 
transport 
Low pressure drop 
Inexpensive 
Disposable device 
 
Unsuitable for gradient 
chromatography 
Low binding capacity 
 
Fluidized or 
expanded bed 
 
Fast 
Suitable for feed containing 
particles 
Poor resolution 
Poor reproducibility 
High energy consumption 
Breakage of chromatographic 
media 
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Table 2-6: Selected chromatography technique for whey protein fractionation in the past 10 years. 
Author Protein of 
interest 
Protein source Materials/configuration Mode of interaction/ Ligand 
Brochier et al. 
2008 
β-Lac microfiltered  
whey  
HyperCel™ column (Pall BioSepra), column volume - 2.5 
mL, 5 mL, 10 mL 
mixed mode - hexyl amine  
Etzel et al. 2008 WPI whey  Mono™ S column (GE Healthcare Technologies), column 
volume - 2.38 L, 10 cm diameter 
cation exchange – methyl 
sulphonate 
Etzel et al. 2008 WPI whey SP Sepharose Big Beads™ (GE Healthcare Technologies), 
column volume - 5.34 L, 20 cm diameter , 17 cm height 
cation exchange - SP 
Liang et al. 
2006 
β-Lac, α-Lac, 
BSA, IgG 
whey  Sephadex™ G-200 (GE Healthcare Technologies); 2.6 cm 
× 70 cm 
gel filtration 
Fee and Chand 
2006 
LF, LP milk SP Sepharose Big Beads, column volume - 5 mL cation exchange - SP 
Schlatterer et 
al. 2004 
β-Lac whey Macro-Prep ceramic hydroxyapatite (BioRad), column 
dimension 12 mm × 88 mm 
- 
Turhan and 
Etzel 2004 
α-Lac, WPI lactic acid whey SP Sepharose Big Beads, column volume - 80 mL cation exchange - SP 
Rojas et al. 
2004 
α-Lac, β-Lac protein fraction 
from ATPS 
Sephadex G-25 HR-10/10 (GE Healthcare Technologies) gel filtration 
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Table 2-6 continued 
Doultani et al. 
2004 
α-Lac, WPI, 
LP, LF 
whey  SP Sepharose Big Beads, column volume - 80 mL cation exchange - SP 
Neyestani et al. 
2003 
β-Lac, α-Lac, 
BSA 
whey 1) Sephadex G-50 (GE Healthcare Technologies), 
column volume - 131 mL, dimension 1.6 cm × 65 cm 
2) DEAE column (GE Healthcare Technologies), column 
volume - 5 mL 
size exclusion and anion 
exchange - DEAE 
Vyas et al. 2002 β-Lac whey Calcium bio-silicate particles affinity - all-trans-retinal 
ligand 
Gurgel et al. 
2001 
α-Lac WPI Polyhydroxylated methacrylate - TosoHaas AF Chelate 650 affinity - peptide ligand 
Tellez and Cole 
2000 
β-Lac, α-Lac, 
BSA, IgG 
whey Biogel™ A 0.5 m and 5 m (Bio-Rad); column 1- dimension 
1.5 cm × 30 cm, column 2- dimension 2.5 cm × 60 cm 
electrochromatography 
Ye et al. 2000 α-Lac, β-Lac 
A, β-Lac B, 
LP, LF 
whey 1) SP-Toyopearl™ (Toyosoda), dimension 1.5 cm × 18 
cm 
2) Quaternary aminoethyl-Toyopearl (Toyosoda), 
dimension 1.5 cm × 18 cm 
anion and cation exchange 
Abbreviation: WPI - whey protein isolates, α-Lac - α-lactalbumin, β-Lac - β-lactoglobulin, BSA - bovine serum albumin, LF - lactoferrin, LP -
lactoperoxidase, IgG - immunoglobulin G, SP - sulfopropyl, DEAE - diethylaminoethyl, ATPS - aqueous two phase systems. 
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years. Detailed descriptions of selected processes are elaborated in the following 
paragraph. 
 
Column chromatography used for whey protein fractionation is dominated by ion 
exchange chromatography. In whey protein fractionation, either selective adsorption 
or selective elution can be performed. In selective adsorption, whey protein of 
interest is adsorbed onto the column while leaving a whey solution depleted in that 
protein. In selective elution, all the whey proteins are trapped simultaneously onto an 
adsorbent, rinsed free of contaminants and then eluted one-by-one (Almecija et al. 
2007). 
 
Doultani et al. (2004) used selective elution method to recover different fractions of 
whey protein that bound onto an SP Sepharose Big Beads (GE Healthcare 
Technologies), cation exchanger column at pH 4. Different elution sequences can be 
used to recover the bound whey protein to produce the following fractions:  
 
(1) Single WPI by using 10 mM NaOH 
(2) α-Lac and WPI depleted in α-Lac fraction by using 100 sodium acetate 
pH 4.9 and 10 mM NaOH elution buffer respectively 
(3) α-Lac, WPI depleted in α-Lac, LP and LF by using this elution sequence: 
100 sodium acetate pH 4.9, 50 mM sodium phosphate pH 6.5, 0.35 M 
NaCl in 50 mM sodium phosphate pH 6.5 and 1.20 M NaCl in 50 mM 
sodium phosphate pH 6.5 
According to them, this method offers a flexibility to switch between different 
protein fractions day-to-day depending on the market and customer demands. 
 
This selective elution was also successfully applied for producing α-Lac and WPI 
depleted in α-Lac fraction by Turhan and Etzel (2004) using the same 
chromatographic column. The purity of α-Lac achieved in this study was 93% while 
the WPI depleted in α-Lac contains less than 2% α-Lac. Ye et al. (2000) used a salt 
gradient for selective elution of whey protein by using two different types of ion 
exchanger columns. Whey at pH 6.5 was passed through into first cation exchanger 
column (SP-Toyopearl) to bind LP and LF. These proteins were eluted from a cation 
column using salt gradient of 0-0.55 M NaCl in 50 mM Tris-HCl buffer at pH 6.5. 
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The unbound whey solution that previously passed through a cation column was 
adjusted to pH 8.5 to feed into a second anion exchanger column (quaternary 
aminoethyl-Toyopearl) to bind α-Lac and β-Lac. Bound α-Lac was eluted from the  
anion column using 0-0.15 M NaCl in 50 mM Tris–HCl, pH 8.5. Next, the column 
was adjusted to pH 6.8, and β-Lac was eluted using salt gradient of 0-0.20 M NaCl in 
50 mM Tris–HCl, pH 6.8. However, this method did not produce IgG and BSA 
fractions. 
 
Neyestani et al. (2003) used a series of chromatography steps to obtain pure β-Lac 
from whey after precipitation with 50% (NH4)2SO4. Both precipitate and supernatant 
obtained were dialyzed and lyophilized for further separation by chromatographic 
method. Lyophilized precipitate fraction was reconstituted in distilled water and run 
onto gel filtration column (Sephadex G-50, 131 mL column volume, 65 cm length) to 
obtain a first peak of the mixture of BSA and casein, and second peak of pure β-Lac. 
The yield of β-Lac was 166 mg based on 50 mL of starting milk. Meanwhile, 
lyophilized supernatant was dissolved in water and injected to DEAE column. 
Stepwise elution was applied onto the column resulted in two separate peak; a 
mixture of BSA and α-Lac in the first peak and single β-Lac in the latter peak. The 
yield of β-Lac was estimated about 178 mg β-Lac per 50 mL of milk for the second 
peak. The mixture of BSA and α-Lac was further applied to gel filtration column to 
separate a single protein fraction. The yield of BSA and α-Lac based on 50 mL milk 
was calculated about 11.5 mg and 54.5 mg respectively from the resolved peak. 
 
Besides packed bed columns, whey protein fractionation can also be operated in 
batch adsorption or fluidized (expanded) bed chromatography. de Jongh et al. (2001) 
used a batch process to isolate β-Lac using DEAE sepharose resin. Whey was diluted 
with water to a low conductivity value of 6.7 mS at pH 7.2. At this conductivity 
value, almost 80-90% β-Lac could be bound from 1 L whey by 77 g of resin used. 
The bound β-Lac was eluted by 0.25 M NaCl and this fraction was desalted by 10 
kDa UF membrane. Final purification was achieved using Superdex 75 gel filtration 
column, followed by UF concentration to achieve a final β-Lac with purity > 98%. 
The yield of β-Lac production from 1 L was calculated higher than 80%. When 25 L 
whey was used, 50 g of β-Lac could be produced and the yield of the process 
dropped to a value between 65-70%.  
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Vyas et al. (2002) compared the performance of three different operating systems 
(packed column, stirred tank and fluidized bed column) for isolating β-Lac using 
affinity chromatography. The ligand used was all-trans-retinal immobilized on 
calcium bio-silicate resin. The packed column, stirred tank and fluidized bed 
produced β-Lac with purity of 80%, >95% and >95% and recovery of 0.65, 2.88, and 
2.88 g β-Lac kg-1 of resin respectively. The fluidized bed column was considered 
best suited for industrial point of view and scale up. Noppe et al. (1999) directly 
isolated α-Lac from defatted bovine and goat milk using hydrophobic expanded bed 
chromatography. Upon Ca2+ removal by ethylenediaminetetraacetic acid (EDTA) 
presented in the buffer, α-Lac underwent a significant conformation change 
rendering it more hydrophobic. At this conformation, it can selectively bind to 
Streamline® Phenyl (GE Healthcare Technologies) hydrophobic resin. Pure α-Lac 
was recovered from defatted goat milk, while α-Lac from bovine milk was 
contaminated by small amount of γ-casein. This casein can easily be removed by 
further size exclusion chromatography if necessary to achieve a pure α-Lac. 
 
Some interesting techniques in whey protein fractionation using chromatography 
methods had also been made in recent years. Fee and Chand (2006) successfully 
demonstrated that it is possible to extract LF and LP directly from the raw milk 
without affecting the gross properties of milk (fat content, protein content). They 
passed raw milk through a SP Sepharose Big Beads column by controlling the 
temperature at around the milking temperature 35-37°C. At this temperature, fat was 
believed to soften and did not block the column, so over 100 column volumes of 
milk were able to flow through. The dynamic binding capacity of the column was 48 
mg mL-1 for LF and 0.55 mg mL-1 for LP. Brochier et al. (2008) demonstrated the 
feasibility of using a mixed-mode chromatography column for isolation of β-Lac 
from whey without the need for pH or conductivity adjustment using a hexyl amine 
mixed mode column (HyperCel™, Pall BioSepra, Cergy, France). A smooth 
scalability from 2.5 mL to a 10 mL column volume (CV) was achieved to extract all 
β-Lac content from 5CV of whey loaded into the column. Bound β-Lac was eluted at 
pH 4 with the purity was estimated to be around 75%. Meanwhile, Schalatterer et al. 
(2004) used ceramic hydroxyapatite column (Macro-Prep, BioRad, Munich, 
Germany) to isolate β-Lac from acid whey originating from milk of healthy and 
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mastitic cows. A single peak of β-Lac could be eluted at a sodium fluoride 
concentration of 0.6 M. Using whey from a healthy cow, the yield of β-Lac around 
50-55% with purity more than 96% was achieved. For mastitic whey, the yield of β-
Lac was between 18-20% with low purity, contaminated by IgG, BSA and LF.  
 
Most of the latest studies related to the whey protein fractionation by 
chromatographic techniques described above are still based on a lab scale 
production. Further challenge in scale up procedures will be involved for pilot plant 
development. Compared with packed bed columns, expanded bed chromatography 
shows a benefit for direct capture of whey protein without requiring whey pre-
filtration. However, a lack of studies has been done so far for this kind of 
chromatography for whey protein fractionation. 
 
2.9 Conventional membrane filtration for whey protein 
fractionation 
Membrane processes are well known in dairy processing plants. They are extensively 
used in the separation of fat globules in cream manufacturing, reduction of bacteria 
and spores in skim milk and concentration of casein micelles as a pre-treatment in 
cheese manufacturing (Brans et al. 2004; Pouliot 2008). Ultrafiltration (UF) is 
normally used for preparing WPC or is combined with dialfiltration (DF) in 
producing WPI (Zydney 1998). Figure 2-4 matches common membrane process with 
the components typically found in milk which are based on size ranges (Brans et al. 
2004). However, full milk fractionation is very challenging due to the broad particle 
size distribution of milk component and various concentration levels for each 
component in milk. 
 
Generally, in size-based separation process, the size difference between the 
components to be separated should be at least a factor of ten. Single whey protein 
fractionation by conventional membrane filtration (UF particularly) is impossible due 
to the similar size of whey protein components. Using a few stages of membrane 
module or combination with other separation processes is possible, however high 
costs and complicated operational procedures will be involved.  
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Figure 2-4: Membrane process classification based on the size of milk component. 
Abbreviation: MF- microfiltration, UF- ultrafiltration, NF- nanofiltration, RO- 
reverse osmosis (Brans et al. 2004). 
 
 
Wide pore size distribution, membrane fouling and concentration polarization 
phenomena are the main reasons for unsuccessful application of UF for protein 
separation (Van Reis et al. 1997). However, a new version of UF, known as high 
performance tangential flow filtration (HPTFF), has been developed to overcome 
these limitations. HPTFF exploits a number of different strategies by selecting 
specific conditions such as (Van Reis et al. 1999; Van Reis et al. 1997; Zydney 
1998): 
 
• proper choice of pH and ionic strength to maximize the differences in the 
effective hydrodynamic volume of the different proteins  
• use of electrically charged membranes to enhance the retention of charged 
proteins 
• operation in the pressure-dependent regime to maximize the selectivity  
• use of a diafiltration mode to wash impurities through the membrane 
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The success of HPTFF in proteins separation of similar size has been demonstrated 
by several researchers as demonstrated in table 2-7 (adapted from Zydney 1998). The 
application of HPTFF has gradually been applied to whey protein fractionation in the 
past 10 years. The following paragraph will summarize some related membrane 
based separation processes for the purpose of whey protein fractionation.  
 
A few studies have concentrated on the optimization of membrane operating 
conditions in order to isolate the protein of interest from whey. Muller et al. (2003b) 
conducted a series of experiments by varying physico-chemical and hydrodynamic 
operating conditions on UF of α-Lac from whey.  In the first part of the experiment, 
the effect of transmembrane pressure (TMP), whey concentration, ionic strength, pH 
and flow velocity were studied using Carbosep™ 150 kDa ceramic membrane from 
Orelis (St-Maurice-de-Beynost, France). Then, different types of tubular membrane, 
Ceram™ 150 kDa, 220 kDa and 300 kDa (Tami Industries, Nyons, France) were 
tested. The α-Lac purity was increased from 0.25 in initial liquid whey to 0.44 in 
permeate, with the yield around 53% using 300 kDa membrane.  
 
In a study by Almecija et al. (2007), they selected  a 300 kDa tubular ceramic 
membrane to fractionate acid whey into permeate fraction of α-Lac and β-Lac, and 
retentate fraction of BSA, LF and IgG. The membrane was run in a continuous 
diafiltration mode (4 diavolumes) at various pH, ranges from pH 3 to pH 10. 
Different flux was pattern was observed at different pH values. Based on the result, 
the purity of BSA and LF was 1.5 times higher than the original whey (2.4 and 0.9%, 
respectively) when operated at pH 3 and 9. For IgG, purity was improved 1.6 times 
from the initial value of 9.4% at pH 9. More recently, Metsamuuronen and Nystrom 
(2009) tested a series of Nadir® UF membrane (Celgard/Microdyn) with different 
hydrophobicities and different pore sizes (20, 30, 50 and 100 kDa) for enrichment of 
α-Lac from fresh whey. The effects of whey pH, cross flow TMP and temperature on 
protein transmission were studied. Using a Nadir UH030 30 kDa PES membrane 
operated at pH 6.4 and 40°C, 23-fold α-Lac/β-Lac ratio was achieved in permeate 
stream in comparison with initial whey ratio. 
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Table 2-7: Protein separation using high performance tangential flow filtration (adapted from Zydney 1998). 
Retentate product Permeate product MW 
ratio 
∆pI Selectivity Membrane Reference 
BSA Lysozyme 4.8 6.2 170 PTTK 30 kDa PSF 
(Millipore) 
 
Iritani et al. 1995 
BSA Myoglobin 3.9 2.2 25 Diaflo YM30 cellulose 
(Amicon) 
 
Nakatsuka and Michaels 1992 
BSA Hemoglobin 1.0 2.2 140 Omega 100kDa PES (Filtron) 
 
Van Eijndhoven et al. 1995 
BSA dimer BSA monomer 2.0 - 32 Biomax 100kDa PES 
(Millipore) 
 
Van Reis et al. 1997 
IgG BSA 2.3 2.2 50 Omega 100kDa PES (Filtron) 
 
Saksena and Zydney 1994 
Myoglobin Cytochrome C 1.3 2.0 40 Prototype polyacrylonitrile Yang and Tong 1997 
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A drastic selectivity improvement of targeted whey protein through UF membrane 
could also be achieved by using a charged membrane. In a study by Cowan and 
Ritchie (2007), PES membrane (100 kDa, Millipore) was modified with negatively 
sulfonated group. The finding showed that α-Lac selectivity was 5 times better as 
compared to unmodified membrane at pH 7.2 based on single protein transmission 
experiment. Similar improvement was also demonstrated in a study by Lucas et al. 
(1998) who used inorganic membrane (Carbosep 150 kDa, Tech-Sep) coated with 
positively charged polyethyleneimine. At pH 7 and low ionic strength (< 0.02 mol L-
1), the transmission of β-Lac was reduced to 1% while α-Lac transmission was 10%, 
which gave selectivity close to 10. More recently, Bhushan and Etzel (2009) 
modified regenerated cellulose membrane (YM30 30 kDa, Millipore) with a 
positively charged quaternary amine to enhance the transmission of neutral 
glycomacropeptide (GMP) from cheese whey at pH 3. The selectivity of GMP to 
other whey proteins of 13 was obtained by this charged UF membrane. 
 
In another option, membrane filtration is combined with other unit operations in 
order to achieve the desired recovery for particular protein from whey solution. Xu et 
al. (2000), for example, used a combination of batch adsorption and ultrafiltration to 
recover IgG from acid whey and colostral whey. In this study, major acidic whey 
protein (β-Lac, α-Lac, BSA) was removed from 2 L whey by batch adsorption into 
Amberlite IRA93 (20% w/v) anion exchanger resin in four cycles to give a spent 
whey which is enriched in IgG content. The removal percentage for acidic whey 
protein was 95 %, 97% and 52% for α-Lac, β-Lac and BSA respectively in spent 
whey. The effect of pH and NaCl addition on the operation of YM100 10 kDa 
(Amicon) UF membrane for spent whey filtration was then studied. IgG was 
recovered on the retentate side of UF membrane and was subjected to diafiltration for 
further removal of small protein impurities. The final IgG powder recovered from 
acid and colostral have a 43% and 93% of IgG respectively, based on the total solid 
content.  
 
Bhattacharjee et al. (2006) used two stages UF membrane (10 and 30 kDa PES, 
Millipore) in rotating disc membrane module followed by anion exchanger 
membrane chromatography (Vivapure™ Q Mini-H column) to isolate β-Lac from 
whey protein concentrate. The effects of stirrer speed, membrane disc rotation, TMP 
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and solution pH on permeate flux and rejection were investigated in UF stage. The 
researchers suggested that the pH of whey should be kept in the range where β-Lac 
exists as a monomer (pH below 3) in order to obtain a highest separation between α-
Lac and β-Lac in UF module. The purity of final β-Lac products achieved after 
membrane chromatography step is 87.6%. Konrad et al. (2008) combined UF process 
with trypsin hydrolysis of β-Lac in order to recover adequate purity of α-Lac from 
sweet whey. The purity of α-Lac in the permeate fraction of Omega 100 kDa PES 
(Filtron), operated at optimal condition of 45°C, 2 bar TMP and pH 6.7, was only 
36%, which was 2.6 times higher than its initial value in whey. In order to increase 
the purity of α-Lac, this permeate fraction was further treated with trypsin hydrolysis 
to degrade all β-Lac found in the solution. The hydrolysate was subjected to second 
UF and diafiltration using a 10 kDa membrane to give the final α-Lac purity about 
90–95%.  
 
Based on the various studies described above, membrane filtration has great potential 
for isolating a single protein fraction from the whey. With the introduction of the 
high performance tangential flow filtration concept, it is believed that membrane 
filtration will become common in the near future especially for α-Lac recovery from 
whey.  
 
2.10 Membrane chromatography for whey protein 
fractionation 
There is a potential for membrane chromatography to be used as a large scale whey 
protein fractionation for several reasons. The similarities between membrane 
chromatography module and the existing ultrafiltration membrane in terms of 
processing configurations could be one of the benefits for installing membrane 
chromatography without the need of expensive changes in dairy plant (Etzel 1995). 
In view of the large volumes of whey that are produced every day in milk processing 
plants, a high throughput chromatographic system such as membrane 
chromatography has a significant potential for improving process efficiency (Splitt et 
al. 1996). In addition, membrane chromatography is not a volume dependent, rather 
it depends mostly on the capacity of the adsorbent in the membrane. 
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Table 2-8 shows the application of membrane chromatography for whey protein 
fractionation. Splitt et al. (1996) demonstrated that the chromatographic conditions 
were transferable from the cellulose- to the polymer-based membrane adsorbers 
carrying the same functional groups for whey protein fractionation. Under the 
optimized binding conditions at pH 6.5 with fine-tuned gradient elution, they are able 
to resolve BSA, α-Lac and β-Lac in single elution peak. Freitag et al. (1996) 
investigated the concept of mixed mode interaction membrane chromatography to 
bind all whey protein in a single pass through a connected series of membrane 
modules. Two modules of commercial anion exchanger membrane adsorber 
(Sartobind MA Q15, Sartorius, Gottingen, Germany) and one module of cation 
exchanger membrane chromatography (Sartobind MA S15, Sartorius) were 
connected in series and whey passed through at pH 6. However, elution of anion and 
cation module was done separately because α-Lac and IgG was eluted at the same 
salt concentration. Sartobind MA Q15 managed to resolve a single peak of α-Lac, 
BSA, β-Lag A and β-Lac B, while Sartobind MA S15 gave a single peak of IgG.  
 
Recent studies by Goodall et al. (2008) used anion exchange membrane 
chromatography to selectively bind β-Lac from whey. Goodall et al. (2008) observed 
in their flow through experiment that when the anionic membrane was saturated with 
whey, at some stage β-Lac could displace the other bound protein from the 
membrane. This can produce a flow through fraction that was depleted in β-Lac with 
increased concentration of α-Lac and BSA as compared to the original concentration 
in whey.  
 
For basic whey protein fractionation, Chiu and Etzel (1997) measured the 
breakthrough curves for LP and LF in sweet whey using a Sartobind membrane 
adsorber and demonstrated sustained membrane adsorber performance after 12 
repeated cycles of loading and elution, without cleaning between cycles. Ulber et al. 
(2001) used a two-step membrane process to recover LF from sweet whey. The first 
non-adsorptive step removed insoluble particles, such as lipids, caseins and 
precipitated proteins, by cross-flow filtration. The permeate stream was then fed to a 
commercial Sartobind cation exchange membrane adsorber. LF and LP were bound 
then eluted with a three-step NaCl salt gradient, yielding almost 95% LF purity. Plate 
et al. (2006) demonstrated that LF, LP and enzymatically prepared lactoferricin could  
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Table 2-8: Whey protein fractionation using membrane chromatography. 
Author Membrane type Ligands Protein 
of 
interest 
Protein source 
Goodall et al. 
2008 
Sartobind MA D-type and Q-
type (Sartorius) 
Q, 
DEAE 
β-Lac, α-
Lac, 
BSA 
whey, single β-
Lac, α-Lac and 
BSA, binary β-
Lac and BSA 
Wolman et al. 
2007 
PSF hollow fiber MF  Red 
HE-3B 
dye 
LF colostrum, whey 
Bhattacharjee 
et al. 2006 
Vivapure Q Mini-H 
(Vivasciences) 
Q β-Lac, α-
Lac 
permeate from 
two stage UF 
Plate et al. 
2006 
Sartobind MA S15, S-type cat. 
# S-10k-15-25 (Sartorius)  
SP LF, LP, 
LFcin 
whey 
Ulber et al. 
2001 
Sartobind S-type cat. # S-10k-
15-25 (Sartorius) 
SP LF whey 
Girardet et al. 
1998 
MemSep 1000 (Millipore) DEAE β-Lac, α-
Lac, 
BSA, 
whey 
Chiu and Etzel 
1997 
Sartobind MA S120 (Sartorius)  SP LF, LP whey 
Splitt et al. 
1996 
Sartobind MA Q15, MA Q100, 
MA D15 (Sartorius)  
Q, 
DEAE 
β-Lac, α-
Lac, 
BSA 
whey 
Freitag et al. 
1996 
Sartobind MA Q15, MA S15 
(Sartorius)  
 
Q, SP β-Lac, α-
Lac, 
BSA, 
IgG 
whey 
Weinbrenner 
and Etzel 1994 
MemSep 1010 (Millipore) SP α-Lac, 
BSA 
single α-Lac, 
single BSA, 
binary α-Lac and 
BSA 
Abbreviations: PSF - polysulfone, MF - microfiltration, Q - quaternary ammonium, SP - sulfopropyl, 
DEAE - diethyleaminoethyl, α-Lac - α-lactalbumin, β-Lac - β-lactoglobulin, BSA - bovine serum 
albumin, LF - lactoferrin, LFcin- lactoferricin, LP - lactoperoxidase, IgG - immunoglobulin. 
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be recovered with a Sartobind membrane adsorber at high purity and biological 
activity. The membrane was easily scaled up to 2 m2, with an LF recovery of about 
88%. 
 
Contrary to most previous studies which used ion exchange, Wolman et al. (2007) 
used affinity membrane chromatography (triazinic dye, RED HE-3B) for LF 
recovery from bovine whey and colostrum. A static binding capacity of 111 mg LF 
mL-1 was obtained and in flow through experiments, the LF recovery from colostrum 
was about 89%. The application of membrane chromatography for whey protein 
fractionation was predicted to be expanded and become more important in the future 
years. 
 
2.11 Other separation techniques for whey protein 
fractionation 
Besides chromatographic and membrane based separation techniques described in 
the above section, there are still an abundance of other techniques that have been 
employed in whey protein fractionation. This section highlights some of these 
methods although it is not the objective to cover all of them exhaustively. 
 
β-Lac was selectively isolated from the whey by forming a complex with chitosan 
(Casal et al. 2006; Montilla et al. 2007), by addition certain concentration of 
ammonium sulphate (Lozano et al. 2008), by precipitation of α-Lac with sodium 
citrate (Alomirah and Alli 2004) and by peptic hydrolysis followed with membrane 
filtration (Konrad et al. 2000). 
 
β-Lac interacted reversibly with chitosan by electrostatic interaction and formed a 
precipitate at pH 6.2. The β-Lac can be recovered by dissolving the precipitated in 
100 mM sodium acetate, pH 9 to give a recovery of 90% with a purity of 95% 
(Montilla et al. 2007). The isolated β-Lac can maintain its native structure and such 
use of non toxic chitosan would be of interest by in the industrial application. 
Meanwhile, Alomirah and Alli (2004) recovered a β-Lac from the supernatant of the 
α-Lac precipitation with sodium citrate. After several additional steps (i.e. washing, 
centrifuge, dialysis), single β-Lac with the purity ranging from 83-90% was 
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recovered. The yield of the β-Lac isolated from this process was reported in the range 
of 47-69%.  
 
A study by Lozano et al. (2008) showed that by precipitation with 50% (NH4)2SO4, 
β-Lac could be separated from the other whey protein. The precipitate was dissolved 
and separated again using 70% (NH4)2SO4, leaving a supernatant liquid enriched in 
β-Lac. After dialysis, lyophilize and reconstitute in water, the final purification was 
done by weak cation exchange chromatography. The total yield and purity of β-Lac 
from 3.5 L whey was 14.32% and 95% respectively. 
 
Konrad et al. (2000) compared four different techniques to isolate β-Lac from whey 
in large scale operations. These techniques were based on a peptic treatment, 
trichloroacetic acid precipitation, salting out procedure and selective thermal 
precipitation. The theoretical yield of native β-Lac after being normalized to 1 kg of 
whey achieved by different methods was 67.3, 44.9, 46.7 and 49.6% for the peptic 
treatment method, acid precipitation, salting out procedure and thermal precipitation 
respectively. The purity of β-Lac achieved by all methods was more than 90%. The 
peptic treatment technique was successfully applied to treat 10,000 L of whey 
without any difficulty in technical operation and product quality. 
 
Chemical precipitation with sodium hexametaphosphate was used to recover α-Lac 
from whey (Alomirah and Alli 2004). The yield of α-Lac precipitation with sodium 
hexametaphosphate was reported about 44-89% with α-Lac purity between 86-90% 
(Alomirah and Alli 2004). Tolkach et al. (2005) used selective thermal precipitation 
to isolate native α-Lac from WPC. Before precipitation, the environmental 
parameters of WPC were optimized in terms of total protein, lactose and calcium 
content, as well as pH value. The purity of α-Lac achieved by selective thermal 
precipitation of optimized properties of WPC was 98% with a recovery about 75%. 
 
Muller et al. (Muller et al. 2003a; Muller et al. 2003b) used two step processes to 
purify α-Lac from whey protein concentrates. In the first step, whey was filtered 
through 30 kDa UF with a proper operating condition to enhance the ratio of α-
Lac/β-Lac in permeate stream by minimizing the passing of other whey proteins 
(Muller et al. 2003a). In the second step, two options were investigated, second UF 
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module or selective precipitation route using citric acid (Muller et al. 2003b). The 
precipitation route was more promising as compared to UF, with the purity of α-Lac 
achieved in the range of 77-99% and yield of 46-83%, depending on the permeate 
properties from the first step of UF. Due to the excellent properties and promising 
application of whey protein components, it is believed that new technique was 
explored from time to time to achieve a single protein fractionation in economic 
ways. 
 
2.12 Conclusion 
The efforts in producing single proteins from whey grow continuously from year to 
year. Although most new techniques are based on lab scale operation, some of them 
have potential for large scale operation. Expanded bed chromatography for instance, 
could capture directly whey protein components without requiring whey pre-
treatment steps. High column backpressure is also absent in this operation mode 
compared to normal packed bed column chromatography. However, it is complex 
and consumes large amounts of buffer. In conventional membrane separations based 
on size, high performance tangential flow filtration has good potential for isolating 
small proteins such as α-Lac. With proper manipulation of the buffer system and 
membrane properties, α-Lac can be selectively permeated through the membrane 
while leaving other proteins in the retentate stream. However, the permeate is 
typically dilute and the need to manipulate the feed material conditions is a drawback 
compared with processing milk or whey directly.  
 
Membrane chromatography, which combines the principles of chromatography and 
membrane filtration, seems to have potential for whey protein fractionation. 
Membrane chromatography is not volume dependent but depends mostly on the 
capacity of the adsorbent in the membrane. It also can be operated at high throughput 
without affecting its performance. However, the normal routine for preparation of 
chromatographic membranes seems to be very complicated and involves many 
chemical steps. The concept of MMM preparation is interesting and feasible for large 
scale membrane manufacturing. However, until recently no one has applied MMM 
chromatography to whey protein separations. Therefore, the objectives of the current 
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study were to prepare various types of MMMs and to test their feasibility for 
applications in whey protein fractionation. 
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3 General materials and methods 
3.1 Materials 
EVAL (a random copolymer of ethylene and vinyl alcohol) with an average ethylene 
content of 44 mol% was purchased from Sigma (St. Louis, MO, USA) and used 
without chemical modification to cast membranes. Dimethysulfoxide (DMSO) 
(Fluka, Steinheim, Germany) was employed as the EVAL solvent and 1-octanol 
(Fluka) as a non-solvent additive in casting solutions. Adsorptive resins MMM 
include Lewatit MP500 (Lanxess) for anionic MMM, SP Sepharose Fast Flow (GE 
Healthcare Technologies) for cationic MMM and Phenyl Sepharose Low Substitute 
(GE Healthcare) for hydrophobic interaction MMM. 
 
β-Lac, α-Lac, BSA, LZY and cytochrome C were purchased from Sigma (St. Louis) 
and used without further purification. LF of known purity was sourced from Tatua 
Co-operative Dairy Company Ltd, Morrinsville, New Zealand.  
 
Sodium phosphate binding buffers were prepared from sodium phosphate dibasic 
heptahydrate (Sigma), sodium dihydrogen orthophosphate 1-hydrate (BDH 
Chemicals, Poole, England) and NaCl (BDH Chemicals). For sodium acetate buffer, 
sodium acetate (Merck, Darmstadt, Germany) and acetic acid (J. T. Baker, 
Philipsburg, NJ, USA) were used. (NH4)2SO4 for hydrophobic interaction buffer was 
purchased from BDH Chemicals. All buffer solutions were prepared using deionized 
(DI) water.  
 
3.2 Preparation of mixed matrix membrane 
Figure 3-1 showed the steps involved in preparing a MMM during this study. A 
homogenous polymer solution, consisting of 15 wt% EVAL polymer and 15 wt% 1-
octanol in DMSO was prepared by continuous stirring at about 60°C for several 
hours until all EVAL pellets were completely dissolved. The adsorbent resin to be 
incorporated into the polymer solution was firstly ground into a smaller size. The 
resin was ground using an ultra centrifugal mill (Retsch ZM100, Haan, Germany)  
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Figure 3-1: Preparation of mixed matrix membrane chromatography. 
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and screened to obtain a particle fraction that passed through at least 38 µm stainless 
steel mesh (or otherwise size mentioned). Ground resin was added to the prepared 
polymer solution at certain weight fraction (relative to the EVAL content in the 
polymer solution) and this mixture was stirred until a homogeneous casting slurry 
was obtained. 
 
A conventional casting method was used for making flat sheet mixed matrix 
membranes. The casting solution was poured onto a glass plate support and then 
spread to form a thin film using a stainless steel block (figure 3.2) with a 400 µm 
recess milled into the bottom surface. Immediately after casting, the glass plate with 
the film on the surface (now gelled through brief exposure to the atmosphere) was 
carefully immersed for coagulation in a water bath at 40°C until the membrane was 
completely solidified and detached from the glass. The resulting mixed matrix 
membrane was washed with water several times and left in the water bath overnight 
to completely remove traces of solvent from the membrane structure. The wet MMM 
was then freeze-dried to remove water without affecting the structure of the 
membrane.  
 
 
 
Figure 3.2: Membrane casting block made from stainless steel 316. The length of the 
block is about 220 mm with 45 mm equal width and height. Each edge of the block 
was milled to have different recess thicknesses of 200, 300, 400 and 500 µm.  
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3.3 Preparation of whey 
Skim (0.05% fat) milk was purchased from a retail store and heated to 40 °C in a 
water bath. Casein was precipitated by adjusting the pH between 4.6-4.8 with 0.5 M 
HCl under stirring. The precipitated casein was discarded and the whey supernatant 
was centrifuged at 17,902 g at 4 °C for 20 min using an Eppendorf Centrifuge Model 
5810R. Final whey filtration was achieved with a 0.45 µm membrane filter. The 
whey was adjusted to the desired pH using 0.5 M NaOH. 
 
3.4 Membrane porosity 
Membrane porosity was measured according to previously published methods 
(Avramescu et al., 2003; Saiful et al., 2006), with porosity, ε (%), defined as: 
 
%100×
−
=
wet
drywet
V
VV
ε     (3-1) 
 
where Vdry and Vwet are, respectively, the volume of the dry membrane and the 
volume of the swollen membrane after 24 h of immersion in a water bath at room 
temperature. The volume of dry membrane was calculated as the ratio between the 
weight of dried membrane and the polymer density. Before weighing the wet 
membrane, surface water was removed by lightly patting the membrane with filter 
paper. Average values were obtained from at least three different samples. 
 
3.5 Static binding capacity 
A known mass (dry basis) of adsorbent in different format (i.e. intact or ground resin, 
membrane) was equilibrated in binding buffer, 20 mM sodium phosphate pH 6.0 for 
at least 3 h. Pre-equilibrated adsorbent was then incubated with a series of initial 
protein concentration in a small Eppendorf tubes. Adsorbent and liquid in these tubes 
were gently mixed by inversion throughout binding for at least 12 h at room 
temperature. The binding capacity of each adsorbent was determined by the 
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difference between initial and the final total solution protein content per mass of 
adsorbent used. All experiments were carried out at least in triplicate. 
 
Static (equilibrium) binding capacity data was tested to fit using either Langmuir or 
Freundlich adsorption isotherm using a least-square regression method. Langmuir 
isotherm is given in Equation 3-2 and Freundlich isotherm is given in Equation 3-3. 
In these equations, q and qm are the equilibrium and maximum protein binding 
capacities in mg protein bound g-1 adsorbent respectively, c is the equilibrium protein 
concentration in mg mL-1, Kd is the Langmuir dissociation constant in mg mL-1 and K 
and n are the Freundlich constants. 
 
  
cK
cq
q
d
m
+
=        (3-2) 
 
 
nKcq =        (3-3) 
 
 
3.6 Dynamic binding capacity 
Sheets of MMM were cut into circles of diameter 44 mm to fit into a 47 mm 
diameter polypropylene filter holder (GE Osmonics Labstore, Minnetonka, MN) for 
dynamic binding experiments by dead-end filtration. A single membrane (volume 
0.304 mL) was used in all experiments. The filter holder was connected to an 
AKTAexplorer™ 100 (GE Healthcare Technologies) liquid chromatography system 
controlled by Unicorn™ software (GE Healthcare Technologies, Uppsala, Sweden). 
The membrane was equilibrated with a binding buffer before each protein or whey 
solution was continuously injected into the module. The permeate was collected 
using a fraction collector and the concentration in each fraction was assayed. If the 
same membrane was used for repeated experiment, the membrane was cleaned with 
0.5 M NaOH solution (30 min, 1 mL min-1 permeate flow rate) and flushed with 
water until the permeate pH was neutral. 
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The dynamic binding capacity was determined at 10% breakthrough using 
Equation 3-4, where qDBC is the dynamic binding capacity, VBT is the permeate 
volume at 10% breakthrough, cF is the feed protein concentration and m is dry mass 
of the MMM. 
 
m
cV
 q FBTDBC
×
=                  (3-4) 
 
 
3.7 Single protein assay 
3.7.1 UV-visible spectrophotometer 
Most of the single protein concentrations were assayed by measuring absorbance of 
solution at 280 nm using an UV-Visible spectrophotometer (Model Ultraspec 2100 
Pro, Amersham Biosciences, England). An absorbance-concentration standard curve 
was developed from six standard concentrations from 0 to 1 mg mL-1. Samples were 
diluted with reference buffer to within the absorbance range of the standard curve. 
 
3.7.2 Size exclusion chromatography 
Single protein concentrations of β-Lac and α-Lac for determined a static binding 
capacity of anion exchanger MMM were measured by size exclusion 
chromatography using a Superdex200™ HR 30/10 column (GE Healthcare 
Technologies) (length 300 mm, diameter 10 mm) attached to an AKTAexplorer 10 
liquid chromatography system controlled by Unicorn 4.0 software. Protein samples 
(40 µL) were injected into the column by an autosampler and eluted isocratically 
with one column volume of phosphate buffered saline (pH 7.4) at 0.5 mL min-1. The 
absorbance of the system was continuously monitored at 280 nm and the protein 
concentrations were determined by comparing the peak areas of unknown samples 
with those of a set of standard samples.  
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3.8 Whey protein assay 
Whey protein components were assayed using a reverse phase chromatography 
(RPC) column following the established method by Elgar et al. (Palmano and Elgar 
2002; Elgar et al. 2000). The assay was run on an AKTAexplorer 10 liquid 
chromatography system controlled by Unicorn 4.0 software with samples manually 
injected through a sample injection loop. A 1 mL Resource™ RPC column (GE 
Healthcare Technologies) was used with 0.1% v/v trifluoroacetic acid (TFA) (Sigma) 
in DI water as buffer A and 0.09% v/v TFA, 90% acetonitrile (J. T. Baker) in DI 
water as buffer B. The column was equilibrated with five CV’s of 20% buffer B 
before a 500 µL sample was injected manually. A series of linear gradients were then 
applied as follows: 0-1 CV, 20% B; 1-6 CV, 20-40% B; 6-16 CV, 40-45% B; 16-19 
CV, 45-50% B; 19-20 CV, 50% B; 20-23 CV, 50-70% B; 23-24 CV, 70-100% B. 
The column was then held for 1 CV at 100% B, followed by a 2 CV linear gradient 
to 20% B, then held for 3 CV. Detection was by absorbance at 214 nm and a flow 
rate of 2 mL min-1 was used. The standard curve of peak area versus concentration 
was developed using a dilution series from a mixture of pure proteins corresponding 
to their composition in whey. Figure 3-3 shows an example of whey chromatogram 
assayed by this technique. 
 
3.9 Gel electrophoresis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was run 
using a NuPAGE® Novex® 4-12% Bis-Tris Midi Gel from Invitrogen (Carlsbad, CA, 
USA) under non-reducing or reducing conditions. Protein samples were mixed with 
NuPAGE LDS 4X (Invitrogen) sample buffer and/or NuPAGE Reducing Agents 
10X (Invitrogen), and heated at 80°C for about 10 minutes. The gel was mounted 
into a XCell4 SureLock™ Midi-Cell (Invitrogen), filled with NuPAGE MES SDS 
(Invitrogen) running buffer and connected to PowerPac™ HC (BioRad, Hercules, 
CA, USA) power supply. 5 µL of Novex Sharp Pre-Stained (Invitrogen) protein 
standard (or in some experiment using BioRad Precision Plus Protein Pre-Stained 
Standards), was used as a protein marker and 20 µL of sample was loaded in each 
well. The gel was run for 40 minutes at constant voltage of 200 V. Proteins were 
stained with Coomassie Brilliant Blue R 250 (Sigma), 0.125% (w/v) in 10% acetic  
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Figure 3-3: Chromatogram for whey assayed using Resource RPC 1 mL reverse phase chromatography. Abbreviation: α-Lac- α- lactalbumin, LF 
- lactoferrin, BSA - bovine serum albumin, β-Lac - β-lactoglobulin, IgG - immunoglobulin. 
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acid and 40% methanol. Destaining was carried out in a solution of 10% acetic acid 
and 20% methanol in water. Typical SDS-PAGE gels for whey protein under 
reducing and non-reducing conditions are shown in figure 3-4. 
 
3.10 AKTA cross-flow system 
Cross-flow experiments were run using an AKTAcrossflow™ (GE Healthcare Life 
Sciences) tangential flow filtration system. The filtration system was fully automated 
and controlled by Unicorn 5.11 software. 
 
The main system components were a 350 mL reservoir tank, the membrane module, 
a transfer valve (8 lines), retentate valve (3 lines) and a permeate valve (4 lines) 
(figure 3-5). All pressures in feed, retentate and permeate lines were recorded 
continuously by the system. On the permeate side, conductivity, pH and UV 
absorbance were continuously monitored. The instrument could be run under either a 
constant flux or a constant TMP mode. A custom plate-and-frame module was 
fabricated to connect to the cross-flow instrument (figure 3-6). The module was 
rectangular, with dimensions 10.5 cm × 15.5 cm. This module could house several 
layers of membrane, each with an effective active membrane area of 50 cm2.  
 
Cross-flow experiments were conducted for LF recovery from whey using cation 
exchange MMM. 20 mM sodium phosphate pH 6 was used as a binding buffer and 1 
M sodium chloride was added to binding buffer as an elution buffer in cross-flow 
experiment. The feed flow rate of 50 mL min-1 and permeate flux of 100 L m-2 h-1 
(LMH) was used throughout the experiment, except in whey loading step where flux 
of 50 LMH was used. 
 
The membrane was equilibrated with binding buffer until the cumulative permeate 
volume reached to a value of 300 mL. During loading, 150 mL of whey was 
circulated past the membrane and both retentate and permeate streams were recycled 
back into the feed reservoir. Whey loading was completed when the cumulative 
permeate volume reached 300 mL. After the loading step, a liquid in retentate side 
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Figure 3-4: Typical SDS-PAGE for whey protein run under (a) non-reducing and (b) reducing condition. 
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Figure 3-5: AKTAcrossflow™ tangential flow filtration system. 
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was drained and flushed several times with binding buffer (about 1000 mL). Then, 
200 mL of fresh binding buffer was transferred to the reservoir for a washing step. 
 
The buffer was fed into the membrane until the cumulative permeate volume reached 
150 mL. The remaining fluid in the reservoir after the washing step was drained for 
the next step. The reservoir was filled with 120 mL of elution buffer and fed into the 
membrane until the permeate volume of 90 mL. All the retentate and permeate 
fractions in each steps were collected for the analysis. Fresh membranes were used 
for each part of cross-flow experiment and triplicate experiments were conducted in 
each experiment.  
 
 
 
Figure 3-6: Plate-and-frame module used in AKTAcrossflow system which is made 
from perspex. Each part of the module has a dimension about 155 mm × 105 mm 
with 23 mm thickness. The effective membrane exposure dimension is about 100 
mm × 50 mm which give an effective membrane area of 50 cm2. 
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4 Anion exchange mixed matrix membrane 
chromatography for β-lactoglobulin fractionation 
from whey 
4.1 Introduction 
In this chapter, the development of anion exchange MMM chromatography for acidic 
whey protein fractionation is described. The MMM chromatography was prepared 
using EVAL polymer and Lewatit MP500 anion exchanger resin to form a flat sheet 
membrane. The MMM was characterized in terms of structure and its static and 
dynamic binding capacities were measured. The anionic MMM shows a selective 
binding to β-Lac in whey with a binding preference order of β-Lac > BSA > α-Lac. 
The β-Lac content of bovine milk (El-Agamy 2007; Fox and McSweeney 1998)  is 
much higher than in human milk and this has been identified as a potential source of 
allergic reactions to infant formulae seen in some children (El-Agamy 2007; Monaci 
et al. 2006; Suutari et al. 2006). Selective removal of β-Lac may therefore be of 
interest in the commercial application of this anionic MMM chromatography. 
 
4.2 Materials and methods 
4.2.1 Anion exchanger resin 
Lewatit anion exchanger, MonoPlus MP500 resin was selected as a resin to be 
incorporated in membrane matrix. This resin was a gift from Lanxess (Leverkusen, 
Germany) through their local supplier (Ashland Drew, New Zealand Limited). 
MP500 resin is a macroporous, strong anion exchanger made from a 
divinylbenzene/styrene base matrix with a quaternary amine functional group. The 
mean diameter of the resin particles as reported by the supplier was approximately 
0.62 mm, the average pore size was 43 nm, porosity was 0.2 mL g-1, surface area 20 
m2 g-1 and the pKa of the resin was 9-9.5. 
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4.2.2 Preparation of mixed matrix membranes 
Ground MP500 resin particles, which have a particle size smaller than 43 µm, were 
added to the membrane polymer solution at 50% weight fraction relative to the 
EVAL content in the polymer solution. This mixture was stirred until a homogenous 
casting slurry was obtained and was cast into a flat sheet membrane as described in 
detail in section 3.2. The porosity of the membrane was measured according to the 
protocol in section 3.4. 
 
4.2.3 Preparation of whey 
Whey was prepared from skim milk by acid precipitation of casein at pH 4.8 as 
described in section 3.3. The final pH of whey after a series of filtration was adjusted 
to pH 6.0. The concentrations of the major protein components in whey were 
determined using reverse phase chromatography as described in section 3.8. Table 4-
1 shows the major acidic protein composition of the whey prepared by this method. 
 
Table 4-1: Composition of β-lactoglobulin, α-lactalbumin and bovine serum albumin 
in whey prepared in this study. Data shown is based on average values ± one 
standard deviation (n=3). 
Protein Concentration, mg mL-1 
β-Lactoglobulin 3.716 ± 0.715 
α-Lactalbumin 1.030 ± 0.141 
Bovine serum albumin 0.102 ± 0.022 
 
4.2.4 Static binding capacity 
Static binding capacities of the MMM as well as intact and ground MP500 resin were 
determined for both α-Lac and β-Lac pure protein solutions. A known mass of each 
adsorbent, typically 10 mg of intact resin and ground resin, and about 30 mg of 
MMM (a single, rectangular piece of membrane, 12 mm × 22 mm, volume 5.3 × 10-2 
mL), was equilibrated for 3 h in binding buffer at the optimum binding pH (6.0) and 
then incubated with six initial protein concentrations from 0.25 to 8 mg mL-1 protein 
overnight. Samples were mixed gently by inversion throughout binding. The binding 
capacity of each adsorbent was determined by difference between initial and final 
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total solution protein content per mass of adsorbent used (dry basis). The equilibrium 
protein concentrations were assayed using a size exclusion chromatography method 
(section 3.7.2). All experiments were carried out at least in triplicate. Several 
experiments were conducted using protein solutions with salt concentrations that 
gave a conductivity equal to that of whey. Binding capacities were also determined 
with whey by the same methods.  
 
The effect of pH on binding was also determined. Sodium phosphate (20 mM) 
buffers at seven pH values (pH 4.0-8.0) were prepared and the static (equilibrium) 
binding capacity of the intact MP500 resin was measured. A predetermined amount 
of resin was measured accurately and equilibrated for 3 h in binding buffer, then 
incubated overnight in 3 mg mL-1 β-Lac in binding buffer at each pH before 
determining the equilibrium binding capacity as described above. 
 
4.2.5 Dynamic binding capacity 
The dynamic binding capacity of MMM for β-Lac was measured at different flow 
rates from 1 to 5 mL min-1 according to the method described in section 3.6. The 
binding capacity for BSA was also measured to compare it with published values for 
other adsorptive membranes. Using a similar method to that of Goodall et al. (2008), 
1 mg mL-1 BSA solution was loaded on to the pre-equilibrated membrane and 
permeate fractions were collected and monitored for UV absorbance. Protein loading 
was stopped when the absorbance of the permeate reached the same absorbance as 
the feed solution. The membrane was then washed with binding buffer until 
absorbance of the permeate fell to the original baseline. The bound BSA was 
determined by the mass difference between the feed protein and the protein collected 
in the permeate fractions. 
 
4.2.6 Batch fractionation of whey 
Batch fractionation of whey was tested using small pieces of membrane of known 
weight. Five randomly selected samples of MMM were equilibrated for 3 h in 20 
mM sodium phosphate at pH 6.0 and then incubated in whey at pH 6.0 overnight at 
room temperature. The membrane was removed from the whey solution and washed 
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with equilibration buffer for 30 min. It was then incubated overnight in an elution 
buffer of 1 M NaCl in 20 mM sodium phosphate, pH 6.0, to recover the adsorbed 
protein from the membrane. 
 
Another experiment was conducted to find the binding preference of major acidic 
protein in whey to anionic MMM. Two sets of whey solution were used. The first set 
was whey prepared with a serial dilution of concentration using the binding buffer. 
The second set was a simulated whey solution consisting of the major whey acidic 
proteins β-Lac, BSA and α-Lac at a similar concentration ratio to whey but with the 
concentration of β-Lac undergoing a serial dilution while the concentrations of BSA 
and α-Lac kept constant at 0.15 mg mL-1 and 1.2 mg mL-1, respectively. The 
membrane was first equilibrated for 6 h in binding buffer. After drying by lightly 
padding the membrane with adsorptive tissue, the membrane was incubated with 1 
mL of whey solution overnight at room temperature (20°C). 
 
4.2.7 Single and mixture protein assay 
Single proteins were assayed using a Superdex200™ HR30/10 column (GE 
Healthcare Technologies) as described in section 3.7.2. For whey protein 
components, a 1 mL Resource™ (GE Healthcare Technologies) reverse phase 
chromatography column was used with the detailed protocol described in section 3.8. 
 
4.3 Results and discussion 
4.3.1 Structure of mixed matrix membranes 
Membrane structure can have a significant impact on membrane performance, such 
as adsorption capacity and adsorption rate, especially when substances of different 
sizes are to be separated (Liu and Bai 2006). Sponge-like and macrovoid-free 
structures, with highly interconnected and open pores are desirable for adsorptive 
membranes because they provide large internal surface areas for adsorption and 
uniform flow across the membranes to ensure process efficiency (Avramescu et al. 
2002; Liu and Bai 2006). The presence of macrovoids should be avoided because 
these cause weak spots in the membrane, leading to mechanical failure under 
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pressure. Furthermore, macrovoids create channels and lead to lower dynamic 
adsorption capacities, due to by-passing of part of the adsorptive area (Avramescu et 
al. 2003b). 
 
Figure 4-1 shows the structure of the base (EVAL) membrane and the corresponding 
MMM by scanning electron microscope (SEM). Although the EVAL membrane has 
the desired open interconnected pore structure from the bottom to the top surface, 
there are minor macrovoids evident near the top of the membrane surface. However, 
these macrovoids disappeared after incorporating MP500 resin particles to form the 
MMM. According to Avramescu et al. (2003b) the solid particles can act as nuclei in 
casting solutions, limiting the growth of macrovoids. (Large holes in the MMM seen 
in figure 4-1 are likely due to removal of resin particles during the membrane 
fracture process after freezing in liquid nitrogen for SEM analysis.) The top and 
bottom surfaces of the MMM do not contain resin particles so retain the same 
permeable areas as the base membrane. Thus, MMMs are expected to have similar 
pressure drops to other membrane chromatography systems.  
 
Although it would be unwise to extrapolate results, for a single membrane thickness 
(200 µm) we observed (data not shown) backpressures of less than 1 bar at pure 
water permeate flow rates up to 20 mL min-1, corresponding to a flux rate of 788 L 
m
-2
 h-1(LMH), which is well in excess of normal membrane flux rates (less than 100 
LMH).  
 
Resin grinding allows the resin particles to bind tightly within the MMM structure 
and improves the homogeneity of distribution of resin particles throughout the 
membrane matrix. A potential disadvantage of the MMM approach to creating 
adsorptive membranes, compared to chemically modified membranes, is that the 
embedded resin particles within the membrane present a diffusive path length that 
might slow down dynamic binding. However, resin particle size reduction by 
grinding also increases the interfacial surface area between permeate and resin and 
decreases the diffusion path length to the internal ion exchange sites, both of which 
improve the dynamic ion exchange capacity. Figure 4-1 shows that the resin particles 
are tightly held within the membrane matrix, although the uniformity of the particle 
size could perhaps be improved. A narrow size distribution of resin particles should 
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improve membrane structure and minimize batch-to-batch variations in membranes 
during manufacture. 
 
 
a  
 
d 
 
b 
 
e 
 
c  
 
f  
 
Figure 4-1: Structure of EVAL and mixed matrix membranes. (a) EVAL membrane 
cross section; (b) EVAL membrane top surface; (c) EVAL membrane bottom 
surface; (d) MMM cross section; (e) MMM top surface; (f) MMM bottom surface. 
 4-7 
The porosity of the membrane was calculated to be approximately 74%, which is 
quite similar to membranes prepared by Wessling’s group (Avramescu et al. 2003a; 
Saiful et al. 2006). The thickness of the membrane after freeze drying was measured 
by a micrometer to be approximately 200 µm. 
 
4.3.2 Effects of pH on binding capacity of MP500 resin 
Figure 4-2 shows the binding capacity of intact MP500 resin for β-Lac at different 
pH values. The maximum binding capacity was achieved around pH 5-6 which is 
near the pI of β-Lac (pH 5.35-5.49 (Fee and Chand 2006)). Intuitively, one would 
expect the binding to increase as the pH of binding deviates upwards from the pI of 
the protein, as the protein would be more highly charged at higher pH values. 
However, several authors have reported similar results where the highest binding 
capacity occurs near the pI of the protein (Saiful et al. 2006; Yamamoto and Ishihara 
1999) and it is recognized now that ion exchange properties of proteins cannot be 
fully explained by the net charge concept alone (Kacar and Arica 2001). Changes of 
buffer pH can alter the charge distribution, charged group in the contact regions, 
conformational structure, and zeta potential of the surface of proteins. All of these 
effects will influence the protein binding to the adsorbent. According to Norde and 
Lyklema (1991), at the pI of protein, a compact structure is favored, due to the 
London–van der Waals interactions, which can allow the protein to pack more tightly 
on the surface of the adsorbent. One would not expect β-Lac to bind at pH values far 
below its pI and the low binding observed at pH 4.0 is likely due to small 
hydrophobic interactions or weak electrostatic interactions due to uneven charge 
distributions on the protein surface. 
 
4.3.3 Binding capacity of MP500 resin 
The binding capacity of intact and ground MP500 resin is shown in figure 4-3 for β-
Lac and α-Lac. The data was fitted to a Freundlich adsorption isotherm (Equation 3-
3) using a least-square regression method (table 4-2). A Langmuir isotherm did not 
provide a good fit to the data, contrary to previous work (Avramescu et al. 2003a; 
Avramescu et al. 2003b; Lin et al. 2001; Saiful et al. 2006). The Freundlich constants 
for different forms of adsorbent are shown in table 4-2. 
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Figure 4-2: Binding capacity of intact MP500 Lewatit anion exchange resin for β-
Lac at various pH values. Error bars are ± one standard deviation (n=3). 
 
 
 
Table 4-2: Freundlich isotherm constants (Equation 3-3) for different types of 
adsorbents in static binding experiments. 
β-Lactoglobulin  α-Lactalbumin 
Adsorbent K n  K n 
Intact MP500 104.031 0.325  98.874 0.341 
Ground MP500  254.374 0.149  131.990 0.269 
MMM Chromatography 136.263 0.090  74.889 0.207 
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Figure 4-3: Static binding capacity of intact and ground MP500 resin for a range of 
β-Lac and α-Lac solution concentrations at pH 6 and room temperature (20°C). Error 
bars are ± one standard deviation (n=3). 
 
 
As mentioned above, one reason for grinding the MP500 resin was to increase the 
protein adsorption capacity of the resin by reducing diffusion path lengths. Figure 4-
3 shows that the equilibrium adsorption capacity for both β-Lac and α-Lac also 
improved dramatically after the resin was ground into particles less than 43 µm 
diameter. The equilibrium binding capacity of β-Lac increased from about 150 mg β-
Lac g-1 resin to 300 mg β-Lac g-1 resin, and for α-Lac it increased from 140 mg α-
Lac g-1 resin to 180 mg α-Lac g-1 resin. The smaller resin particles would have 
possessed increased total surface areas for binding and, although not reflected in 
equilibrium data, equilibrium would be reached faster because of reduced diffusion 
path lengths between the protein and adsorbent.  
 
β-Lac, which is a larger molecule than α-Lac, showed a significant increase in 
binding capacity in ground resin relative to the increase in α-Lac binding. It is 
possible that grinding increased accessibility to internal pores, especially if there are 
 4-10 
compartmentalized regions within the intact resin between which proteins cannot 
transport. The higher β-Lac adsorption than α-Lac adsorption in both intact and 
ground resins at pH 6.0 may be due to the charge distribution and structural 
rearrangements of β-Lac molecules being more favorable to the adsorption process 
than those of α-Lac molecules, despite their similar isoelectric points. 
 
4.3.4 Binding capacity of membrane 
Figure 4-4 shows the static binding capacities of the EVAL membrane and the 
MMM for β-Lac and α-Lac single protein solutions. The EVAL base membrane 
showed a low non-specific adsorption of β-Lac, following a linear relationship with 
protein concentration. Incorporation of ground MP500 resin in the base membrane 
increased the β-Lac adsorption capacity about sevenfold, with elution by salt. 
Clearly, the anion exchange resin particles in the membrane structure accounted for 
the increase in adsorption. The adsorption of β-Lac was higher than α-Lac for all 
feed solutions applied during this study. The maximum β-Lac capacity approached 
150 mg β-Lac g-1 membrane compared to an α-Lac capacity of only 90 mg α-Lac g-1 
membrane. The equilibrium binding capacities of these proteins at the concentrations 
typically found in bovine whey (3 mg mL-1 β-Lac and 1.2 mg mL-1 α-Lac 
(Bhattacharjee et al. 2006)) were about 140 mg β-Lac g-1 membrane and 75 mg α-
Lac g-1 membrane. Goodall et al. (2008) showed a similar pattern in which the static 
binding capacity of β-Lac capacity is higher than α-Lac in commercial Sartobind 
strong and weak anion exchange membranes. However, in whey, the existence of 
other proteins and salts could potentially influence the adsorption process. We tested 
the binding of these proteins individually in solutions with the same conductivity as 
whey (6.14 mS cm-1) and at their typical whey concentrations (figure 4-4). The 
binding capacities under these conditions were 80 mg β-Lac g-1 membrane and 20 
mg α-Lac g-1 membrane. The binding capacity for β-Lac at the typical whey 
conductivity was almost as high as that of salt-free α-Lac. 
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Figure 4-4: Static binding capacity of an EVAL membrane and a MMM for β-Lac 
and α-Lac. For β-Lac (salt) and α-Lac (salt) data, the conductivity of the binding 
buffer was the same as that of a typical whey solution (6.14 mS cm-1). All 
measurements were at pH 6 and room temperature (20°C). Error bars are ± one 
standard deviation (n=3). 
 
4.3.5 Batch fractionation of whey proteins using MMM chromatography 
Experiments on fractionation of the major acidic whey proteins resulted in average 
binding capacities of 3.540 mg α-Lac g-1 membrane, 0.543 mg BSA g-1 membrane, 
and 75.639 mg β-Lac g-1 membrane (table 4-3). Recoveries of 77.7-84.6% compares 
well with reported values for packed bed chromatography (Doultani et al. 2003). The 
MMM capacity for β-Lac in whey was almost the same as for pure β-Lac binding 
with a similar conductivity (figure 4-4). However, the α-Lac binding capacity in 
whey was significantly reduced compared to its value with pure protein at the same 
conductivity as whey. This result is consistent with a previous study on the binding 
of whey proteins by chitosan, which also showed selective binding of β-Lac over  
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Table 4-3: Whey protein fractionation using MMM chromatography in batch adsorption at room temperature overnight. 
ID MMM mass 
(mg) 
Protein 
type 
Total protein in 
solution (mg) 
Protein bound to membrane 
(mg) 
mg protein bound g-1 
membrane 
Protein elute after elution 
(mg) 
Recovery 
(%) 
1 16.20 α-Lac 
BSA 
β-Lac 
1.250 
0.109 
4.252 
0.060 
0.011 
1.220 
3.716 
0.682 
75.329 
0.000 
0.000 
0.983 
0.00 
0.00 
80.51 
2 17.52 α-Lac 
BSA 
β-Lac 
1.250 
0.109 
4.252 
0.041 
0.008 
1.287 
2.367 
0.456 
73.448 
0.000 
0.000 
1.089 
0.00 
0.00 
84.60 
3 17.07 α-Lac 
BSA 
β-Lac 
1.250 
0.109 
4.252 
0.053 
0.020 
1.263 
3.082 
1.149 
73.995 
0.000 
0.000 
1.004 
0.00 
0.00 
79.49 
4 16.95 α-Lac 
BSA 
β-Lac 
1.250 
0.109 
4.252 
0.082 
0.006 
1.352 
4.831 
0.328 
79.749 
0.000 
0.000 
1.050 
0.00 
0.00 
77.69 
5 17.14 α-Lac 
BSA 
β-Lac 
1.250 
0.109 
4.252 
0.063 
0.002 
1.297 
3.704 
0.103 
75.675 
0.000 
0.000 
1.039 
0.00 
0.00 
80.09 
Average α-Lac 
BSA 
β-Lac  
  3.540 ± 0.910 
0.543 ± 0.398 
75.639 ± 2.474 
 0 
0 
80.48 ± 2.54 
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other proteins in whey at pH 6.0 (Casal et al. 2006). This behaviour may be due to 
the distribution of electrostatic charges on the surface of the protein. It is believed 
that in α-Lac molecules, most of the positively charged amino acid residues are 
located near each other and there is also one particularly large charge patch, 
consisting of a cluster of six positively charged groups (De Vries 2004). The 
presence of this large positively charged patch may give rise to a strong reduction in 
the electrostatic attraction between α-Lac and the MP500 resin, favoring competitive 
adsorption of β-Lac from whey. 
 
4.3.6 Binding preference of acidic whey proteins to anionic MMM  
At pH 6, all negatively whey protein like β-Lac, α-Lac and BSA has an ability to 
interact with anion exchanger membrane. However, in previous studies (Goodall et 
al. 2008), β-Lac showed most selective binding toward strong anion exchanger 
membrane. It even could displace other positively proteins bound onto the anionic 
membrane. The binding strength of three major proteins on anion exchanger 
membrane could be postulated according to this order: β-Lac > BSA > α-Lac 
(Goodall et al. 2008; Weinbrenner and Etzel 1994). To verify this order, a series of 
batch adsorption using whey and simulated whey was conducted. Figure 4-5 shows 
the amount of individual protein bound onto the anion exchange MMM from a series 
of initial whey solution with different dilution factor. As illustrated in figure 4-5, β-
Lac is preferably bound to the anion exchange membrane and for the small area of 
membrane used in this experiment, it has a specific capacity of about 1 mg for β-Lac 
(or capacity of 21 mg β-Lac mL-1 MMM). We may see that when the whey was 
diluted 4 times (whey 4X), nearly 100% β-Lac was bound, 90% BSA bound and less 
than 10% α-Lac bound. In whey 8X, since β-Lac in solution was less than 1 mg, all 
the β-Lac was firstly bound and at this stage the remaining membrane capacity would 
go for another protein as shown in an increase in binding percentage (almost 80% for 
α-Lac and 90% for BSA).  
 
A further experiment using a simulated whey solution with serial dilution of β-Lac 
concentration (i.e. α-Lac and BSA concentration kept constant) was also conducted 
for another verification. Figure 4-6 shows the binding capacity of the MMM for this 
simulated whey solution. The specific β-Lac capacity was above 1.5 mg which was  
 4
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Figure 4-5: Individual protein bound onto anion exchange MMM using a 1 mL of whey solution with different initial concentration. Whey was 
diluted with the binding buffer in a serial dilution. Error bars are ± one standard deviation (n=3). 
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Figure 4-6: Individual protein bound onto anion exchange MMM using a 1 mL of simulated whey solution with different initial of β-Lac 
concentration. The concentration of α-Lac and BSA was kept constant at 1.2 mg mL-1 and 0.15 mg mL-1 respectively. Error bars are ± one 
standard deviation (n=3).
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higher than a real whey solution previously. This could be due to the absence of ion 
or another minor proteins or peptide component in this simulated whey which has 
minimized the competitive β-Lac binding to the membrane. The pattern was similar, 
after one stage when there was not enough β-Lac for the MMM to bind, this specific 
capacity will goes to another protein preferably BSA. In the simulate whey solution 
3, almost 50% of BSA bound compared to α-Lac which is only 20 % bound. The rest 
of solution showed almost 90% of BSA bound and the percentage of α-Lac bound 
was gradually increased. These results confirmed that anion exchange MMM 
followed a similar binding preference order of β-Lac > BSA > α-Lac as reported in 
the previous studies (Goodall et al. 2008; Weinbrenner and Etzel 1994). 
 
4.3.7 Dynamic binding capacity of MMM chromatography 
The capacity of the MMM for a standard protein, BSA, was 96 ± 7.4 mg BSA g-1 
MMM or 29 ± 2.3 mg BSA mL-1 MMM or 0.58 ± 0.04 mg BSA cm-2 MMM. This 
compares well with the binding capacities for several adsorptive membranes reported 
by Roper and Lightfoot (1995) that ranged from 3 to 50 mg macromolecule mL-1 of 
membrane and with the commercial membrane Sartobind Q, which has a reported 
capacity of about 0.8 mg BSA cm-2 membrane (Goodall et al. 2008). 
 
Figure 4-7 shows the effect of flow rate on the β-Lac dynamic binding capacity of 
the MMM. A flow rate of 5 mL min-1 in the MMM corresponds to a permeate flux 
rate of just under 200 LMH, which is a high flux rate for a membrane. The results 
show that flow rate does not have a significant effect on dynamic binding capacity, 
which is most likely due to the high rate of convective transport of the protein within 
the membrane and minimal diffusive path lengths within the membrane and the 
finely ground resin particles. This is a characteristic of almost every adsorptive 
membrane system reported in the literature and is one of the main advantages of this 
technology, an advantage apparently not reduced by the incorporation of resin 
particles rather than chemical modification of the base membrane. 
 
It is interesting to note that the dynamic binding capacity of β-Lac in whey is higher 
than that of pure β-Lac prepared in the binding buffer as shown in figure 4-7 (protein 
concentration of 3 mg mL-1).  
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Figure 4-7: Effect of flow rate on the β-Lac dynamic binding capacity of MMM 
chromatography for pure (salt-free) protein solution of 3 mg mL-1 and 4 mg mL-1, 
whey and a pure protein solution 3 mg mL-1 having the same conductivity as whey 
(6.14 mS cm-1). All measurements were at pH 6 and room temperature (20°C). Error 
bars are ± one standard deviation (n=3). 
 
 
We hypothesized that this difference might be due to the salt concentration in whey 
allowing a greater surface mobility of the bound protein near pore entrances, thus 
lowering steric hindrance of subsequent binding events. Therefore we adjusted the 
conductivity of the pure β-Lac solution to the same value as found in whey and tested 
its dynamic binding capacity (labelled ‘β-Lac (3mg mL-1, salt)’ in figure 4-7). 
However, the dynamic binding capacity for pure β-Lac (salt) was much lower than 
that of pure β-Lac prepared in either low-salt binding buffer (3 mg mL-1) or actual 
whey. 
 
Due to the variation of the β-Lac concentration in whey, there is a possibility that its 
concentration may have been higher than 3 mg mL-1. Since higher initial protein 
concentration will contribute to higher binding capacity, especially in the region 
below its saturation point, the dynamic binding capacity of the MMM was checked 
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using a higher initial β-Lac concentration. As expected, the dynamic binding capacity 
at 4 mg mL-1 was higher than at 3 mg mL-1 and in whey (figure 4-7), consistent with 
the concentration in whey being between 3 and 4 mg mL-1 (table 4-1). The same 
membrane was used after cleaning between runs for all dynamic capacity 
experiments and figure 4-7 shows that there was no significant loss of capacity with 
re-use of the membrane. 
 
When considering how these results relate to industrial scale applications, a suitable 
size basis must be chosen for calculating productivity (i.e., production rate of protein 
per unit size of equipment). Productivity comparisons between membrane 
chromatography and packed-bed chromatography on the basis of unit volume is not 
straightforward, as membrane volume alone does not account for hold-up volume in 
the membrane housing, which is typically about four times the membrane volume. 
Resin volume figures, on the other hand, usually include void volume (approximately 
40%) so approximate the total column volume. For membrane separations, 
equipment is usually sized by membrane area so productivity calculations on this 
basis are probably the most appropriate, unless comparisons with packed-bed 
chromatography are desired. 
 
In the following productivity estimates, figures calculated using all three bases are 
given. A 1,000 m2 MMM has a volume of about 200 L (at 200 µm thickness) and 
from our results this has an adsorption capacity of about 5 kg of protein, equivalent 
to the β-Lac content of 1,666 L of whey. If we allow for a typical chromatographic 
cycle of 5 CV equilibration buffer, 1,666 L feed loading, 2 CV wash, 1 CV elution 
and 2 CV regeneration, this amounts to 3,366 L of permeate per cycle. At a modest 
50 L m-2 h-1 permeate flux rate, this would have a total cycle time of approximately 
4 min. Productivity on the basis of membrane volume is therefore 371 g L-1membrane h-
1
. A 1,000 m2 spiral-wound membrane module would typically have a hold-up 
volume of 1 m3 (Cheryan 1998) so this productivity corresponds to 74 g L-1module h-1 
on a membrane module volume basis or 74 g m-2 h-1on a membrane area basis. These 
values compare well with reported values in the range 18-60 g L-1resin h-1 for 
laboratory-scale batch and packed-bed chromatography systems for whey protein 
isolate production and 240 g L-1resin h-1 estimated for industrial-scale systems 
(Doultani et al. 2003). 
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4.4 Conclusions 
MMMs, which incorporate adsorptive particles during membrane casting, can be 
prepared simply and have performances that are competitive with other membrane 
chromatography materials. MMM prepared in this study showed excellent potential 
for a whey protein fractionation application, particularly for selective binding of β-
Lac. The membrane had a defect-free structure and provided a high binding capacity 
for β-Lac in whey solution, compared with other proteins. The MMM had maximum 
equilibrium binding capacities of 150 mg β-Lac g-1 membrane (36 mg mL-1 
membrane) and 90 mg α-Lac g-1 membrane (27 mg mL-1 membrane) in individual 
pure protein experiments. In batch fractionation of whey, the MMM had almost the 
same binding capacity for β-Lac as it did for pure β-Lac. The dynamic binding 
capacity of β-Lac in whey solution was not affected significantly by flow rate and 
had a value of about 80 mg β-Lac g-1 membrane (24 mg mL-1 membrane), which is 
promising for the selective capture of β-Lac from bovine whey. This is the first 
reported application of MMM chromatography to a dairy feed stream. 
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5 Recovery of lactoferrin from whey using cross-
flow cation exchange mixed matrix membrane 
chromatography  
5.1 Introduction 
In this chapter, a cation exchange MMM was developed by incorporating SP 
Sepharose Fast Flow resin (GE Healthcare Technologies) into an EVAL membrane. 
The static binding capacity of SP Sepharose based adsorbent in different formats: 
intact resin, ground resin and membrane were measured for pure LZY and LF. This 
cationic MMM is expected to bind LF from whey solution. The feasibility of cross-
flow MMM chromatography for LF recovery was demonstrated and the performance 
of the MMM was evaluated, in terms of protein binding capacity, permeate flux rate, 
LF recovery and purity. CLSM was used to identify the location of protein 
adsorption within the cationic MMM. 
 
5.2 Materials and methods 
5.2.1 Chemicals 
All chemicals used for making a membrane, buffer preparation and proteins used to 
test the membrane performance were described in detail in section 3.1. 
 
5.2.2 Cationic resin 
Three types of Amberlite® cation exchange resin, Amberlite IRC50, Amberlite IRP64 
and Amberlite CG120 (Sigma), and two types of Lewatit® cation exchange resin, 
Lewatit SP112 and Lewatit CNP80 (Lanxess), were selected for screening as 
potential adsorbents for incorporation into the mixed matrix membrane. Low cost 
and convenient availability were the main criteria for selection. 
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5.2.3 Preparation of mixed matrix membranes 
Mixed matrix membranes were prepared following procedures reported previously in 
section 3.2 but using SP Sepharose resin as the embedded adsorbent. A homogenous 
EVAL polymer solution, consisting of 15 wt% EVAL polymer and 15 wt% 1-octanol 
in DMSO was prepared by continuous stirring at about 60°C for several hours until 
all EVAL pellets were completely dissolved. SP Sepharose resin was ground using 
an ultra centrifugal mill (Retsch ZM100, Haan, Germany) and screened to obtain a 
particle fraction that passed through a 38 µm stainless steel mesh. Ground resin was 
added to the prepared polymer solution to make a 30% weight fraction (relative to 
the EVAL content in the polymer solution) and this mixture was stirred until a 
homogeneous casting slurry was obtained. A flat sheet MMM was cast on a glass 
plate from the slurry, as previously described (section 3.2) and the wet MMM was 
then freeze-dried to remove water without affecting the structure of the membrane.  
 
5.2.4 Preparation of whey 
Whey was prepared from skim (0.05% fat) milk purchased from the local retail store 
as previously described in section 3.3. 
 
5.2.5 Static binding experiment 
The static binding capacities of adsorbents in different forms (i.e. intact, ground and 
membrane forms) were measured using single protein solutions. Because LF is 
expensive, most capacities were determined using LZY. 20 mM sodium phosphate 
buffer, pH 6.0, was used as a binding buffer and 1 M NaCl was added to this for 
elution buffers. The amount of adsorbent used in static experiments depended on the 
resin form and was expressed on a dry mass basis. During cation resin scouting 
experiments, 20 mg of intact resin was used. Pre-equilibrated resin was incubated in 
small Eppendorf tubes with 1 mL of protein solution at an initial concentration of 1 
mg mL-1. Resin and liquid in these tubes were gently mixed by inversion throughout 
binding for at least 12 h at room temperature. The tubes were then spun in a 
centrifuge at 16,100 g for 5 min and the supernatant was discarded and replaced with 
the elution buffer. Elution was carried out by inversion mixing for another 12 h at 
room temperature. Protein concentrations in supernatants were assayed by 
 5-3 
spectrophotometer (as described below). The binding capacity of each adsorbent was 
determined by the difference between initial and the final total solution protein 
content per mass of adsorbent. All experiments were carried out at least in triplicate.  
 
To determine the equilibrium static binding capacity, 2 mg of intact and ground SP 
Sepharose resin were used. For membrane measurements, pieces of MMM with 
dimensions 12 mm × 22 mm were used, corresponding to a mass between 17 and 20 
mg. These pieces of MMM had a volume of 5.3 × 10-2 mL. The adsorbent was 
incubated with 1 mL of known concentrations of protein solution in a series from 1 
to 8 mg mL-1. The equilibrium concentration was measured after 12 h and the 
maximum adsorbent capacity was calculated by fitting data to the Langmuir isotherm 
(equation 3-2 in previous section 3.5). 
 
To determine protein recovery after adsorption, the MMM was incubated with 1 mL 
of 1 mg mL-1 of either LF or LZY solution for 12 h, then surface liquid was removed 
from the membrane by patting with a tissue and the MMM was transferred to a new 
tube containing elution buffer for another 12 h. The concentration of protein in both 
solutions was assayed and the recovery was calculated as the percentage of protein in 
the elution fraction per protein bound on the membrane. Various elution buffer NaCl 
concentrations from 0.25-1.0 M were tested for LF recovery from the membrane.  
 
5.2.6 Single protein assay 
Concentrations of LF and LZY were determined by measuring absorbance at 280 nm 
using a UV/Visible spectrophotometer (Model Ultraspec 2100 Pro, Amersham 
Biosciences, Amersham, England) as in section 3.7.1. A standard curve was 
developed from six standard concentrations from 0 to 1 mg mL-1. Unknown samples 
were diluted with reference buffer to within the absorbance range of the standard 
curve.  
 
5.2.7 Lactoferrin assay in whey fractions 
The LF concentrations in whey and cross flow fractions were assayed using a RPC 
column following the method established by Palmano and Elgar (2002), using a 1 
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mL Resource™ RPC column (GE Healthcare Technologies) at a flow rate of 2 mL 
min-1. The assay was run on an AKTAexplorer™ 10 liquid chromatography system 
controlled by Unicorn™ 4.0 software (GE Healthcare Technologies) with 500 µL 
samples manually injected through a sample injection loop. Details of the protocol 
were given in section 3.8. 
 
5.2.8 Membrane porosity and gel electrophoresis 
The membrane porosity was measured according to previously published methods 
(Avramescu et al. 2003a; Saiful et al. 2006), described in detail at section 3.4. For 
qualitative analysis, some of the protein fractions were analyzed by SDS-PAGE 
under reducing conditions, similar to the protocol described in section 3.9 except the 
gel used was 4-12% Bis-Tris Criterion™ XT precast gel (Bio-Rad Laboratories, 
Hercules, CA).  
 
5.2.9 Protein labeling 
Protein for CLSM experiment was labeled with fluorescein isothiocynate (FITC) dye 
from Sigma (St. Louis) according to the protocol recommended by the supplier. LZY 
was dissolved in 100 mM sodium carbonate buffer pH 9.0 at 2 mg mL-1 and FITC 
was dissolved in anhydrous DMSO at 1 mg mL-1. Dye was added at a ratio of 50 
µL/mL of protein solution. The reaction was allowed to proceed under continuous 
stirring for at least 8 h at 4 °C and terminated by adding ammonium chloride to a 
final concentration of 50 mM, under stirring for another 2 h. The protein-dye 
conjugate was separated from non-reacted dye on a gel filtration column, 
simultaneously exchanging into 20 mM sodium phosphate, pH 6.0 buffer. The molar 
dye to protein ratio (D/P) was determined by measuring the absorbance of the 
protein-dye conjugate at wavelengths of 495 nm and 280 nm. The absorbance at 495 
nm corresponding to the FITC dye was divided by the absorbance value at 280 nm, 
which corresponds to the protein absorbance, to give the D/P ratio value. The D/P 
value for labeled LZY was 0.16. 
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5.2.10 Confocal laser scanning microscopy  
A small piece of equilibrated membrane (paper hole punch size) was incubated 
overnight at room temperature with 1 mL of FITC-LZY solution prepared as above. 
The membrane was washed several times with binding buffer before placing it on a 
clean, dry glass slab. A drop of glycerol was dropped onto the membrane and another 
small glass slab was used to cover the membrane. CLSM images were acquired using 
a Leica TCS SP5 confocal microscope (Leica Microsystems, Wetzlar, Germany) 
with a 63X objective lens. An argon laser provided excitation of FITC at 488 nm. 
The image resolution was 1024 × 1024 pixels and up to 28 images were taken at 
depths separated by 1 µm throughout the membrane thickness. 
 
5.2.11 Cross-flow system 
Cross-flow experiments were run using an AKTAcrossflow™ (GE Healthcare Life 
Sciences) tangential flow filtration system under the control Unicorn 5.11 software. 
The membrane setup was described in section 3.10 previously.  
 
Cross-flow experiments were conducted in triplicate, using one, two and three pieces 
of membrane. During loading, 150 mL of whey was circulated past the membrane 
and both retentate and permeate streams were recycled back into the feed reservoir. 
Whey loading was completed when the cumulative permeate volume reached 300 
mL. Throughout the cross-flow experiments, the feed flow rate was kept constant at 
50 mL min-1 and the permeate flux was operated at 100 L m-2 h-1 (LMH), except 
during the whey loading, when the permeate flux was reduced to 50 LMH. After 
loading, the retentate side of the system was drained and flushed several times with 
about 1000 mL of binding buffer. 200 mL of fresh binding buffer was then 
transferred to the reservoir for the membrane washing step and circulated past the 
membrane under constant flux conditions as above until the cumulative permeate 
volume reached 150 mL. The remaining fluid in the reservoir was then drained, filled 
with 120 mL of elution buffer and circulated past the membrane under constant flux 
conditions as above until the permeate volume reached 90 mL. Retentate samples 
and permeate fractions were collected for analysis at each step. LF recovery (the 
percentage of mass of LF in elution per mass of LF in feed whey) was calculated and 
the TMP profile during whey loading was also recorded. Fresh membranes were used 
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for each cross-flow experiment. Before starting an experiment, each membrane was 
pre-treated with 0.5 M NaOH for 30 min and flushed with water until a neutral pH 
was obtained. 
 
5.3 Results and discussion 
5.3.1 Cation resin scouting 
Figure 5-1 shows the binding capacity of LZY on the cation resins and the 
percentage of bound LZY recovered during salt elution. The amount of LZY bound 
on Amberlite resins was relatively low compared with that on Lewatit resins and 
most resins yielded low protein recoveries, indicating the presence of irreversible 
protein adsorption. Although Amberlite CG120 had high recovery (90%), the 
binding capacity was less than 5 mg LZY g-1 resin. In our hands, neither Amberlite 
nor Lewatit cation exchange resins performed well, contrary to recovery values of 
over 90% reported in previous work for Lewatit CNP80 (Saiful et al. 2006) and 
Lewatit SP112 (Avramescu et al. 2003a) resins. Therefore, in this study we decided 
to use SP Sepharose Fast Flow (GE Healthcare Technologies), which was designed 
for high resolution protein purification. 
 
5.3.2 Confocal imaging 
Interest in the use of CLSM in membrane research originated from its novel 
application to the characterization of resin bead chromatography media. Hubbuch 
and Kula (2008) recently reviewed the use of CLSM as an analytical tool in 
chromatography research. In the membrane field, CLSM has been used for various 
purposes, such as to visualize protein binding within the chromatographic membrane 
structure (Reichert et al. 2002; Wang et al. 2008) and to characterize the morphology 
of microfiltration membranes (Charcosset and Bernengo 2000; Charcosset et al. 
2000) as well as to characterize fouling mechanisms in membranes (Ferrando et al. 
2005 ).  
 
To date, mainly commercial membrane chromatography materials have been 
examined using the CLSM technique (Reichert et al. 2002; Wang et al. 2008; 
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Wickramasinghe et al. 2006). For mixed matrix membranes, it is of interest to see 
whether or not the resin particles embedded within the membrane scaffold can 
perform their function. Therefore, the objective of the CLSM experiment was to 
visualize LZY binding on the SP Sepharose particles embedded inside the MMM 
structure at different depths throughout the membrane thickness. Figure 5-2 shows a 
CLSM image of a selected area of the MMM at different membrane depths (z-axis) 
from the top towards the bottom of the membrane. Clearly, LZY binding occurs only 
on the SP Sepharose resin particles within the MMM and no nonspecific binding of 
LZY to the base EVAL membrane was observed. Furthermore, a greater number of 
resin particles were found below the surface than at the top of the membrane and, as 
expected, particle fracture during grinding did not inhibit binding. The membrane 
thickness was about 200 µm but an attempt to scan deeper than 17 µm resulted in a 
loss of fluorescent signal. 
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Figure 5-1: Adsorption and desorption of lysozyme on Amberlite and Lewatit cation 
exchange resins. The binding buffer was 20 mM sodium phosphate, pH 6.0 (no salt) 
and the elution buffer was 1 M NaCl in binding buffer. A triplicate sample was used 
for each resin. Error bars are ± one standard deviation (n = 3). 
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Figure 5-2: CLSM images of a cation exchange MMM at increasing depths through the membrane. LZY was labeled with FITC dye, showing 
binding to the SP Sepharose resin particles within the membrane matrix. 
 5-9 
5.3.3 Isotherms for protein adsorption 
Figure 5-3 shows the protein adsorption isotherms for intact and ground SP 
Sepharose resin and a MMM developed using the resin. A Langmuir adsorption 
isotherm was fitted to the equilibrium protein capacity data of the adsorbents in 
figure 5-3, using a least-squares regression method. The maximum LZY binding 
capacities calculated using the Langmuir isotherm were 832 mg g-1 intact resin, 1032 
mg g-1 ground resin or 262 mg g -1 membrane (dry resin and membrane weight 
bases).  
 
In Chapter 4 work on anionic MMMs, the β-Lac binding capacity was doubled when 
the intact resin was ground into a smaller size. This increment was probably due to 
the increased total surface area for binding and the improvement of protein 
accessibility to the internal pores within the resin. The current result, however, 
demonstrates that grinding the SP Sepharose resin resulted in a 24% improvement in 
LZY static binding capacity. LZY apparently has high accessibility to the internal 
pores of the intact SP Sepharose structure but a small fraction of the intact ion 
exchanger, not normally accessible to the protein, was made available upon grinding, 
contributing to an increase in protein binding capacity. The main objective of 
grinding the SP Sepharose resin was to improve the adhesion and homogeneous 
distribution of the resin within the membrane matrix rather than to change the 
adsorption capacity of the particles. However, smaller resin particles may also 
improve the dynamic binding capacity in MMM because the diffusion path lengths to 
the internal ion exchange sites would decrease and there would be a simultaneous 
increase in the interfacial surface area between permeate and resin as demonstrated in 
Chapter 4 previously. 
 
Thirty weight percent of SP Sepharose ground resin (relative to the mass of EVAL 
polymer) was added to the casting polymer solution to prepare the cationic MMM. 
This loading percentage is quite low compared with the loading percentages (50 wt% 
of Lewatit MP500 anion resin in Chapter 4 or 65 wt% Lewatit CNP80 cation resin 
(Saiful et al. 2006)) used in other MMM preparations. SP Sepharose resin swelled 
significantly more in the solvent than the Lewatit resin so at higher resin loadings, 
the casting polymer solution became highly viscous and was difficult to cast as a 
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membrane. Based on figure 5-3, the cationic MMM had a maximum static binding 
capacity for pure LF of 384 mg g-1 membrane, 155 mg mL-1 membrane or 3.11 mg 
cm-2 membrane. LZY gave values of 262 mg g-1 membrane, 79 mg mL-1 membrane 
or 1.58 mg cm-2 membrane. These capacities are competitive with the values for 
other membranes reported in the literature. Non-specific protein binding to the 
EVAL base membrane was relatively low and can be neglected (Chapter 4 and Saiful 
et al. 2006). The LZY binding capacity achieved was similar to the values reported 
for cation exchange hollow fibers (84 mg mL-1 membrane) by Camperi et al. (1999)  
and was higher than for Whatman (46.5 mg mL-1 membrane, Lin and Suen 2002) and 
Sartobind S (15.6 mg mL-1 membrane, Fang et al. 2004) commercial cation exchange 
membranes. Although Saiful et al’s (2006)  cation MMM showed the highest 
capacity of 147 mg mL-1 membrane, they used a 65 wt% cationic resin loading, more 
than double the SP Sepharose resin loading used in the current study. 
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Figure 5-3: Static (equilibrium) binding capacities of intact and ground SP 
Sepharose resin and a cation exchange MMM for LZY and LF. The adsorption data 
was fitted using the Langmuir isotherm using triplicate adsorbents samples. Error 
bars are ± one standard deviation (n = 3). 
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The maximum binding capacity of the MMM for LF was 155 mg mL-1, which is 
higher than the value of 111 mg mL-1 reported for a dye affinity hollow fiber 
membrane (Wolman et al. 2007). At an LF equilibrium concentration of 0.12 mg mL-
1
 (within the normal LF concentration range found in whey), the cationic MMM 
showed a capacity of 85 mg g-1 membrane or 30 mg mL-1 membrane.  
 
5.3.4 Elution experiments 
NaCl concentrations from 0.25 to 1 M were tested for their ability to desorb bound 
LF from the MMM. The results shown in figure 5-4 demonstrate that at least 0.75 M 
salt was required to achieve more than 80% LF recovery desorption from the 
membrane after protein binding and that close to 100% recovery of LZY was 
achieved at 1.0 M NaCl. Therefore, in subsequent cross-flow experiments, 1M NaCl 
was adopted to ensure maximum recovery. 
 
5.3.5 Cross-flow filtration of whey on membrane chromatography 
According to Lin and Suen (2002), a plate-and-frame module with a flat sheet 
membrane is the best design for adsorptive membranes for large scale separations. 
Advantages include high capacity, convenience of scale up and the capability of 
combining filtration and adsorption in one step (Lin and Suen 2002; Tsai and Suen 
2001).  
 
Figure 5-5 shows an example chromatogram from a cross-flow experiment. Based on 
permeate volumes (excluding the time taken to fill the reservoir and to flush the 
system), the equilibration step took 36 min, the whey loading step took 72 min, the 
washing step took 18 min and the final elution step took 11 min. The total time was 
therefore about 137 min for a total permeate volume of 840 mL. In figure 5-5, it is 
clear from the UV and conductivity curves that less time is required for the 
equilibration, wash and elution steps, potentially saving approximately 370 mL of 
permeate or 47 minutes. In that case, the process would take approximately 90 
minutes, 80% of which would be for loading. 
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Figure 5-4: Adsorption and desorption of LF at various salt concentrations and LZY 
at 1 M NaCl for a cation exchange MMM. 1 mg of protein (1 mL of 1 mg mL-1 
protein solution in 20 mM sodium phosphate pH, 6.0 (no salt)) was adsorbed to the 
membrane and recovered using different salt concentrations during elution. A 
triplicate sample was used for each salt concentration. Error bars are ± one standard 
deviation (n = 3). 
 
 
The pure water flux for the cationic MMM is shown in table 5-1. Water flux values 
for flat sheet membrane chromatography materials are rarely reported in the 
literature. For a general comparison, the water flux value for the single membrane 
layer was normalized with pressure to give a value of 16.72 LMH kPa-1. The cationic 
MMM prepared by Saiful et al. (2006) had a water flux value of 10 LMH kPa-1, 
measured in dead end filtration mode. A polyvinyl difluoride (PVDF) microfiltration 
membrane with pore size 0.5 µm had a water flux value 5.22 LMH kPa-1 (Brisson et 
al. 2007). From the water flux value obtained, we believe that the cation exchange 
MMM prepared in this study has an adequate pore size for permeation of whey 
proteins. In addition, the cation resin particles embedded within the membrane 
apparently did not cause significant resistance to fluid flow through the membrane. 
The cationic MMM had a porosity value of about 72%, which is quite similar to 
other types of MMM reported in previous studies (Avramescu et al. 2003b; Saiful et 
al. 2006). 
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Figure 5-6 shows the TMP profile of the cross-flow system as a function of 
accumulated permeate volume during the whey loading step. A constant flux value of 
50 LMH was used during the loading step to ensure that system backpressure was 
maintained below the maximum allowable value of 520 kPa. The whey circulation 
step took about 72 min to complete. Higher flux values could possibly have been 
used to reduce the process time, with a corresponding increase in the TMP but there 
is danger that a critical flux rate might be exceeded and cause severe fouling 
(Bacchin et al. 2006; Field et al. 1995). An alternative method to reduce the 
circulation time would be to operate at a constant TMP just below the maximum 
allowable system pressure. An attempt to use a TMP of 200 kPa, however, gave a 
significant flux loss (data not shown), supporting the existence of a critical flux rate 
beyond which significant fouling occurs. With three membrane layers in the module, 
the flux rate decline occurred immediately at 200 kPa TMP and eventually leveled 
off to a value of around 10 LMH, which is far below the flux rates acceptable for 
industrial membrane processing. Therefore, a moderate, constant flux of 50 LMH 
was selected for subsequent studies and the TMP profiles and binding properties of a 
varying number of membrane layers were studied in a plate-and-frame module.  
 
 
Table 5-1: Average1 water flux, LF binding capacity and recovery for cation 
exchange mixed matrix membranes using differing numbers of membranes in a 
plate-and-frame module. The total amount of LF in 150 mL of whey feed was 17.63 
mg. 
Number of 
membranes in 
module 
Water flux at a 
transmembrane 
pressure of 25 
kPa, L m-2 h-1 
Mass of LF in 
elution 
fraction, mg 
Recovery,2 % 
 
1 418.0±19.4 11.51±1.25 65.31±7.06 
2 255.6±17.5 13.75±0.11 78.02±0.62 
3 188.0±31.2 15.46±0.62 87.71±3.53 
1
 Average values ± one standard deviation (n = 3) 
2
 Recovery = (mass of protein in elution fraction/mass of protein in feed) x 100% 
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Figure 5-5: Chromatogram of a typical cross flow experiment (three pieces membrane) recorded by the AKTAcrossflow™ system. The solid 
line represents the absorbance value and the dotted line represents the conductivity in the permeate. 
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Figure 5-6: Typical TMP profiles during whey loading for differing numbers of 
cation exchange MMM in the module. 150 mL of whey was passed through the 
membrane, with both permeate and retentate recycled to the feed solution. 
 
 
As shown in figure 5-6, there was no significant increase in TMP for one piece of 
membrane up to an accumulated permeate volume of 300 mL. The use of two or 
three pieces of membrane caused a gradual increase in TMP under constant flux 
control, although the values remained below the maximum system backpressure. The 
increase in TMP during permeate accumulation is likely to have been caused by 
gradual membrane fouling. Advances in fouling control techniques such as the use of 
turbulence promoters, pulsed/reversed flow, additional electrical fields or addition of 
surfactants to the feed solution (Chilukuri et al. 2001; Wakeman and Williams 2002) 
may be applicable in the development of cross-flow membrane chromatography but 
consideration of fouling is beyond the scope of this chapter. 
 
Although unusual in conventional packed-bed chromatography columns and dead-
end adsorptive membrane processes, recycle of the permeate stream to the feed tank 
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can easily be allowed for in cross-flow operation for multiple passes through the 
adsorbent to maximize adsorption. Increasing the number of membrane layers 
contained in one module was expected to increase the protein binding capacity of the 
membrane chromatography system. In addition, using multiple layers of membrane 
should provide a more uniform flow distribution, with any defects in one layer 
compensated for by the flow through subsequent layers (Suen and Etzel 1992).  
 
Table 5-1 shows the amount of LF bound on the cationic MMM and recovered from 
150 mL of whey for 1, 2 and 3 membrane layers. Recovery was defined as the 
percentage of the LF originally contained in the whey feed obtained in the eluted 
fraction. The concentration of LF in the feed whey was 117.50 ± 14.55 mg L-1. Three 
pieces of membrane gave an average recovery of 88%, which is quite competitive 
with previous studies in other systems. For example, Lu et al. (2007) reported 82% 
recovery using ultrafiltration, followed by ion exchange chromatography to purify 
LF from bovine colostrum. Other studies reported LF recoveries of about 88% from 
1000 L of whey using a 2 m2 commercial Sartobind membrane module (Plate et al. 
2006) and 89% using dye affinity membrane chromatography from 25 mL of whey 
(Wolman et al. 2007). The LF recovery could be increased further by adding more 
membrane layers, with diminishing economic returns eventually giving an optimum 
number of membrane layers and binding capacity (Lin and Suen 2002). However, 
optimization of economics is beyond the scope of the current study. 
 
Figure 5-7 shows an SDS gel image of LF in the fractions collected during the cross-
flow chromatography run. A single band of LF can be seen in the elution fraction 
from each of the cross-flow experiments. The RPC chromatogram for the cross-flow 
fractions sampled during the single membrane experiment is shown in figure 5-8, 
with LF eluting at approximately 14 mL. The results show that the acidic proteins β-
Lac, α-Lac and BSA are removed in the wash steps and that the elution fraction 
contains mainly LF. 
 
5.4 Conclusions 
A cation exchange MMM, designed for the recovery of LF from acid whey, was 
prepared using ground SP Sepharose resin cast into an EVAL base membrane. The 
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static LF binding capacity of the MMM had a maximum protein capacity of 384 mg 
g-1 membrane, 155 mg mL-1 membrane or 3.11 mg cm-2 membrane, which is 
competitive with commercially available membranes and other cationic adsorptive 
membranes reported in the literature.  
 
The chromatographic steps were carried out using a cross-flow operation to minimize 
concentration polarization and enhance the binding capacity of the MMM by 
recycling both permeate and retentate streams into the feed during the whey loading 
step. Several layers of MMM were inserted into a plate-and-frame module, each with 
an effective membrane area of 50 cm2. Three pieces of MMM in the module gave an 
average LF recovery of 88% from 150 mL of feed whey. The eluted LF had a high 
purity, as shown by SDS-PAGE and RPC. This is the first reported study of cross-
flow cationic MMM chromatography for recovery of LF from whey. The results 
indicate that mixed matrix membranes, which are easily prepared and customizable, 
have potential for the industrial separation of whey proteins.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-7: SDS-PAGE gel of selected fractions from a cross-flow experiment. Lane 
1 - marker; Lane 2 – feed whey. Experiment using one piece of membrane: Lane 3 – 
whey (retentate) after loading; Lane 4 – permeate from washing step; Lane 5 – 
permeate from elution step. Experiment using two pieces of membrane: Lane 6 – 
retentate whey; Lane 7 – permeate washing; Lane 8 – permeate elution. Experiment 
using three pieces of membrane: Lane 9 – retentate whey; Lane 10 – permeate 
washing; Lane 11 – permeate elution; Lane 12 – feed whey. 
LF
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Heavy chain IgG
Light chain IgG
β-Lac
α-Lac
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Figure 5-8: Chromatograms for RPC of various solutions in a cross-flow experiment 
using two pieces of cation exchange MMM for LF recovery from whey. (a) whey – 
14X dilution with RPC running buffer (b) retentate whey – 6X dilution with RPC 
running buffer (c) permeate washing – 2X dilution with RPC running buffer (d) 
permeate elution – 2X dilution with RPC running buffer. Retention volumes for α-
Lac, LF, BSA and β-Lac were approximately 11, 14, 16 and 19 mL, respectively. 
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6 Phenyl Sepharose hydrophobic interaction mixed 
matrix membrane chromatography for whey 
protein fractionation 
 
6.1 Introduction 
This chapter describes the development of Phenyl Sepharose hydrophobic interaction 
MMM chromatography for whey protein fractionation. A flat sheet membrane was 
fabricated using EVAL base polymer with ground Phenyl Sepharose resin added as 
an adsorbent particle. The optimum ammonium sulphate concentration in binding 
buffer was determined for binding the major whey proteins (β-Lac, α-Lac, BSA and 
LF) at pH 6. The static binding capacity of hydrophobic interaction MMM was 
measured for the major whey protein components and tested for the feasibility of 
whey protein fractionation. The performance of hydrophobic interaction MMM was 
compared with 1 mL HiTrap™ Phenyl FF (GE Healthcare Technologies) for whey 
protein fractionation. 
 
6.2 Materials and methods 
6.2.1 Chemicals 
All chemicals, proteins and materials used in this chapter were described previously 
in section 3.1. 
 
6.2.2 Preparation of mixed matrix membranes 
Flat sheet mixed matrix membranes were prepared using a similar technique in 
section 3.2, but using Phenyl Sepharose resin as the embedded adsorbent. The resin 
was ground and screened to obtain a particle fraction that passed through a 38 µm 
stainless steel mesh. Ground resin was added to the prepared polymer solution (15 
wt% EVAL and 15 wt% 1-octanol in DMSO) to make a 20 wt% (relative to the 
EVAL content in the polymer solution) of homogenous casting slurry solution. 
Conventional dry-wet casting process was then applied to make a flat sheet 
membrane. The membrane thickness after solvent exchange and drying process was 
about 200 µm. 
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6.2.3 Preparation of whey  
Whey was prepared according to the method described in section 3.3 and adjusted to 
pH 6. (NH4)2SO4 salt was added into this whey solution to give a salt concentration 
of 2 M. After the salt was completely dissolved in the solution, whey was centrifuged 
one more time at 17,902 g at 4 °C for 20 min.  
 
6.2.4 Binding capacity of Phenyl Sepharose resin at different 
ammonium sulphate concentration 
About 30 mg (wet mass) of intact Phenyl Sepharose resin was used in salt scouting 
experiment to determine the optimum salt concentration for binding. (NH4)2SO4 salt 
concentration varied from 0-2.5 M at 0.5 M interval which gives 6 set of 
experiments. Each experiment was repeated for single protein of α-Lac, β-Lac, BSA 
and LF. 
 
Pre-equilibrated resin was incubated with 1 mL of 1 mg mL-1 of single protein 
solution in small Eppendorf tubes. Resin and liquid in these tubes were gently mixed 
by inversion throughout binding for at least 12 h at room temperature, 22°C. After 
binding, the tubes were spun in a centrifuge at 16,100 g for 5 min and the 
equilibrium protein concentrations in supernatants were assayed by 
spectrophotometer (as described below). The bound protein was calculated by the 
difference between the initial protein content to the protein content in the equilibrium 
solution after binding. 
 
6.2.5 Static binding capacity of adsorbent 
Static binding capacity of the adsorbent was measured according to the protocol 
described in section 3.5. The amount of intact and ground resin used was between 2-
4 mg based on dry mass. For membrane, single rectangular piece of membrane with 
dimensions 12 mm × 22 mm (corresponding to the volume of 5.3 ×10-2 mL) was 
used with the mass range between 16-20 mg. 2 M (NH4)2SO4 in 20 mM sodium 
phosphate pH 6 was used as a binding buffer. Pre-equilibrated adsorbent was 
incubated with 1 mL of known concentration protein solution in a series from 0.5 to 
5 mg mL-1. Final equilibrium concentration was measured after 12 h incubation 
period and was assayed by the spectrophotometric method. 
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6.2.6 Batch elution  
In batch elution experiments, three random samples of membrane with a dimension 
of 15 mm × 15 mm were used. Pre-equilibrated membranes were incubated with 1 
mL of 2 mg mL-1 protein solution and gently mixed by inversion throughout binding 
for 12 h. Then, the surface liquid was removed from the membrane by patting with a 
tissue and the membrane was transferred to a new tube containing elution (salt free) 
buffer for another 12 h. The concentration of protein in both solutions was assayed 
and the recovery was calculated as the percentage of protein in the elution fraction 
per protein bound on the membrane. The elution experiment was also repeated for 
eluting bound proteins from the range of (NH4)2SO4 salt concentrations used in 
binding buffer. 
 
6.2.7 Flow through experiment 
Flow through experiments were conducted on AKTAexplorer™ 100 liquid 
chromatography system (GE Healthcare Technologies) using Phenyl Sepharose 
MMM and a 1 mL HiTrap Phenyl FF column. Sheets of MMM were cut into circles 
of diameter 44 mm to fit into a 47 mm polypropylene filter holder (GE Osmonic 
Labstore, Minnetonka, MN). The buffer used for flow through experiments was 2 M 
(NH4)2SO4 in 20 mM sodium phosphate pH 6 as a binding buffer and salt free buffer, 
20 mM sodium phosphate pH 6 as an elution buffer. The flow rate was kept constant 
at 3 mL min-1 for both columns and the protein absorbance at 280 nm was monitored. 
 
In whey fractionation experiments, the column was equilibrated with 40 mL binding 
buffer, followed by 8 mL of whey injection, 32 mL washing with binding buffer and 
isocratic elution with salt free buffer for 40 mL. The flow through fractions were 
collected at 5 mL fraction volumes for further protein analysis.  
 
6.2.8 Single protein assay  
Concentrations of single proteins were determined by measuring absorbance at 280 
nm using a UV/Visible spectrophotometer (Model Ultraspec 2100 Pro, Amersham 
Biosciences, England) as in section 3.7.1.  
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6.2.9 Whey protein assay 
Individual whey protein component was assayed using an established method by 
Elgar et al. (2000) using 1 mL Resource™ RPC column (GE Healthcare 
Technologies). Buffer A and buffer B used were 0.1% v/v TFA in DI water and 
0.09% v/v TFA, 90% v/v acetonitrile in DI water respectively. The detailed assay 
protocol was described previously in section 3.8. Samples from flow through 
experiment were desalted with HiTrap 5 mL desalting column (GE Healthcare 
Technologies) before being injected onto the RPC column.  
 
6.2.10 Gel electrophoresis 
Protein fractions from flow through experiments were analyzed by SDS-PAGE under 
reducing conditions. The detail protocol was previously described in section 3.9. 
 
6.3 Results and discussion 
6.3.1 Ammonium sulphate salt concentration scouting on Phenyl 
Sepharose resin 
Figure 6-1 shows the binding capacity of intact Phenyl Sepharose resin for the single 
protein components typically found in whey at various (NH4)2SO4 concentrations. 
Although the hydrophobicity of protein normally increases with increasing salt 
concentration, protein precipitation is another factor that needs to be considered in 
selecting the optimum salt concentration. At a very high salt concentration, protein 
tends to precipitate from the solution. The percentage of protein precipitation from 1 
mg mL-1 protein solution at room temperature, 22°C, in different (NH4)2SO4 salt 
concentrations is shown in figure 6-2. At 1.5 M salt, only β-Lac experienced a small 
extent of protein precipitation. At 2.0 M salt concentration, all proteins start to 
precipitate with less than 10% precipitation, except β-Lac which precipitated at about 
20%. Severe protein precipitation occurs at salt concentration of 2.5 M, especially for 
BSA and LF. By considering the resin binding capacity and the protein precipitation 
percentage, an optimum (NH4)2SO4 salt concentration of 2.0 M was selected for 
further development of Phenyl Sepharose MMM in this study. 
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Figure 6-1: Phenyl Sepharose binding capacity at various ammonium sulphate salt 
concentrations. 1 mg mL-1 of single protein solution was incubated with the resin for 
12 h at room temperature, 22°C. Error bars are ± one standard deviation (n=3). 
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Figure 6-2: Precipitation of 1 mg mL-1 of single protein solution at 22°C under 
gentle mixing by inversion for 12 h in 20 mM sodium phosphate buffer pH 6 at 
various ammonium sulphate concentrations. Error bars are ± one standard deviation 
(n=3). 
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6.3.2 Static binding capacity of intact and ground Phenyl Sepharose 
resin 
The static (equilibrium) binding capacity of intact and ground Phenyl Sepharose 
resin for single whey protein component is shown in figure 6-3. Both intact and 
ground resins had a similar protein binding capacity value. The functional group 
within the pore structure of Phenyl Sepharose resin was fully accessible by the 
protein even in its intact form. Previously, for anion exchanger resin, Lewatit MP500 
in Chapter 4 and cation exchanger resin, SP Sepharose in Chapter 5, grinding 
improved the protein binding capacity by increasing the resin surface area for 
binding and enhancing the protein accessibility to the internal pores within the resin. 
Although the intact Phenyl Sepharose resin already had a good protein accessibility 
and high binding capacity, grinding into small particles is still necessary to improve 
the adhesion and homogeneous distribution of the resin within the membrane matrix 
during the formation of MMM. According to the resin capacity value in figure 6-3, 
LF has the highest capacity value while β-Lac has the lowest capacity value. 
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Figure 6-3: Static (equilibrium) binding capacity of intact and ground Phenyl 
Sepharose resin for single whey protein component in 2 M ammonium sulphate in 20 
mM sodium phosphate buffer pH 6. Error bars are ± one standard deviation (n=3). 
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6.3.3 Static binding capacity of Phenyl Sepharose mixed matrix 
membrane 
The static binding capacity of Phenyl Sepharose MMM is shown in figure 6-4 for 
single protein components in whey. The data was fitted with the Langmuir isotherm 
(Equation 3-2). The values for Langmuir isotherm constants are tabulated in table 6-
1. Phenyl Sepharose MMM shows a comparative capacity value to that found in the 
literature: 12 mg mL-1 of monoclonal antibody by PVDF membrane (Ghosh 2001), 
0.94-2.10 mg cm-2 of LZY and 0.78-1.29 mg cm-2 of conalbumin by glass fiber 
membrane modified with short-chain organosilicon (Chen et al. 2007), 30 mg g-1 of 
BSA by butyl amine hollow fiber (Kubota et al. 1997a) and 0.65 mg cm-2 of IgG for 
commercial Sartobind Phenyl membranes (Fraud et al. 2008). 
 
 
0
20
40
60
80
100
120
0.0 1.0 2.0 3.0 4.0
Equilibrium concentration, mg mL-1
m
g 
pr
o
te
in
 
g-
1  
m
em
br
an
e
MMM - LF
MMM - α-Lac
MMM - BSA
MMM - β-Lac
Langmuir Fitting
 
Figure 6-4: Static (equilibrium) binding capacity of Phenyl Sepharose MMM for 
single whey protein component in 2 M ammonium sulphate in 20 mM sodium 
phosphate buffer pH 6. Error bars are ± one standard deviation (n=3). 
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Table 6-1: Langmuir isotherm constant for different proteins by Phenyl Sepharose 
mixed matrix membrane chromatography. 
Langmuir 
constant 
β-Lactoglobulin α-Lactalbumin Bovine serum 
albumin 
Lactoferrin 
qm, mg g-1 62.729 123.354 112.930 121.427 
KD, mg g-1 0.620 0.518 0.518 0.271 
     
qm, mg mL-1 20.539 45.573 38.651 42.046 
KD, mg mL-1 0.475 0.561 0.594 0.382 
     
qm, mg cm-2 0.411 0.911 0.733 0.841 
KD, mg cm-2 0.475 0.561 0.594 0.382 
 
 
6.3.4 Batch elution of Phenyl Sepharose mixed matrix membrane 
The binding and elution recovery of Phenyl Sepharose MMM and EVAL membrane 
are shown in figure 6-5. Protein binding only occurs in the presence of (NH4)2SO4 
salt in the system, as compared to zero salt concentration (figure 6-5(a)) at which 
there is an insignificant amount of protein bound to the MMM. This suggests that the 
protein bound onto Phenyl Sepharose MMM is mainly governed by the hydrophobic 
interaction mechanism. Similar to the optimum salt concentration found in intact 
Phenyl Sepharose resin, MMM also shows an optimum binding-elution performance 
at 2 M (NH4)2SO4 concentration (figure 6-5 (d)). However, at this salt concentration, 
the EVAL base membrane also shows some non specific hydrophobic interaction 
with the protein especially for β-Lac and α-Lac (figure 6-5 (f)). This non-specific 
binding contributed to higher α-Lac binding capacity than BSA capacity as observed 
in Phenyl Sepharose MMM (figure 6-4), although the intact and ground resin shows 
the opposite trend (figure 6-3). The elution recovery of β-Lac was lowest compared 
to other proteins at 2 M (NH4)2SO4 concentration. This may be related to the low 
elution recovery for some portion of β-Lac bound by non-specific interactions to the 
EVAL membrane (less than 30% as in figure 6-5 (f)) at 2 M salt. 
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Figure 6-5: Single protein binding of Phenyl Sepharose MMM and EVAL base 
membrane at different ammonium salt concentration in 20 mM sodium phosphate 
buffer. 2 mg mL-1 of feed protein was prepared in different salt concentration binding 
buffer and elution was done using salt free buffer. (a) MMM at 0 M salt; (b) MMM 
at 1.0 M salt; (c) MMM at 1.5 M salt; (d) MMM at 2.0 M salt; (e) MMM at 2.5 M 
salt and (f) EVAL at 2.0 M salt. Error bars are ± one standard deviation (n=3). 
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6.3.5 Flow through fraction of whey by Phenyl Sepharose mixed matrix 
membrane 
Whey protein component was precipitated in some extent after the addition of 
(NH4)2SO4 up to 2 M concentration. The precipitation percentage for each protein is 
shown in table 6-2. The performance of Phenyl Sepharose MMM and HiTrap Phenyl 
column are compared in table 6-3 for whey protein fractionation in flow through 
mode. A typical chromatogram for this fractionation is shown in figure 6-6. 
Although the elution peak of HiTrap Phenyl is larger than Phenyl Sepharose MMM, 
the performance of Phenyl Sepharose MMM in terms of bound protein per mL of 
adsorbent used was comparable. According to table 6-3, Phenyl Sepharose MMM 
shows binding capacities (mg protein bound mL-1 column) of 4.728, 1.001, 1.931 and 
9.647 for α-Lac, LF, BSA and β-Lac, respectively. For HiTrap Phenyl column, the 
values are 4.306, 0.572, 1.285 and 11.062 for α-Lac, LF, BSA and β-Lac, 
respectively.  
 
Based on the binding percentage in table 6-3, both columns showed a binding 
preference for α-Lac, LF and BSA and a lower preference for β-Lac. From the gel 
picture in figure 6-7, all bound proteins were detected in elution fraction. Compared 
to commercial HiTrap column, Phenyl Sepharose MMM is suffered from low protein 
recovery while most of them had an elution recovery less than 80%. This is likely 
contributed by the non-specific binding of base EVAL membrane at 2 M salt as 
observed in the previous section.  
 
 
Table 6-2: Whey protein concentration before and after addition of ammonium 
sulphate salt at pH 6. After salt addition whey was centrifuged at 17, 902 g at 4 °C 
for 20 min. Data shown is based on average values ± one standard deviation (n=3). 
Protein 0 M (NH4)2SO4,  
mg mL-1 
2 M (NH4)2SO4,  
mg mL-1 
Precipitation 
percentage, % 
α-Lactalbumin 0.897 ± 0.026 0.646 ± 0.015 28 
Lactoferrin 0.097 ± 0.015 0.074 ± 0.007 24 
Bovine serum albumin 0.195 ± 0.019 0.170 ± 0.024 13 
β-Lactoglobulin 3.565 ± 0.106 2.871 ± 0.056 19 
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(a) Phenyl Sepharose MMM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) HiTrap Phenyl column 
 
Figure 6-6: Typical chromatogram for whey fractionation in flow through mode 
using the AKTAexplorer 100 liquid chromatography system for (a) a Phenyl 
Sepharose MMM and (b) a HiTrap Phenyl column. 
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Table 6-3: Flow through fractionation of whey by (a) Phenyl Sepharose mixed matrix membrane chromatography and (b) HiTrap Phenyl 1 mL 
column at 2 M ammonium sulphate concentration pH 6. Bound protein was eluted in step elution with salt free buffer. Data shown is based on 
average values ± one standard deviation (n=3). 
(a) Phenyl Sepharose mixed matrix membrane  
 α-Lac Lactoferrin BSA β-Lac 
Feed protein, mg 5.171 0.588 1.364 22.967 
Bound protein, mg 1.438 ± 0.095 0.304 ± 0.015 0.587 ± 0.037 2.934 ± 0.357 
Binding percentage, % 27.81 ± 1.84  51.75 ± 2.57  43.07 ± 2.68  12.77 ±1.56  
mg protein bound mL-1 membrane 4.728 ± 0.313 1.001 ±0.050 1.931 ± 0.120 9.647 ± 1.176 
Eluted protein, mg 0.995 ± 0.083 0.235 ± 0.019 0.387 ± 0.017 2.214 ± 0.190 
Elution recovery, % 69.23 ± 3.52  77.02 ± 3.36  65.88 ± 2.54  76.39 ±13.39  
(b) HiTrap Phenyl 1 mL column 
 
 
 α-Lac Lactoferrin BSA β-Lac 
Feed protein, mg 5.171 0.588 1.364 22.967 
Bound protein, mg 4.306 ± 0.131 0.572 ± 0.027 1.285 ± 0.041 11.062 ± 0.470 
Binding percentage, % 83.27 ± 2.53 97.32 ± 4.64  94.24 ± 3.00 48.17 ± 2.05 
mg protein bound mL-1 column 4.306 ± 0.131 0.572 ± 0.027 1.285 ± 0.041 11.062 ± 0.470 
Eluted protein, mg 4.057 ± 0.184 0.471 ± 0.001 0.955 ± 0.056 10.719 ± 0.736 
Elution recovery, % 94.19 ± 1.69  82.40 ± 3.95  74.26 ± 2.63  96.83 ±2.69  
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Previously, in Chapter 4, an anion exchange MMM showed selective binding for β-
Lac in the whey. Therefore, this Phenyl Sepharose MMM can be used as a sequential 
step to bind unbound fractions from anion exchange MMM or it can also be used 
alone to produce whey protein isolates which are depleted in β-Lac concentration. 
 
Linear gradient elution was tested for both HiTrap column and Phenyl Sepharose 
MMM. However, neither column could give a distinctive baseline separation 
between whey protein components, as illustrated in figure 6-8. Selected fractions 
from linear gradient elution were further analyzed by SDS-PAGE, as shown in figure 
6-9. It was observed that the eluted protein was diluted by the gradient performed, 
while some protein could not be detected by the gel. This effect was more obvious in 
Phenyl Sepharose MMM because the column volume was 0.304 mL, compared to a 
1 mL column volume for the HiTrap column. Further elution study is therefore 
necessary to resolve single whey proteins during elution, if possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-7: SDS-PAGE of whey protein fractions using hydrophobic interaction 
MMM chromatography: Lane 1 – protein marker, lane 2 – feed whey, lane 3 – 
unbound fraction, lane 4 – elution fraction, and using Phenyl Sepharose column: lane 
6 – feed whey, lane 7 – unbound fraction, lane 8 – elution fraction. 
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Figure 6-8: Linear gradient elution from a hydrophobic interaction column for whey 
protein fractionation. 2 mL of whey was loaded onto (a) a 0.304 mL Phenyl 
Sepharose mixed matrix membrane chromatography column and (b) a 1 mL HiTrap 
Phenyl Sepharose column.  
 
(a) 
(b) 
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Figure 6-9: Fractions from gradient elution of whey protein using a hydrophobic 
interaction column. The lane number corresponds to the fractions in figure 6-8. 
Lanes 1 and 2 represent protein markers and feed whey, respectively. 
 
6.4 Conclusions 
Mixed matrix membrane concept has successfully been applied to make anion or 
cation exchanger membrane chromatography in the previous studies. For the first 
time, the current study has demonstrated the feasibility of incorporating hydrophobic 
Phenyl Sepharose resin into a membrane matrix to prepare hydrophobic interaction 
membrane chromatography. Phenyl Sepharose MMM chromatography was tested for 
fractionation of whey protein components at 2 M ammonium sulphate salt 
concentration. The performance of Phenyl Sepharose MMM was comparable with a 
1 mL HiTrap Phenyl column. Phenyl Sepharose MMM shows binding capacities (mg 
protein bound mL-1 column) of 4.728, 1.001, 1.931 and 9.647 for α-Lac, LF, BSA 
and β-Lac, respectively. Both columns show a lower binding percentage of β-Lac, 
which can be useful in producing whey protein isolates depleted in β-Lac. 
Furthermore, this Phenyl Sepharose MMM can potentially be used in isolating high 
purity α-Lac from whey protein, especially if some of the calcium is chelated out, for 
example using EDTA. 
1      2       3       4       5    6      7     8      9    10   11    12     13    14
LF
BSA
β-Lac
α-Lac
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7 Mixed mode interactions in mixed matrix 
membrane chromatography for protein separation 
7.1 Introduction 
In the present chapter, the feasibility of using the MMM chromatography preparation 
concept was demonstrated for producing a novel mixed mode interaction membrane 
in a single membrane. Mixed mode interaction MMM was synthesized by 
incorporating a certain ratio of SP Sepharose cation resin and Lewatit MP500 anion 
resin into an EVAL base polymer solution. The static binding capacity of mixed 
mode MMM was measured and compared with pure cationic and anionic MMMs. 
The membrane was also tested for binding to a range of model protein mixtures and 
whey protein solutions. Different elution protocols were investigated to elute the 
bound protein from the mixed mode MMM. The productivity of mixed mode MMM 
chromatography for recovering all major proteins in whey was predicted from flow 
through experimental data. This mixed mode interaction membrane chromatography 
has not been studied before and to the best of the author’s knowledge this 
development is the first of its kind to date. 
 
7.2 Materials and methods 
7.2.1 Materials 
All chemicals, proteins and materials used in this chapter were described previously 
in section 3.1. 
 
7.2.2 Mixed mode membrane preparation 
Base membrane polymer solution was prepared according to section 3.2 previously 
which consisted of 15 wt% EVAL polymer dissolved in 15 wt% of 1-octanol and 70 
wt% of DMSO. Relative to the mass of EVAL in the polymer solution, a different 
ratio of anion exchanger resin, Lewatit MP500 and cation exchanger resin, SP 
Sepharose was added to this solution and mixed homogenously to form a membrane 
casting solution.  
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Two different compositions of mixed mode interaction membrane were prepared. 
The first casting solution consisted of equal amounts of anion and cation resins, 15 
wt% of MP500 and 15 wt% of SP Sepharose (“MMM 1”). The second solution was 
set to have a total resin loading of 50 wt% and targeted for capturing all proteins in 
whey. Based on the major protein composition in whey, almost 95% are acidic 
proteins (β-Lac, BSA, α-Lac, IgG) (table 2-1) and the rest are basic proteins (LF, LP, 
IgG). This would indicate that a mixed mode membrane, based on these proportions, 
should comprise 95% anion and 5% cation exchange resins, ignoring the relative 
protein binding capacities of each type. However, for a more practical membrane 
casting formulation, the ratio of 85% acidic protein and 15% basic protein was used, 
which produced a mixed mode membrane with 42.5 wt% of MP500 and 7.5 wt% SP 
Sepharose (“MMM 2”). The assumption is that the membrane should be operated 
well below its total equilibrium protein binding capacity so the 85% proportion of 
anion exchange resin should be more than sufficient, while the 15% cationic resin 
will almost certainly bind the maximum basic proteins as long as the anionic fraction 
is not overloaded. 
 
A conventional casting method was used for preparing a flat sheet membrane as 
described in section 3.2. The thickness of the membrane after drying was about 200 
µm. 
 
7.2.3 Protein binding capacity 
A small piece of membrane with 15 mm × 15 mm dimension (mass around 8-13 mg, 
volume 4.5 × 10-2 mL) was used for protein binding experiment. 20 mM sodium 
phosphate, pH 6 was used an equilibrium/binding buffer. All membranes were pre-
equilibrated with equilibrium buffer for at least 3 h or more before binding to any 
known concentration of protein solution. At least triplicate samples were used for 
each experiment. 
 
For determination of the static binding capacity of mixed mode MMM 1, a pre-
equilibrated membrane was incubated with 1 mL of pure β-Lac or LZY protein 
solutions with different initial concentrations ranging from 0.25-4.00 mg mL-1. The 
equilibrium protein concentration was assayed after 12 h binding time. The capacity-
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equilibrium data were fitted to the Langmuir isotherm using the least-square 
regression method described in section 3.5.  
 
Two acidic proteins (β-Lac, BSA) and two basic proteins (cytochrome C, LZY) were 
selected as model proteins in a quaternary protein mixture for binding to MMM 1. 
The level of protein concentration in the mixture was varied for both acidic and basic 
proteins either as low (0.5 mg mL-1), medium (2.0 mg mL-1) or high (4.0 mg mL-1) 
concentrations. In some cases, the membrane was also tested for binding to a ternary 
proteins mixture of β-Lac, BSA and LZY, or binary mixtures of β-Lac and BSA or 
LF and β-Lac. The protein concentrations were assayed using reversed phase 
chromatography as described below. 
 
7.2.4 Elution experiment 
7.2.4.1 Batch elution 
MMM 1 was tested for binding and eluting of pure protein solutions of 1 mg mL-1 β-
Lac and 1 mg mL-1 LZY, and a binary protein mixture of β-Lac and LZY with 
concentration of 1 mg mL-1 for each protein. A similar binding procedure was 
followed as described above. After the binding step, the membrane was dried by 
lightly patting with tissue and underwent a washing step with binding buffer for 30 
minutes. The membrane was removed from the washing solution and the liquid on 
the surface of the membrane was again dried by patting. 1 M NaCl in binding buffer 
was used as an elution buffer and added to the membrane for at least 12 h elution 
time. Throughout the experiment, 1 mL of solution was used at each step. 
 
7.2.4.2 Flow through elution 
Flow through experiments were conducted using one piece of membrane 44 mm in 
diameter, inserted into a polypropylene filter holder (GE Osmonics Labstore, 
Minnetonka, MN, USA). The module was connected to an AKTAexplorer 100 (GE 
Healthcare Technologies) liquid chromatography system. Pure cation exchanger 
membrane (CEX MMM), pure anion exchanger membrane (AEX MMM) and mixed 
mode MMM 1 were tested for flow through elution. Pure protein solutions of β-Lac 
or LZY and a binary protein solution of β-Lac and LZY were loaded onto the 
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membrane. The concentration of each protein was 1 mg mL-1 and a flow rate of 3 mL 
min-1 was used throughout the flow through experiment. 
 
Two elutions protocols were tested: (1) isocratic elution with salt and (2) pH elution, 
followed by salt elution. In the isocratic salt elution protocol, the membrane was 
equilibrated with 35 mL of 20 mM sodium phosphate pH 6 (binding buffer), injected 
with 2 mL of protein sample, followed by 23 mL of washing with binding buffer and 
finally eluted isocratically with 1 M NaCl in the binding buffer for 25 mL. In the pH 
elution protocol, the same procedure was followed excepted using two elution steps: 
25 mL of 100 mM sodium acetate pH 4 was followed by a second elution with 1 M 
NaCl in the binding buffer for another 35 mL. 2 mL flow through fractions were 
collected in each step by an automatic fraction collector, Frac-950 (GE Healthcare 
Technologies). 
 
7.2.5 Whey fractionation 
7.2.5.1 Batch fractionation 
Throughout the whey fractionation experiment, MMM 2 was used. In batch binding 
of whey, the same protocol as that described in section 7.2.4.1 was followed except 
the dimensions of the membrane used was 12 mm × 22 mm. Whey was prepared 
according to section 3.3 and spiked with an additional amount of LF. Both normal 
whey and LF-spiked whey were tested for batch fractionation. 
 
7.2.5.2 Cross-flow fractionation 
Whey fractionation in cross-flow filtration mode was conducted in the 
AKTAcrossflow (GE Healthcare Technologies) system using one piece of MMM 2 
(membrane area 50 cm2). A detailed description of the cross-flow system was given 
previously in section 3.10. 30 mL of LF-spiked whey was used as feed. The 
membrane was pre-treated with 0.5 M NaOH for 30 minutes and flushed with water 
until a neutral pH was obtained before running each cross-flow whey fractionation 
experiment. Feed flow rate and permeate flux were kept constant at 50 mL min-1 and 
100 LMH, respectively. During the whey loading step, both retentate and permeate 
stream were recycled to the reservoir until a cumulative permeate volume of 150 mL 
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was reached. Bound protein was eluted with 1 M NaCl in 20 mM sodium phosphate 
pH 6. Cross-flow runs were repeated three times with a fresh membrane used in each 
run. 
 
7.2.5.3 Flow through fractionation 
Flow through fractionation was used to determine the capability of MMM 2 to 
extract all whey protein in a single run. Different volumes of LF-spiked whey were 
loaded into three layers of membrane in the filter holder module. The setup was 
similar to that described in section 7.2.4.2 but a flow rate of 2 mL min-1 was applied. 
Different elution protocols were also studied for MMM 2 after 1 mL of LF-spiked 
whey was injected onto it. 
 
7.2.6 Protein assay 
All single or mixture protein concentrations were assayed using a 1 mL Resource 
RPC (GE Healthcare Technologies). The column was operated on an AKTAexplorer 
10 liquid chromatography system controlled by Unicorn 4.0 software (GE Healthcare 
Technologies). Buffer A and buffer B used were 0.1% v/v TFA in DI water and 
0.09% v/v TFA, 90% v/v acetonitrile in DI water respectively. Throughout the 
analysis experiment, a flow rate of 2 mL min-1 was used. Different assay protocols 
were used depending on the protein mixture, as described in the following section. 
 
7.2.6.1 Quaternary protein mixture 
A standard curve for the quaternary mixture of β-Lac, BSA, cytochrome C and LZY 
was developed from a mixture of the individual proteins. The protein absorbance at 
280 nm was monitored during the assay protocol. After 4 CV of column equilibration 
with buffer A, 500 µL of sample was manually injected into the column. A series of 
linear gradients was then applied as follows: 0-2 CV, 0% B; 2-7 CV, 0-35% B; 7-13 
CV, 35-65% B. After the last gradient, the column was hold at 100% B for 3 CV and 
followed by 1 CV of re-equilibration with buffer A. Figure 7-1 shows a 
chromatogram for the quaternary protein mixture and its respective individual 
proteins obtained in RPC assay. 
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Figure 7-1: Chromatogram for quaternary protein mixture and its respective 
individual proteins assayed by 1 mL Resource RPC column. 
 
7.2.6.2 Binary β-lactoglobulin and lactoferrin 
A similar assay protocol as in quaternary protein mixture was used to quantify the 
individual protein content in binary the β-Lac-LF solution. However, a separate 
standard curve was developed because LF was eluted at a similar retention volume to 
BSA by this protocol.  
 
7.2.6.3 Whey protein assay 
Whey’s protein components were assayed using an established method by Elgar et al. 
(Elgar et al. 2000; Palmano and Elgar 2002). Protein absorbance at 214 mAU was 
used to calculate the peak area to quantify the protein content in whey. The protocol 
was run at flow rate 2 mL min-1 with 100 µL of sample injected manually into the 
column. The detailed protocol was described in section 3.8. 
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7.2.7 Gel electrophoresis 
Protein fractions from the experiment were analyzed by SDS-PAGE under non-
reducing conditions. The detailed protocol was previously described in section 3.9. 
 
7.3 Results and discussion 
7.3.1 Static binding capacity of SP Sepharose based adsorbent 
Figure 7-2 shows the static binding capacity of SP Sepharose based adsorbent for 
pure LZY in a single mode CEX MMM (30 wt% of cation resin relative to polymer 
content, prepared in previously in Chapter 5 and MMM 1 (15 wt% of cation resin, 15 
wt% anion resin). The LZY binding capacity was normalized to the content of SP 
Sepharose resin in the membranes in order to compare their capacities with ground 
SP Sepharose resin. Based on the normalized resin capacity, some portion of the SP 
Sepharose resin was apparently not accessible by the protein in the pure CEX MMM. 
As discussed in Chapter 5, SP Sepharose resin swelled strongly in the solvent used in 
preparing the membrane casting solutions and resulted in a relatively high viscosity 
of the casting solution. This viscosity factor may be responsible for the blockage of 
some part of the active groups in the SP Sepharose resin. For the mixed mode 
interaction membrane, in addition to some portion of active group blockage, the 
existence of anion resin in the membrane matrix may interfere with the binding 
capability of the cation resin to some extent. Both anion resin and LZY molecules 
were positively charged and repelled each other but this is not expected to be a very 
strong effect because SP Sepharose has a strong binding to LZY.  
 
7.3.2 Static binding capacity of MP500 based adsorbent 
Figure 7-3 shows the anion exchanger resin, MP500 in a pure AEX MMM (50 wt% 
anion resin, prepared in Chapter 4 was fully accessible by the protein when 
normalized to the resin content. However, in the MMM 1 (15 wt% anion resin, 15 
wt% cation resin), the accessibility of β-Lac to the resin has been affected to a small 
extent by the presence of the cation resin, especially at the highest protein 
concentrations. The viscosity of MP500 casting solution is relatively low compared 
to SP Sepharose resin and the problem of the active group blocking by the polymer 
 7-8 
was absent. In a previous preparation, as high as 65 wt% of MP500 resin could be 
incorporated into MMM (Avramescu et al. 2003a).  
 
7.3.3 Protein binding to the mixed mode MMM 
Acidic proteins (β-Lac and BSA) and basic proteins (Cytochrome C and LZY) were 
mixed together for binding to the mixed mode MMM 1 at different initial protein 
concentrations. Figure 7-4 shows the membrane capacity plotted with increasing 
initial basic protein concentration on the x-axis. Figure 7-5, uses the same data as 
Figure 7-4 but it is arranged so that the x-axis represents the initial acidic protein 
concentration. In both figures, mixed mode MMM 1 had a preferential binding 
capacity for β-Lac and LZY compared with BSA and cytochrome C. 
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Figure 7-2: Static binding capacity of SP Sepharose based adsorbent for pure LZY in 
ground resin, a cation exchange membrane (CEX MMM) and mixed mode 
interaction membrane (MMM 1). Error bars are ± one standard deviation (n=3). 
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Figure 7-3: Static binding capacity of MP500 based adsorbent for pure β-Lac in 
ground resin, a pure anion exchanger membrane (AEX MMM) and a mixed mode 
interaction membrane (MMM 1). 
 
 
As in figure 7-4, when the initial basic protein concentration increased, the LZY 
binding capacity increased accordingly. Almost no cytochrome C bound at high or 
medium LZY concentrations used. In addition, the LZY capacity was not influenced 
by the concentration level of acidic proteins in the protein solution. However, for 
acidic protein binding, as we can see in figures 7-4 (c) and 7-4 (e), representing 
medium and high initial acidic protein concentration respectively, the β-Lac binding 
dropped at low (0.5 mg mL-1) initial basic protein concentrations.  
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Figure 7-4: Protein binding capacity of mixed mode MMM 1 for quaternary protein 
mixtures at different initial acidic and basic protein concentrations. The initial 
concentrations of BSA and β-Lac were fixed at 0.5 mg mL-1 (a), (b), 2.0 mg mL-1 (c), 
(d) and 4.0 mg mL-1 (e), (f). The binding capacity for acidic proteins (BSA and β-
Lac) are represented in (a), (c) and (e) and for basic proteins (cytochrome C and 
lysozyme) in (b), (d) and (f). The x-axis represents the initial basic protein 
concentration. Error bars are ± one standard deviation (n=3). 
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Figure 7-5: Protein binding capacity of mixed mode MMM 1 for quaternary protein 
mixtures at different initial acidic and basic protein concentrations. The initial 
concentration for cytochrome C and lysozyme were fixed at 0.5 mg mL-1 (a), (b), 2.0 
mg mL-1 (c), (d) and 4.0 mg mL-1 (e), (f). The binding capacity for acidic proteins 
(BSA and β-Lac) are represented in (a), (c) and (e) and for the basic proteins 
(cytochrome C and lysozyme) in (b), (d) and (f). The x-axis represents the initial 
acidic protein concentration. Error bars are ± one standard deviation (n=3). 
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In order to examine this trend more clearly, the way data presentation was re-
arranged to show the initial acidic protein concentration on the x-axis in figure 7-5. 
From figure 7-5 (a), it is clear that, at low basic protein concentration, an increased in 
acidic protein concentration does not increase the acidic protein binding capacity 
proportionately. As a first thought, it was suspected that the existence of cytochrome 
C on the membrane influenced acidic protein binding. At low initial basic protein 
concentrations, more cytochrome C was bound, because excess cation groups were 
still available in the membrane after almost all LZY was bound (figure 7-5 (b)). To 
justify this hypothesis, the membrane was tested for binding from the ternary protein 
mixture, in which cytochrome C was excluded, at a low LZY concentration and 
varying β-Lac and BSA protein concentrations. The binding trend is plotted in figure 
7-6. 
 
As shown in figure 7-6, the β-Lac binding capacity still did not increase according to 
the increase in acidic protein concentration despite the absence of cytochrome C. 
Therefore, the β-Lac binding was not influenced by the existence of cytochrome C 
on the membrane. Another possibility might be the free cation group left after 
binding with a low basic protein concentration would repel the acidic proteins from 
approaching the anion groups. However, this is unlikely to be the case because the 
static binding capacity for pure β-Lac was similar to that of the ground resin when 
the protein capacity was normalized to the resin content in the membrane. To 
confirm this, a binary β-Lac and BSA mixture was used as a protein solution and the 
resulting binding capacity is shown in figure 7-7.  
 
Similar to previous observations, the β-Lac binding capacity still did not increase 
with an increase in the initial concentration of this protein in the protein solution. 
However, when doing ternary and binary protein experiments, it was noticed that the 
solution of the ternary protein system was slightly cloudy compared to the binary β-
Lac-BSA protein system. This indicates that some interaction occurred between β-
Lac and LZY in the solution that might cause precipitation. This was more obvious 
when a high β-Lac concentration was used. If this precipitation happened during 
experiments, the β-Lac protein binding in the quaternary protein system in figure 7-4 
(c) and figure 7-4 (e) would have been over calculated (because capacity was 
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Figure 7-6: Protein binding capacity of mixed mode MMM 1 to ternary protein 
system of BSA, β-Lac and LZY. Error bars are ± one standard deviation (n=3). 
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Figure 7-7: Protein binding capacity of mixed mode MMM 1 to a binary protein 
system of BSA and β-Lac. Error bars are ± one standard deviation (n=3). 
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calculated based on the equilibrium protein concentration after binding). 
Furthermore, this cloudiness was not easily noticed initially in experiments with the 
quaternary mixture because the presence of cytochrome C would change the clear 
protein solution to a red color. Based on this observation, the normalized β-Lac 
binding capacity in figure 7-5 (a) was actually already close to its maximum value 
for the small area of membrane used. If the average β-Lac capacity was around 30 
mg β-Lac g-1 MMM in figures 7-6 and 7-7, the normalized value would correspond 
to 200 mg β-Lac g-1 MP500. This value is very close to the static capacity of β-Lac 
shown in figure 7-2. 
 
In further experiments, LZY was replaced by LF to form another binary protein 
solution with β-Lac to avoid β-Lac interaction with the basic protein in the solution. 
The protein binding capacity for this new binary protein solution is shown in figure 
7-8. It is clear from this that the anion exchanger had reached its capacity for the 
small area of membrane used and β-Lac binding could not be further increased at 
higher initial β-Lac concentrations unless a larger membrane area was used. For LF, 
increasing the LF protein concentration did increase the protein binding 
proportionately because the cation resin capacity still had not reached its maximum 
value (based on the LZY capacity in figure 7-3, the ground cation resin would have a 
maximum capacity of around 1000 mg LZY g-1 SP Sepharose). As a conclusion, 
mixed mode ionic interaction in a single membrane matrix was successfully 
demonstrated to bind both acidic and basic proteins simultaneously from a mixed 
protein solution. 
 
7.3.4 Protein elution 
Batch elution data are shown in table 7-1 for MMM 1 for pure β-Lac, pure LZY and 
the binary β-Lac and LZY mixture. The capacity of the membrane for both proteins 
is close to the value previously reported in the Langmuir plot of static binding 
capacity in figures 7-2 and 7-3 (the values at equilibrium concentration being less 
than 0.5 mg mL-1 for β-Lac and less than 0.05 mg mL-1 for LZY). The elution 
recovery for LZY was higher than for β-Lac in static elution data.  
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Figure 7-8: Protein binding capacity of mixed mode MMM 1 for the binary protein 
system of β-Lac and LF at various initial concentrations. One set of experiment was 
conducted with a constant initial lactoferrin concentration at (a) 0.5 mg mL-1, (b) 2.0 
mg mL-1 and (c) 4.0 mg mL-1, while the concentration of β-lactoglobulin was varied 
from 0.5 to 4.0 mg mL-1. Another set of experiments was conducted with a constant 
initial β-lactoglobulin concentration at (a) 0.5 mg mL-1, (b) 2.0 mg mL-1 and (c) 4.0 
mg mL-1, while the concentration of lactoferrin was varied from 0.5 to 4.0 mg mL-1. 
Error bars are ± one standard deviation (n=3). 
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Table 7-1: Batch binding and elution for pure β-Lac, pure LZY and a binary β-Lac 
and LZY mixture by in mixed mode MMM 1. Data shown is based on the average 
values ± one standard deviation (n=3). 
Protein type Lysozyme β-Lactoglobulin 
Feed solution type Single LZY Binary 
LZY-β-Lac 
Pure β-Lac Binary 
LZY-β-Lac 
Mass of membrane, mg 12.52 ± 0.11 12.65 ± 0.12 12.74 ± 0.14 12.65 ± 0.12 
Feed protein, mg 1.00 1.00 1.00 1.00 
Bound protein, mg 0.99 ± 0.00 0.92 ± 0.02 0.47 ± 0.02 0.57 ± 0.02 
Capacity, mg protein g-1 
membrane 
79.22 ± 0.30 73.01 ± 0.55 36.76 ± 1.06 45.35 ± 0.98 
Eluted protein, mg 0.93 ± 0.01 0.89 ± 0.02 0.36 ± 0.01 0.47 ± 0.01 
Elution recovery *, % 93.8 ± 0.3  96.5 ± 1.3  76.1 ± 2.1 82.5 ± 1.6  
* Elution recovery = mass of protein eluted/mass of protein bound × 100% 
 
 
For the flow through mode using an isocratic salt elution, the elution data are given 
in tables 7-2 and 7-3, respectively, for β-Lac and LZY. The performance of mixed 
mode MMM 1 was also compared with its corresponding pure AEX MMM in 
Chapter 4 and pure CEX MMM in Chapter 5 prepared previously. The binding 
performance of the mixed mode membrane in flow through experiments was similar 
for pure or binary mixture protein solutions. However, the mixed mode MMM 
suffered from low elution recovery, especially for LZY.  
 
LZY elution recovery was extremely low in flow through mode compared to batch 
mode. This was however, not experienced by the pure CEX MMM in flow through 
experiment. At present, there does not seem to be a strong reason why this decrease 
in elution recovery occurred only in the mixed mode MMM during flow through 
experiments. The possibility of LZY denaturation was hypothesized to occur in the 
mixed mode MMM in the presence of the anion resin. This denaturation would 
increase the contact area between LZY and the adsorbent surface and thus reduce the 
amount of protein desorbed (Avramescu et al. 2003a). If this happened, the contact 
time between the mobile phase and bound protein should be optimized in flow 
through experiments to allow enough time for LZY desorption. 
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Table 7-2: Flow through binding and elution for β-Lac in different feed solutions 
and different membrane types. The total β-Lac loaded onto the column was 2 mg and 
bound protein was eluted isocratically using 1 M NaCl salt. Data shown is based on 
the averages values ± one standard deviation (n=3). 
Membrane type AEX MMM MMM 1 MMM 1 
Feed solution type Pure β-Lac Pure β-Lac Binary  β-Lac –
LZY  
Mass of membrane, mg 91.25 ± 6.36 63.40 ± 0.58 63.40 ± 0.58 
Adsorbent loading in the 
membrane, % 
50 15 15 
Bound protein, mg 1.83 ± 0.11 0.71 ± 0.13 0.74 ± 0.06 
Capacity, mg protein bound 
g-1 membrane 
20.02 ± 0.35 11.20 ± 2.01 11.75 ± 1.07 
Normalized capacity, mg 
protein bound g-1 adsorbent 
40.16 ± 0.71 74.68 ± 13.38 78.30 ± 7.10 
Eluted protein, mg 1.70 ± 0.08 0.52 ± 0.01 0.54 ± 0.02 
Elution recovery, % 92.8 ± 1.3 75.7 ± 16.2 73.0 ± 4.5 
 
 
Good accessibility of protein into the adsorbent in the mixed mode membrane matrix 
was indicated by its high normalized protein capacity value. However, the direct 
comparison with pure anionic or cationic membranes in table 7-2 and 7-3 were not 
feasible. The maximum capacity for pure AEX or CEX MMMs was still below its 
real capacity value due to limitation of protein loaded into the column. In this pure 
membrane, almost all 2 mg of the protein loaded was bound by the membrane. 
 
In mixed matrix interaction mode, both acidic and basic proteins were demonstrated 
to bind simultaneously onto the membrane. In theory, it would have been possible to 
elute bound acidic protein by decreasing the pH of the system, while bound basic 
protein could be eluted by increasing the pH. Table 7-4 shows the recovery of acidic 
protein eluted by decreasing the pH to pH 4 and then using 1 M NaCl for eluting the 
remaining bound protein in the membrane. A typical chromatogram from this protein 
elution protocol is shown in figure 7-9. 
. 
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Figure 7-9: Typical chromatogram for elution of binary LZY and β-Lac using pH elution followed by 1 M NaCl elution. 
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Table 7-3: Flow through binding and elution for LZY in different feed solutions and 
membrane types. Total LZY loaded onto the column was 2 mg and bound protein 
was eluted isocratically using 1 M NaCl. Data shown is based on the averages values 
± one standard deviation (n=3). 
Membrane type CEX MMM MMM 1 MMM 1 
Feed solution type Pure LZY Pure LZY Binary  LZY – 
β-Lac 
Mass of membrane, mg 92.08 ± 11.70 63.40 ± 0.58 63.40 ± 0.58 
Adsorbent loading in the 
membrane, % 
30  15  15  
Bound protein, mg 1.94 ± 0.05 1.45 ± 0.05 1.51 ± 0.02 
Capacity, mg protein bound 
g-1 membrane 
22.75 ± 2.33 22.80 ± 0.72 23.81 ± 0.57 
Capacity, mg protein bound 
g-1 adsorbent 
75.83 ± 7.70 152.00 ± 4.79 158.72 ± 3.80 
Eluted protein, mg 1.70 ± 0.14 0.93 ± 0.09 0.89 ± 0.03 
Elution recovery, % 87.6 ± 6.4  64.3 ± 7.7  59.2 ± 1.2  
 
 
Total protein elution recovery was still low using this two-step protocol, similar to 
the experience with the previous protocol using salt elution. However, two protein 
fractions could be recovered in high purity by this combination of pH and salt 
elution. The first pH elution fraction contained almost 87% of the target acidic 
protein β-Lac, whereas about 85% of LZY was present in the salt elution fraction as 
shown in table 7-4.  
 
7.3.5 Whey fractionation 
7.3.5.1 Batch fractionation 
Tables 7-5 (a) and 7-5 (b) show batch fractionation data for the mixed mode MMM 2 
using whey and LF-spiked whey, respectively. In figure 7-10, the SDS-PAGE gel 
from each step of the fractionation process was visualized. Among the acidic whey 
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proteins, β-Lac has a binding preference onto this membrane.  The second major 
acidic protein, α-Lac, also bound to a small extent but most was leached out during 
the washing step, as shown in lanes 4 and 8 in figure 7-10. According to the 
literature, the binding strength of the three major proteins on anion exchanger could 
be postulated to be in the order: β-Lac > BSA > α-Lac (Goodall et al. 2008; 
Weinbrenner and Etzel 1994). In fact, in some cases, β-Lac could displace other 
positively proteins bound onto the anionic membrane (Goodall et al. 2008). All LF in 
1 mL of whey was bound onto MMM 2. However, a low elution recovery was 
obtained using the mixed mode MMM for whey fractionation. 
 
 
Table 7-4: Elution recovery of LZY and β-Lac at different pH of elution in flow 
through experiment for mixed mode MMM 1. Data shown is based on the averages 
values ± one standard deviation (n=3). 
Protein type LZY  β-Lac 
Feed protein, mg 2.00  2.00 
Bound protein, mg 1.53 ± 0.04  0.72 ± 0.06 
    
 Elution with 100 mM sodium acetate pH 4 
Eluted protein, mg 0.07 ± 0.01  0.39 ± 0.01 
Elution recovery, % 4.7  ±  0.9  54.6  ±  2.9 
Fraction purity, % 15.4  ±  2.3  86.6  ±  1.0 
    
 Elution with 20 mM sodium phosphate pH 6, 1 M NaCl 
Eluted protein, mg 0.69 ± 0.03  0.11 ± 0.01 
Elution recovery, % 45.3 ± 2.4   14.7 ± 0.7 
Fraction purity, % 84.6  ±  2.3  13.4  ±  1.0 
    
Total recovery, % 50.0 ± 3.1  69.3 ± 2.7 
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Figure 7-10: SDS-PAGE gel for batch whey fractionation by mixed mode MMM 2. 
Lane 1 – marker, normal whey fractionation: lane 2 – whey (4X dilution), lane 3 – 
unbound fraction (4X dilution), lane 4 – washing fraction, lane 5 – elution fraction, 
LF-spiked whey: lane 6 – LF-spiked whey (4X dilution), lane 7 – unbound fraction 
(4X dilution), lane 8 – washing fraction, lane 9 – elution fraction. 
 
7.3.5.2 Cross-flow fractionation 
A plate-and-frame module was used to increase the area of the membrane for whey 
fractionation. Compared to the filter holder module in flow through mode (15 cm2), 
the plate-and-frame module area was 50 cm2 and able to accommodate several layers 
of membrane in the module. However, when using a plate-and-frame module 
operated in cross-flow approach, protein losses and/or dilution can occur due to the 
large tubing volume of the system (permeate side, retentate side, recycle tubing, etc). 
Figure 7-11 shows a typical chromatogram run on the cross-flow filtration system for 
whey fractionation. The protein recovered in the final elution fraction is given in 
table 7-6 and confirmed by an SDS-PAGE gel in figure 7-12. 
 
β-Lac, LF and IgG were recovered by the membrane from the cross-flow experiment. 
Because the run was operated under non-optimized conditions, a low yield resulted. 
In order to get a better yield, the amount of whey loaded onto the system, the number 
of the membranes in the module and the cross-flow operating parameters need to be 
optimized. However, such optimization was beyond the scope of the present work. 
1     2      3     4        5       6      7     8     9 
IgG
LF
BSA
β- Lac
α- Lac
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Table 7-5: Batch binding of mixed mode MMM 2 for (a) whey and (b) LF-spiked whey. 1 mL of whey was incubated with 2.64 cm2 of 
membrane at pH 6 and elute with 1 M NaCl in 20 mM sodium phosphate pH 6. Mass of membrane used was 18.53 ± 0.64 mg. Data shown is 
based on the averages values ± one standard deviation (n=3).  
(a) Whey 
 α-Lac LF BSA β-Lac IgG 
Protein feed to the system, mg 1.344 0.027 0.085 3.631 0.509 
Protein bound to the membrane, mg 0.058 ± 0.010 0.027 ± 0.000 0.017 ± 0.017 0.988 ± 0.015 0.057 ± 0.009 
Capacity, mg protein bound g-1 membrane 3.15 ± 0.49 1.47 ± 0.03 0.92 ± 0.94 54.08 ± 0.71 3.08 ± 0.52 
Capacity, mg protein bound cm-2 membrane 0.02 ± 0.00 0.01 ± 0.00 0.01 ± 0.01 0.37 ± 0.01 0.02 ± 0.00 
Elute protein, mg 0.008 ± 0.001 0.017 ± 0.003 0.000 ± 0.000 0.756 ± 0.089 0.040 ± 0.004 
Recovery, % (protein elute/protein bound) 14.89 ± 2.66 61.88 ± 10.18  0.00 ± 0.00 76.47 ± 7.90 72.58 ± 18.49 
 
(b) LF-spiked whey 
 α-Lac LF BSA β-Lac IgG 
Protein feed to the system, mg 1.383 0.241 0.070 3.762 0.570 
Protein bound to the membrane, mg 0.131 ± 0.042 0.214 ± 0.007 0.000 ± 0.000 1.108 ± 0.150 0.128 ± 0.027 
Capacity, mg protein bound g-1 membrane 7.16 ± 2.24 11.44 ± 0.73 0.00 ± 0.00 59.21 ± 9.90 6.79 ± 1.11 
Capacity, mg protein bound cm-2 membrane 0.05 ± 0.02 0.08 ± 0.00 0.00 ± 0.00 0.42 ± 0.06 0.05 ± 0.01 
Elute protein, mg 0.004 ± 0.005 0.134 ± 0.006 0.000 ± 0.000 0.744 ± 0.043 0.052 ± 0.001 
Recovery, % (protein elute/protein bound) 3.45 ± 4.87 62.56 ± 2.77 0.00 ± 0.00 68.26 ± 12.46 41.97 ± 8.44 
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Table 7-6: Binding properties of mixed mode MMM 2 for 30 mL of whey (LF 
spiked) in a cross flow system. Data shown is based on the averages values ± one 
standard deviation (n=3). 
Protein Protein feed to the 
system, mg 
Protein in elution 
fraction, mg 
Yield, % (protein 
elute/protein feed) 
α-Lactalbumin 42.88 0.00 ± 0.00 0.00 ± 0.00 
Lactoferrin 8.71 1.26 ± 0.19 14.46 ±  0.10 
Bovine serum 
albumin 
2.65 0.00 ± 0.00 0.00 ± 0.00 
β-Lactoglobulin 119.86 20.80 ± 2.67 17.35 ± 2.23 
Immunoglobulin 22.14 1.81 ± 0.17 8.16 ± 0.75 
 
7.3.5.3 Flow through fractionation 
In order to get better productivity estimation for the mixed mode interaction 
membrane, a flow though fractionation experiment at different volumes of whey was 
conducted. The aim was to find the volume at which all interesting proteins in whey 
were bound and eluted by the mixed mode MMM 2. According to figure 7-13, using 
three layers of membrane in a small filter holder (total membrane volume 0.91 mL), 
0.75 mL of whey was completed bound and all proteins could be detected in the 
elution fraction. 
 
For productivity estimation, 1,000 m2 of mixed mode MMM would give a membrane 
volume of 200 L based on the 200 µm membrane thickness. Based on the above 
capacity, this membrane volume could bind total proteins from about 165 L of whey, 
which corresponds to 1.08 kg of total whey protein (6.55 g total protein per 1 mL 
whey). If we allow for a typical chromatographic cycle of 5 CV equilibration buffer, 
165 L whey loading, 2 CV wash, 1 CV elution and 2 CV regeneration, this amounts 
to 2,165 L of permeate per cycle. At a modest 50 L m-2 h-1 permeate flux rate, this 
would have a total cycle time of approximately 2.6 minutes. Productivity based on 
membrane volume is therefore, 125 g L-1membrane h-1. A 1000 m2 spiral-wound 
membrane module would typically have a hold-up volume of 1 m3 (Cheryan 1998) 
so this productivity corresponds to 25 g L-1module h-1 on a membrane module volume 
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Figure 7-11: Typical chromatogram for cross-flow whey fractionation experiments in the AKTAcrossflow system. 
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Figure 7-12: SDS-PAGE of several fractions from cross-flow fractionation of whey. 
Lane 1 – marker, lane 2 – LF-spiked whey (4X dilution), lane 3- unbound whey in 
retentate side (4X dilution), lane 4 – washing fraction in permeate side, lane 5 – 
elution fraction in elution side, lane 6 – marker. 
 
 
basis or 74 g m2 h-1 on a membrane area basis. These values compare well with 
reported values in the range 18 to 60 g L-1 resin h-1 for laboratory-scale batch and 
packed-bed chromatography systems for whey protein isolate production (Doultani et 
al. 2003). 
 
In figure 7-13, the bound protein on the membrane was eluted isocratically using 1 M 
NaCl in binding buffer. Different elution protocols were also tested, as shown in 
figures 7-14, 7-15 and 7-16 for qualitative visualization. In all experiments, 1 mL of 
LF-spiked whey was bound to the three layers of mixed mode MMM 2 in flow 
through mode. Based on these figures, single protein resolution was not achieved by 
the elution protocols tested. Further optimization of elution protocols is needed in 
future study to obtain good whey protein resolution during the elution step. 
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Figure 7-13: Unbound and elution fraction of whey proteins loaded at different 
injection volumes of whey into 3 layers of mixed mode MMM (mass 303.56 mg , 
diameter 44 mm, thickness 600 µm). Bound protein was eluted isocratically with 1 
M NaCl in 20 mM sodium phosphate buffer pH 6. SDS-PAGE was run under non-
reducing conditions. Lane 1 – marker, lane 2 – whey (4X dilution), lane 3 – unbound 
fraction ( 5 mL whey), lane 4 – elution fraction ( 5 mL whey), lane 5 – unbound 
fraction ( 3 mL whey), lane 6 – elution fraction ( 3 mL whey), lane 7 – unbound 
fraction ( 1.5 mL whey), lane 8 – elution fraction ( 1.5 mL whey), lane 9 – unbound 
fraction ( 1 mL whey), lane 10 – elution fraction ( 1 mL whey), lane 11 – unbound 
fraction ( 0.75 mL whey), lane 12 – elution fraction ( 0.75 mL whey), lane 13 – 
unbound fraction ( 0.5 mL whey), lane 14 – elution fraction ( 0.5 mL whey), lane 15 
– unbound fraction ( 0.3 mL whey), lane 16 – elution fraction ( 0.3 mL whey). 
 
7.4 Conclusions 
Mixed mode interaction membrane chromatography was successfully developed 
using the concept of mixed matrix membrane preparation. The ratio of the different 
types of adsorptive resin incorporated into the membrane matrix can be tailor-made 
for protein recovery from a specific feed stream. The mixed mode cation and anion 
membrane chromatography developed was able to bind basic and acidic proteins 
simultaneously from a solution. The binding of target proteins by mixed mode MMM 
was not affected significantly by the presence both ion exchange charges in the 
membrane. However, the elution recovery of bound protein was relatively low, 
especially in flow through operation. A custom mixed mode MMM, consisting of 
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42.5 wt% of MP500 anion resin and 7.5 wt% SP Sepharose cation resin, was 
developed for binding all proteins from whey in a single pass. Based on the 
productivity estimation, this mixed mode MMM showed a productivity of 125 g total 
whey protein per L membrane per h. 
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Figure 7-14: Linear elution gradient to 100 % buffer B. Lane 1 and lane 2 in the SDS-PAGE gel represent a marker and feed whey respectively. 
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Figure 7-15: Linear elution gradient to 50% buffer B, followed by step elution at 100% buffer B. Lane 1 and lane 2 in the SDS-PAGE gel 
represent a marker and feed whey respectively. 
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Figure 7-16: pH elution at pH 4 followed by step elution at 100% buffer B. Lane 1 and lane 2 in the SDS-PAGE gel represent a marker and feed 
whey respectively.
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8 Conclusions and recommendations 
8.1 Conclusions 
Whey protein fractionation using membrane chromatography shows great potential 
for the dairy industry because the system depends mostly on the capacity of the 
adsorbent in the membrane without the need for complex column packing or 
limitations from column backpressures. The concept of MMM chromatography, 
which incorporates adsorptive particles during membrane casting, can be simply 
applied to prepare membrane chromatography and attain performances that are 
competitive with other membrane chromatography materials.   
 
In the current study, anion exchange MMM chromatography was developed from 
EVAL base membrane using Lewatit MP500 as an anion exchange resin in the 
membrane matrix described in Chapter 4. The membrane was characterized in terms 
of structure and its static and dynamic binding capacities were measured. The 
optimum binding for β-Lac was found to be at pH 6.0 using 20 mM sodium 
phosphate buffer. The MMM had a static binding capacity of 120 mg β-Lac g-1 
membrane (36 mg β-Lac mL-1 membrane)  and 90 mg α-Lac g-1 membrane (27 mg α-
Lac mL-1 membrane). In batch fractionation of whey, anion exchange MMM showed 
selective binding towards β-Lac compared to other proteins. The binding preference 
for whey protein component onto anion exchange MMM was demonstrated to follow 
this order:  β-Lac > BSA > α-Lac. The dynamic binding capacity of β-Lac in whey 
solution was about 80 mg β-Lac g-1 membrane (24 mg β-Lac mL-1 membrane), 
which is promising and comparable for whey fractionation using this technology. 
 
A cationic MMM was developed for recovery of LF from bovine whey by 
embedding ground SP Sepharose cation exchange resin into an EVAL polymer base 
membrane in Chapter 5. The static LF binding capacity of the cationic MMM was 
384 mg g-1membrane or 155 mg mL-1 membrane, exceeding the capacity of several 
commercial adsorptive membranes. Adsorption of LZY onto the embedded ion 
exchange resin was visualized by confocal laser scanning microscopy. The 
membrane chromatography system was operated in cross-flow mode to minimize 
fouling and enhance LF binding, resulting in an LF recovery as high as of 91%, with 
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high purity as seen by the band of sodium dodecyl sulfate polyacrylamide gel 
electrophoresis gel and the chromatogram of reversed phase chromatography. The 
system was operated at a constant permeate flux rate of 100 LMH, except during the 
whey loading step, which was run at 50 LMH. This is the first time a cross-flow 
MMM process has been reported for LF recovery from whey. 
 
Hydrophobic interaction membrane chromatography was developed by incorporating 
Phenyl Sepharose resin into the membrane matrix. The Phenyl Sepharose MMM 
showed optimum whey protein binding at 2 M ammonium sulphate buffer at pH 6. 
However, at this salt concentration some nonspecific interaction of β-Lac and α-Lac 
occurred onto the EVAL base membrane. Maximum static binding capacity of 
Phenyl Sepharose MMM calculated by the Langmuir isotherm were 20.539 mg mL-1 
of β-Lac, 45.573 mg mL-1 of α-Lac, 38.651 mg mL-1 of BSA and 42.046 mg mL-1 of 
LF. These values were comparable with the values reported in the literature. In flow 
through whey fractionation, the performance of phenyl sepharose MMM was similar 
to the HiTrap Phenyl column. However, Phenyl Sepharose MMM suffered from low 
elution recovery; most of whey protein component had an elution recovery less than 
80% in step elution using a salt-free buffer. Linear gradient elution was also 
performed to resolve single whey protein components but no baseline separation was 
observed. This was the first attempt at producing a hydrophobic membrane using the 
mixed matrix concept in the membrane chromatography field. 
 
For the first time, mixed mode interaction membrane chromatography was developed 
in a single membrane material using the mixed matrix preparation concept. 15 wt% 
of MP500 anion resin and 15 wt% SP Sepharose cation resin were added together to 
make a mixed mode interaction membrane. This membrane had a maximum static 
binding capacity of 41.877 g β-Lac g-1 membrane and 117.614 g LZY g-1 membrane. 
The membrane was successfully applied to bind acidic and basic proteins 
simultaneously from a mixture. A customized mixed mode MMM was also 
developed to achieve whey protein isolation in single pass, consisting of 42.5 wt% of 
MP500 anion resin and 7.5 wt% SP Sepharose cation resin. Both cross-flow and flow 
through operation was conducted for whey protein fractionation. Based on flow 
through experimental results, a productivity of 125 g whey protein L-1 membrane h-1 
was calculated using this customized mixed mode MMM. By using the mixed matrix 
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preparation concept, the ratio of the different types of adsorptive resin incorporated 
into the membrane matrix can be tailor-made for protein fractionation from specific 
feed streams, offering versatility in preparing novel and efficient membrane 
chromatography materials. 
 
8.2 Recommendations for future work 
In the present study, EVAL was used as a membrane base polymer at a fixed mass 
percentage of 15 wt% in DMSO and 1-octanol. All types of mixed matrix 
membranes prepared in this study were based on this composition. However, 
depending on the type of resin to be incorporated into the membrane matrix, there is 
a limitation of the amount of resin that can be loaded. As an example, due to the 
viscosity factor, only 20% of SP sepharose cation resin can be added into EVAL 
polymer solution compared to 50% of Lewatit MP500 anion resin. Therefore, the 
base polymer composition should be optimized for each type of resin used for 
making different types of MMM chromatography materials. This will lead to the 
optimum resin loading capacity and at the same time may produce better membrane 
structure and properties. 
 
Established polymers for membrane materials, especially hydrophilic polymers like 
cellulose, chitosan, polyamide, etc., can also be a good candidate as a base polymer 
for preparing MMM chromatography. At the same time, searching for different types 
of resin from different manufacturers should be continued in order to find a suitable 
resin with lower cost but comparable performance for protein binding. In terms of 
membrane configuration, the possibility to produce MMM chromatography in 
hollow fiber form for whey protein fractionation should be tested, to get the benefit 
of high surface area to volume ratio offered by this configuration. 
 
It was demonstrated in this study that the cross-flow mode offered a new alternative 
to operate membrane chromatography in a more promising way for whey protein 
fractionation. Unlike in column chromatography, which generally loads a single 
pulse of feed in a single pass, the flow through fraction (i.e. retentate and permeate) 
has a chance to re-load onto the column during the whey loading step to enhance the 
protein binding during cross-flow operation. However, the cross-flow condition and 
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process parameters need to be optimized to fully utilize the potential of membrane 
chromatography using this operation mode. 
 
The mixed mode interaction MMM prepared in Chapter 7, has the ability to adsorb 
both acidic and basic protein simultaneously. A proper elution strategy is necessary 
in order to elute the target protein of interest in an effective way. pH gradient elution 
might be one of the potential ways to obtain the bound protein from this kind of 
mixed mode MMM. Another type of mixed mode interaction membrane such as 
combination of hydrophobic and ionic interaction mechanisms may also be of 
interest for further membrane development. Unique separation ability was predicted 
by this type of membrane chromatography, especially for the protein separation that 
was previously governed by hydrophobic interaction chromatography. The salt 
concentration required for binding might be less by using this kind of mixed mode 
membrane compared to the same separation process using a hydrophobic interaction 
chromatography.  
 
The use of CLSM to visualize the protein bound within the membrane structure 
should be extended to mixed mode interaction MMM developed in this study in 
Chapter 7. By labelling basic and acidic proteins with different fluorescent dyes, we 
would be able to see the binding pattern in mixed mode interaction membranes using 
CLSM. This would help to explain the behaviour of protein binding and assist in 
developing an optimizing structure for mixed matrix membrane chromatography. 
Furthermore, the distribution of anion and/or cation resin inside the membrane 
matrix could be monitored using different types of ionic dyes.  
 
Mixed matrix membrane chromatography developed in the present study focused 
mainly on whey protein fractionation. Further exploration for different applications 
or feed stream is necessary in future work. In the current study, all whey 
fractionation processes were done at a lab scale, therefore pilot scale and scale up 
studies need to be done in further research. 
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Appendices 
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Appendix 1: Whey protein assay using 1 mL Resource RPC column according to 
protocol in section 3.8. 
 
y = 6911.76275x
R2 = 0.99956
0
200
400
600
800
1000
0.000 0.050 0.100 0.150
concentration, mg mL-1
pe
a
k 
a
re
a
α-Lac
Linear (α-Lac)
 
(a) standard curve for α-lactalbumin 
 
y = 2717.68922x
R2 = 0.99885
0
20
40
60
80
100
0.000 0.010 0.020 0.030
concentration, mg mL-1
pe
ak
 
ar
ea
LF
Linear (LF)
 
(b) standard curve for lactoferrin 
 
  A-2 
Continued appendix 1  
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Appendix 2: Quaternary protein assay using 1 mL Resource RPC column according 
to protocol in section 7.2.6.1. 
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Continued appendix 2 
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Appendix 3: Binary β-Lac and LF protein assay using 1 mL Resource RPC column 
according to protocol 7.2.6.2. 
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